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ABSTRACT 
Introduction. Despite a substantial prevalence of subthreshold Attention-
Deficit/Hyperactivity Disorder (ADHD) and research indicating that many youth with 
this disorder have impaired functioning and negative outcomes, few studies have 
considered patterns of symptom and functioning change for youth with probable ADHD, 
subthreshold ADHD and youth without ADHD transitioning from childhood to 
adolescence. Additionally, we are not aware of any studies examining predictors of 
impairment severity among youth with subthreshold ADHD, and few studies have 
examined predictors of treatment utilization and patterns of symptom and functioning 
change based on medication status for youth with subthreshold ADHD compared to 
youth with ADHD. Methods. This study utilized data from the South Carolina Project to 
Learn about ADHD in Youth (SCPLAY). After a two-phase screening, a sample of 
children at high and low risk (frequency-matched on gender) of ADHD and 
parents/caregivers were invited for interviews. The Jacobson & Traux reliable change 
index (RCI) and chi-square tests were used to examine patterns of (ADHD) symptom and 
functional impairment change and logistic regression methods were used to identify 
predictors of impairment severity and medication use. Results. At baseline interview, 
children were identified who met symptom criteria for subthreshold ADHD (N=84), 
probable ADHD (186), and probable non-ADHD (n=211) and patterns of change in 
symptoms and functioning were examined at follow-up (starting three years later) 
(n=292). Subthreshold ADHD symptoms were seen in as many as 17% (N = 84) of the 
vi 
youth studied at baseline. Youth (both non-ADHD and subthreshold ADHD at baseline) 
who achieved probable ADHD status at follow-up are more likely to show impaired 
functioning than individuals achieving subthreshold ADHD or non-ADHD status. Thirty 
three percent of youth who were subthreshold at baseline remained in that category at 
follow-up and 12%-21% showed significant decline in at least one domain of 
functioning. Youth who were subthreshold ADHD at baseline who were subthreshold at 
follow-up and taking medication (year prior to follow-up) declined in four of the five 
domains of functioning and youth who were subthreshold ADHD at baseline and 
probable ADHD at follow-up (and medicated the year prior to follow-up) declined in 
three out of five domains of functioning. Change in functioning, both improved 
functioning and worsened functioning, often occurred when there was no reliable or 
significant change in symptoms. In multivariable analyses, severe impairment was 
significantly predicted by psychiatric comorbidity among probable ADHD cases, being 
male among subthreshold ADHD, and primary parent psychiatric history and medication 
use among individuals without ADHD at follow-up. Use of ADHD medication the year 
prior to follow-up was significantly predicted by parent perceived burden in the 
subthreshold ADHD model and female gender in the probable ADHD model. 
Conclusions. The findings show the importance of examining both symptom and 
functioning constructs in the consideration of their unique contributions to ADHD and 
subthreshold ADHD diagnoses and of acknowledging the need to examine nuanced 
changes in diagnostic status during development. These findings may be relevant to 
efforts to intervene earlier in childhood and to help identify high-risk individuals who 
may be good candidates for targeted interventions. 
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Chapter 1  
INTRODUCTION 
BACKGROUND 
Attention-Deficit/Hyperactivity Disorder (ADHD) is a highly prevalent, 
persistent, heterogeneous, costly, and impairing disorder. In 2006, 7% (1.5 million) of 
American children aged 3-17 had ADHD (Bloom & Cohen, 2007). Using a strict 
diagnostic case definition, a recent longitudinal community-based study in South 
Carolina (SCPLAY) reported an 8.7% ADHD prevalence rate among children 5-13 years 
of age (M. L. Wolraich et al., 2012). Rates of parent-reported ADHD diagnosis increased 
3% annually from 1997 to 2006 (Pastor & Reuben, 2008), and by 2007, parents reported 
nearly one in ten American school-aged children had received a diagnosis (CDC, 2010). 
While diagnostic retention (maintaining full ADHD diagnostic status over time) 
rates vary, both clinical and community-based studies show that a considerable 
proportion of childhood ADHD cases persist into adolescence (Bussing, Mason, Bell, 
Porter, & Garvan, 2010; Polanczyk & Jensen, 2008). Symptom trajectory studies, those 
that determine the number of ADHD symptoms exhibited across recurring assessments, 
show a decrease in ADHD symptoms with increasing age; however, there is clear 
evidence of variable symptom persistence for many (Holbrook, 2012; Willoughby, 2003). 
The 1980’s marked the turning point when researchers began to refute the assumption 
that ADHD remitted by adolescence (Willoughby, 2003). Since that time, the perception 
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of ADHD has changed from characterization as a childhood disorder to that of a lifespan 
disorder (McGough & Barkley, 2004). 
ADHD is heterogeneous in terms of symptom and functional impairment 
expression and course. ADHD is characterized by hyperactive-impulsive and/or 
inattentive symptoms (present before age 7) that continue over time and cause associated 
social, academic, and/or occupational impairment in functioning in at least two settings 
(e.g., home and school) (American Psychiatric Association, 2000). ADHD expression 
reflects a dynamic interplay of individual characteristics and the circumstances of each 
child (Johnston & Mash, 2001). The clinical complexity of ADHD is also marked by 
frequent co-morbid disorders such as Oppositional Defiant Disorder (ODD), Depression, 
and Conduct Disorder (CD) (Steinhausen, 2009). 
The public health cost of ADHD is high both in fiscal and human terms. In the 
US, the annual societal cost of ADHD in childhood and adolescence is approximately 
$42.5 billion; an estimated yearly cost (health care, education, parental work loss, and 
juvenile justice cost data from 13 studies in 2005) of $14,576 for individuals with ADHD 
(W. E. Pelham, Foster, & Robb, 2007). In terms of the human toll, children with ADHD 
have marked impairments which impact many aspects of the individual’s life (Health, 
1998 Nov 16-18). Children with ADHD can experience adverse educational, vocational, 
economic and social-emotional outcomes which, in turn, have a profound impact on 
affected youth’s development, their families, schools, and society (Health, 1998 Nov 16-
18). Functional impairments, not symptom count or symptom severity drives these large 
fiscal and societal costs (Goldstein & Naglieri, 2009). 
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The developmental course of ADHD functioning from childhood to middle 
adolescence has been described by one researcher as “a bumpy road for many” 
(Mannuzza & Klein, 2000). Those who encounter prolonged underachievement and 
failure, associated with ADHD, may fare more poorly throughout life (Young & 
Gudjonsson, 2008) and childhood impairment is the best predictor of short- and long-
term outcomes for children and adolescents (Fabiano & Pelham, 2009). As a result of the 
significant ADHD-associated impairment experienced by youth, frequent utilization of 
health services, and the large personal, economic, and societal impact, ADHD is 
recognized as a major public health concern (W. E. Pelham, et al., 2007; Scahill et al., 
1999). 
STATEMENT OF THE PROBLEM 
Symptoms:  Only Part of the ADHD Developmental Course Picture 
Diagnostic retention and symptom trajectory studies, while valuable in helping to 
shape our understanding of the persistence of ADHD and ADHD symptomatology, only 
provide part of the ADHD developmental course picture. ADHD is a chronic condition 
for many, and although symptoms tend to decline over time, this does not necessarily 
mean that normalized functioning follows (Willoughby, 2003). Distress is caused more 
by impairment than symptoms, and impairment is the main reason for treatment referrals. 
(J. S. Owens, Johannes, & Karpenko, 2009). Impairment in daily function, rather than the 
number of symptoms, determines one’s quality of life (Goldstein & Naglieri, 2009) and 
allows for an understanding of service needs (Gordon et al., 2006). Measures of 
impairment are as important as measures of symptoms in determining diagnosis (Lahey et 
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al., 2004); and, measuring functional impairment is even more important in treatment 
planning than measuring symptoms (Lahey, et al., 2004). 
Functional Impairment:  An Understudied Area 
With regard to ADHD, much less research attention has been devoted to the study 
of impairment than the study of symptoms (Fabiano & Pelham, 2009). Relatively few 
studies have examined adolescents compared to children (Seidman, 2006), and more 
prospective studies of children transitioning to adolescence are needed (Willoughby, 
2003). The functional forms that developmental changes take are unclear, and potential 
heterogeneity in patterns of change is an understudied area (Willoughby, 2003). 
Assessing ADHD function is a weighty undertaking for clinicians and researchers 
from both legislative and insurance standpoints because assessment results have 
implications for youth obtaining treatment access (Canino, Costello, & Angold, 1999). 
Many federal and state agencies and insurance company policies include the presence of 
impairment as a requirement for service provision approval for ADHD (Canino, et al., 
1999). Decisions about the presence or absence or degree of impairment can affect 
treatment, referrals, estimates of geographical service area needs, income support awards, 
and eligibility of school services which in turn impacts youths' lives (Canino, et al., 
1999). Policies for assessment of impairment require that ADHD be evaluated using the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR; a guidebook used 
by professionals to make psychiatric diagnoses) criteria (American Psychiatric 
Association, 2000), but do not contain recommendations or guidance on measuring 
impairment (Canino, et al., 1999). The DSM-IV-TR, too, offers little guidance on how to 
measure impairment (Gordon, et al., 2006). 
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Youth with Subclinical ADHD: Need for Further Research 
Research indicates that a sizable number of youth, not meeting symptom criteria 
for a diagnosis of ADHD, experience significant functional impairment that may require 
intervention (Angold, Costello, Farmer, Burns, & Erkanli, 1999; Steinhausen, 2009). This 
subclinical group may have just as much impairment as youth who meet ADHD 
diagnostic criteria (Goldstein & Naglieri, 2009).Researchers considering subclinical 
ADHD have employed various terminologies (e.g., functional persistence, subsyndromal, 
subthreshold, symptomatic persistence, ADHD Not Otherwise Specified (NOS), ADHD 
residual type, and ADHD in partial remission). The term subclinical is used broadly in 
this study to include any of these diminished forms of ADHD. Definitions of subclinical 
ADHD often differ on the number of inclusionary symptoms, inclusion or exclusion and 
degree of impairment, and inclusion or exclusion of other ADHD diagnostic criteria. 
Chapter 1 provides a more in depth discussion of the nosological inconsistencies in the 
ADHD literature. This study uses subthreshold ADHD, a term proposed by the American 
Academy of Pediatrics in 1997, defined as three to five ADHD-HI or ADHD-IA 
symptoms (using the DSM-IV diagnostic criteria (S. Faraone et al., 2006). When 
referring to other studies or papers in which the authors use a different term for a 
subthreshold form of ADHD that term will be used. 
To date, there have been relatively few prospective longitudinal studies following 
subthreshold cohorts of youth. We are not aware of any studies examining predictors of 
impairment severity (e.g. socio-economic status, comorbidity, severity of symptoms, etc.) 
among youth with subthreshold ADHD and few studies have examined predictors of 
treatment utilization for youth with subthreshold ADHD compared to youth with ADHD 
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(Bauermeister et al., 2003; Leslie et al., 2005). This is an area in need of study because 
subthreshold ADHD (as with full ADHD diagnosis) is not a short-lasting problem and 
may not be outgrown. 
Youth who do not meet symptom count criteria, but demonstrate sufficiently 
impairing symptoms, are a group who may be denied services based on current policies 
(Canino, et al., 1999). For example, though children with subthreshold ADHD (meeting 
fewer than the required symptoms for a diagnosis) are more likely to have poor 
outcomes, they generally do not qualify for school or treatment services (Bussing, 2010). 
Children and adolescents who fail to achieve full diagnosis or full remission but continue 
to struggle with functional burden are a group in need of research and clinical attention 
(Karpenko, Owens, Evangelista, & Dodds, 2009). 
Symptom and Functional Impairment Trajectories: Patterns of Change 
Recently in the ADHD literature, two studies have emerged focusing on the 
poorly understood connection between reliable change in symptoms relative to 
functioning (E. B. Owens, Hinshaw, Lee, & Lahey, 2009; Rosenblatt & Rosenblatt, 
2002). “Reliable change” (RC) is a statistical approach to measuring an individual’s 
change in performance on a standardized outcome measure (e.g.,. symptomatology or 
impairment) (Jacobson & Truax, 1991). 
Clinically significant (CS) change involves calculating the Reliable Change Index 
(RCI) to determine if “the magnitude of change for a given client is statistically reliable” 
(Jacobson & Truax, 1991) and evaluating if scores move from a clinical to a normative 
distribution (Karpenko, et al., 2009). CS is often defined as return to normal functioning, 
or when the level of functioning at the follow-up time point is closer to the mean of an 
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individual (assesses change at the individual level) without ADHD than an individual 
with ADHD (Jacobson & Truax, 1991). 
Studies using CS change (Karpenko, et al., 2009) and RCI (Karpenko, et al., 
2009; E. B. Owens, et al., 2009; Rosenblatt & Rosenblatt, 2002) methodology confirm 
that change in functioning, both improved functioning and worsened functioning, often 
occurs when there is no reliable or significant change in symptoms. CS change may be 
overly conservative compared to the RCI method alone for certain disorders, especially 
ones in which a complete return to normal functioning is not expected (e.g. schizophrenia 
and ADHD) because, while declines in symptoms and improvement in functioning may 
occur, normative scores may only be achievable for a small number of individuals (J. S. 
Owens, et al., 2009). Even if someone does not return to the normal range of functioning, 
there is value in calculating the magnitude and direction of the impairment change (J. S. 
Owens, et al., 2009). Of the various methods proposed to measure reliable change, 
Jacobson and Traux’s method is recommended to enhance uniformity across studies (J. S. 
Owens, et al., 2009). 
Better understanding of the discordance between symptom and impairment 
change (i.e., change in either, but not both, symptoms or impairment) would help in the 
treatment decision making process (e.g., to continue or discontinue treatment/intervention 
or to focus on specific domains of functioning) (J. S. Owens, et al., 2009). There is a need 
for research in this area (Karpenko, et al., 2009) and to date, no studies have considered 
patterns of change between symptoms and functional impairment comparing children in 
the community with subthreshold ADHD to children with and without ADHD using 
longitudinal naturalistic data. A consideration of the complex processes through which 
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functional impairment trajectories unfold in relation to symptoms is the main focus of 
this study. 
PURPOSE OF THE STUDY 
Study Overview 
Project to Learn about ADHD in Youth (PLAY) is a joint collaboration 
research project with the University of South Carolina and the University of Oklahoma 
Health Sciences Center, funded by Centers for Disease Control and Prevention’s 
(CDC) National Center on Birth Defects and Developmental Disabilities (NCBDDD). 
PLAY is one of the largest community-based, epidemiologic investigations of ADHD in 
the United States. This study will utilize data from the South Carolina site (South 
Carolina Project to Learn about ADHD in Youth (SCPLAY)). 
Study Goals 
This study will examine the relationship between change in symptoms and 
reliable change in functioning in children and adolescents with ADHD, subthreshold 
ADHD, and children without ADHD who participated in the South Carolina Project to 
Learn about ADHD (SCPLAY). Subthreshold ADHD is defined here as youth identified 
as having three-to-five symptoms from either the inattentive or hyperactive/impulsive 
ADHD subtype symptom lists (using the DSM-IV-TR). This study will enrich the literature 
in several ways. First, while many studies have examined symptom trajectories, this 
study is one of only a small handful of ADHD studies that examines the relation between 
change in symptoms and domains of functioning (Gathje, Lewandowski, & Gordon, 
2008; Karpenko, et al., 2009; Kazdin, 1999; J. S. Owens, et al., 2009; Rosenblatt & 
Rosenblatt, 2002). Second, this study will use the Diagnostic Interview Schedule for 
Children Version 4 (DISC-IV) (Shaffer, Fisher, Lucas, Dulcan, & Schwab-Stone, 2000) 
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to longitudinally assess patterns of change in symptoms among youth with ADHD, sub-
clinical ADHD, and without ADHD. The DISC-IV is a highly structured, computer-based 
diagnostic interview used to assess psychiatric symptoms of children and adolescents. 
Third, the present study will incorporate parent/caregiver reports of functioning across 
multiple domains (social, classroom, home, leisure activity, and intrapersonal), using the 
Strengths & Difficulties Questionnaire (SDQ) (Goodman, 1999), to examine patterns of 
change between symptoms and functioning using individual-level analysis. The SDQ 
measure was selected because it allows for a consideration of functional impairment in 
youth with subthreshold ADHD and control children, whereas, the DISC-IV only 
assesses functioning in youth who meet symptom and other diagnostic criteria for 
ADHD. Fourth, this study is novel in that it is the first to evaluate the association between 
changes in symptoms and functioning based on treatment status (medicated/ not 
medicated) considering youth with probable ADHD, youth with subthreshold ADHD, 
and youth without ADHD in a community sample using the RCI methodology. Fifth, 
predictors associated with more severe forms of ADHD functional impairment will be 
explored to see if they are similar for youth with ADHD and youth with subthreshold 
ADHD. Finally, predictive factors associated with subthreshold ADHD medication use 
remain poorly understood; this study will identify child and family-related factors (e.g. 
impairment severity and parent reported burden) that predict medication use among youth 
with ADHD and youth with subthreshold ADHD. 
RESEARCH QUESTIONS 
Research Question 1:  How do youth with subthreshold ADHD, youth with ADHD 
and youth without ADHD change from baseline to follow-up with regard to patterns 
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of change in symptoms and domains (both specific and aggregate) of functioning? 
The 5 domains of functioning include social (friendships), school (classroom 
learning), home (home life), intrapersonal (self), and free time (leisure activities). 
Research Question 2:  Are the risk factors that are associated with more severe 
forms of ADHD functional impairment similar for youth with ADHD, youth with 
subthreshold ADHD and youth without ADHD? 
Research Question 3:  How do youth with subthreshold ADHD, and youth with 
ADHD change from baseline to follow-up with regard to patterns of change in 
symptoms and functioning (both specific domains and aggregate) based on treatment 
status? The 5 specific domains of functioning include social (friendships), school 
(classroom learning), home (home life), intrapersonal (self), and free time (leisure 
activities). 
Research Question 4:  Are the risk factors that are associated with ADHD 
medication use similar for youth with subthreshold ADHD compared to youth with 
ADHD? 
PUBLIC HEALTH SIGNIFICANCE OF THE STUDY 
Eight major goals addressing the public health mission of promoting mental 
health and treatment of mental disorders in children were outlined at the Office of the 
Surgeon General’s conference on Children's Mental Health: Developing a National 
Action Agenda on September 18 – 19, 2000 in Washington, DC (U.S. Public Health 
Service, 2000). In seeking to understand patterns of change between symptoms and 
functional impairment trajectories of youth and exploring predictors of impairment and 
service use, this research addresses four of the eight major public health goals outlined in 
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the action agenda:  1. Promote social, emotional, and behavioral well-being as an integral 
part of a child's healthy development; 2. Support research in developmental 
psychopathology to help clarify diagnoses, 3. Increase provider understanding of 
children's mental healthcare needs; and, 4. Increase research on diagnosis, prevention, 
treatment, and service delivery issues to address disparities in access to mental healthcare 
services, especially among different racial, ethnic, gender, and socioeconomic groups 
(U.S. Public Health Service, 2000). 
A better understanding of ADHD and subthreshold ADHD impairment and 
symptom persistence and medication use has major clinical, scientific, and public health 
relevance. Clinically, it may help in the design of targeted treatment strategies and 
improvement in patient outcome. Evaluating patterns of change between symptoms and 
impairment provides direct comparisons between individuals for a better understanding 
of individual needs. Clinically, pinpointing areas of individual need is important so that 
this information can be communicated clearly and meaningfully to caregivers and 
individuals with ADHD and diminished forms of ADHD. Improved understanding of the 
heterogeneity in the developmental characteristics that differentiate individuals with 
ADHD versus subthreshold ADHD related to symptom and functional impairment 
change would help clinicians who advise caregivers on matters related to prognosis, 
treatment, and course. 
This research can help identify individuals with a higher likelihood of 
experiencing severe impairment and service utilization. It can also identify patterns that 
have important implications for conceptualizing treatment in research and practice. 
Additionally, this research will add to the existing understanding of ADHD and 
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subthreshold diagnoses and explore RCI methodology that can be useful in interpreting 
community longitudinal data. From a public health perspective, this knowledge can help 
focus scarce societal resources toward youth at higher risk for persistent impairment. This 
will allow us to better target early intervention and secondary prevention initiatives, with 
the goal in mind of improving functioning of children and adolescents with subthreshold 
ADHD and ADHD.  
CHAPTER PREVIEW 
A review of the scientific literature relating to child and adolescent ADHD and 
subclinical ADHD developmental trajectories, predictors of impairment and service use 
is presented in Chapter 2. Chapter 3 describes study methodology including overall 
research purpose, study aims, questions, and hypotheses, participant screening and 
recruitment, study design, measurement, data collection and analysis. Two manuscripts 
are presented in Chapter 4 and include key study results. Chapter 5 provides a summary 
of research results and discusses study implications and recommendations for future 
research. 
TERMINOLOGY AND KEY CONCEPTS 
Adolescents:  Minors ages 13 through 17 years 
Attention-Deficit/Hyperactivity Disorder (ADHD):  The term ADHD is used here to 
refer to that subgroup of the population previously identified as attention deficit disorder 
(ADD) with hyperactivity and without hyperactivity (DSM-III) (American Psychiatric 
Association, 1980), ADHD (subtypes were discarded) (DSM-III-R) (American 
Psychiatric Association, 1987), ADHD-combined type and hyperactive-impulsive type 
(DSM-IV) (American Psychiatric Association, 1994) or, more recently predominantly 
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inattentive type (ADHD-I), predominantly hyperactive/impulsive type (ADHD-HI), and 
combined type (ADHD-C) (American Psychiatric Association, 2000). 
Burden:  “Effect the patient has upon the family, or the impact that living with the 
patient has on the family's daily routines and, possibly, health. Studies have found that 
caregivers experience relatively high levels of both objective burden (e.g., providing 
transportation, assisting the patient with daily tasks) and subjective burden (e.g., reduced 
caregiver well-being, worry)” (Angold et al., 1998). 
Caregiver:  Individual/s, over age 18, responsible for the direct care, safety, and 
supervision for the participant in this study. 
Children:  Children ages 6 through 12 years 
Diagnostic Retention Studies:  A strategy for investigating the developmental course of 
ADHD involving “identifying youth that met diagnostic criteria for ADHD (or its 
historical precedents) at one point in time and determining what proportion of these youth 
continued to meet diagnostic criteria at subsequent assessments” (Willoughby, 2003). 
Ecologic Level Data:  “Information limited to characteristics of aggregates (groups) of 
individuals” (Greenland, 2001). 
Group Level Analyses (statistically significant):  “Most studies use inferential 
statistical analyses to make conclusions about an average child/adolescent based on the 
differences between group means” (Karpenko, 2009). 
Impairment:  In the ADHD literature, impairment is conceptualized as the “negative 
impact of the symptom on the child’s functioning” (Fabiano & Pelham, 2009), the 
“consequences in reality that ensue from symptom expressions” (Goldstein & Naglieri, 
2009) and “An objectively measured assessment of a deviation from the mean for a broad 
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range of functional domains” (Danckaerts, 2010). Functional impairments are defined 
as “specific deficits in multiple domains of functioning developing subsequent to 
ADHD” (Winter, 2005). In this study impairment and functional impairment are used 
interchangeably. 
Individual Level Data:  “Individual level data denote information about individuals, 
either contributed by the individuals themselves in surveys etc., or collected from 
registers” (Hårfagres, 2012). 
Individual Level Analysis [clinically significant (CS)]:  “Change in treatment that is 
meaningful and noticeable to the individual client or to significant people in the client’s 
life” (Karpenko, et al., 2009). 
Medicated Group:  Participants who were taking ADHD medication (stimulant/non-
stimulant) 
Mental Health:  “A state of successful performance of mental function, resulting in 
productive activities, fulfilling relationships with other people, and the ability to adapt to 
change and to cope with challenges. Mental health is essential to personal well-being, 
family and interpersonal relationships, and the ability to contribute to community or 
society” (Healthy People 2020, 2012). 
Parent:  Parent or legal guardian (biological mother in most cases) 
Preschoolers:  Children ages 3 through 5 years 
Quality of Life (QOL):  “Describes an individual’s subjective perception of their 
position in life as evidenced by their physical, psychological, and social functioning” 
(Danckaerts et al., 2010). 
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Symptoms:  “Any subjective evidence of disease or of a patient's condition, i.e., such 
evidence as perceived by the patient; a change in a patient's condition indicative of some 
bodily or mental state” (Symptom. (n.d.), 2007). The focus of this study is on objective 
symptoms - “ones that are evident to the observer” (e.g. parent or teacher) (Symptom. 
(n.d.), 2007). One definition of symptoms provided by a well known ADHD researcher is 
“the physical, cognitive or behavioral expressions of an individual that may signal the 
presence of a disorder” (Barkley, 2010). 
Symptom Trajectory Studies:  A strategy for investigating the developmental course of 
ADHD by “determining the number of ADHD symptoms that individuals exhibit across 
repeated assessments” (Willoughby, 2003). 
Trajectory:  “The presentation of changes in functional status over time in terms of 
development” (Halfon & Hochstein, 2002). 
Youth:  Children and adolescents 
DSM Diagnostic Classifications 
ADHD In Full Remission:  “There are no longer any symptoms or signs of the disorder, 
but it is still clinically relevant to note the disorder” (American Psychiatric Association, 
2000). 
ADHD In Partial Remission:  “For individuals (especially adolescents and adults) who 
currently have symptoms that no longer meet full criteria…If clinically significant 
symptoms remain but criteria are no longer met for any of the subtypes, the appropriate 
diagnosis is ADHD, In Partial Remission” (American Psychiatric Association, 2000). 
ADHD Not Otherwise Specified (NOS):  “When an individual’s symptoms do not 
currently meet full criteria for the disorder and it is unclear whether criteria for the 
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disorder have previously been met, ADHD NOS should be diagnosed. Examples include 
1. Individuals whose symptoms and impairment meet the criteria for ADHD, 
Predominantly Inattentive Type but whose age at onset is 7 years or after; 2. Individuals 
with clinically significant impairment who present with inattention and whose symptom 
pattern does not meet the full criteria for the disorder but have a behavioral pattern 
marked by sluggishness, daydreaming, and hypoactivity” (American Psychiatric 
Association, 2000). 
ADHD Residual Type:  “DSM-III and DSM-IV (but not DSM-III-R) versions include an 
ADHD ‘residual type’ that could be assigned to an individual who previously had ADHD 
and currently have significant impairment but do not meet the full symptom count 
criteria” (Biederman, Mick, & Faraone, 2000). 
Non-DSM Diagnostic Classifications 
Functional Persistence:  Subjects who were functionally impaired with a Global 
Assessment of Functioning (GAF) score less than or equal to 60 (Biederman, 2011). 
Note: definitions vary from study to study. GAF considers psychological, social, and 
occupational functioning on a hypothetical continuum (0-100) of mental health-illness. 
(DSM-IV-TR, p. 34.) 
Remission:  “A loss of diagnostic status based on standardized measures of ADHD, 
minimal or no symptoms, and optimal functioning when individuals are being treated 
with or without medication” (Steele, Jensen, & Quinn, 2006). 
Subclinical:  Subclinical is often used more similarly to the term subsyndromal in the 
ADHD literature to mean exhibiting symptoms that are not severe enough for diagnosis. 
Little consensus for a definition exists and disparate definitions are used. For example, 
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one study created a subclinical ADHD outcome variable including 4 or 5 endorsed 
symptoms (Bussing, et al., 2010) while another study considered subclinical ADHD to be 
<6 symptoms (Fuemmeler, Østbye, Yang, McClernon, & Kollins, 2010). In this study, 
subclinical ADHD is used broadly to mean any diminished form of ADHD that does not 
meet full ADHD diagnostic criteria. 
Subsyndromal:  “Characterized by or exhibiting symptoms that are not severe enough 
for diagnosis as a clinically recognized syndrome” (Subsyndromal, 2012). This term is 
used less frequently in the ADHD literature than the term subclinical or subthreshold. 
Subthreshold:  “Subthreshold conditions are defined as slightly below the threshold for 
diagnosis” (Malmberg, Edbom, Wargelius, & Larsson, 2011). As proposed by the AAP 
in 1997, subthreshold is three to five ADHD-HI or ADHD-IA symptoms (using the 
DSM-IV diagnostic criteria) (S. Faraone et al., 2006). Some have included “without 
substantial functional impairment” in the definition (Scahill, et al., 1999). “Subthreshold 
ADHD seems to be a milder form of the disorder, or perhaps a heterogeneous group of 
true ADHD cases and false positives” (S. V. Faraone et al., 2007). Note: this definition is 
not in the DSM and no clear definition exists in the literature. This study uses the AAP’s 
definition of subthreshold ADHD. 
Symptomatic persistence:  Subjects meeting subclinical DSM criteria (more than half of 
the symptoms required for a full diagnosis) (Biederman, 2011). Note: definitions vary 
from study to study. 




Chapter 2  
LITERATURE REVIEW 
INTRODUCTION 
This review is intended to be an in-depth overview and discussion of the 
importance of symptoms and associated impairment for a better understanding of the 
developmental course of child and adolescent Attention-Deficit/Hyperactivity Disorder 
(ADHD). It begins with an inquiry into a longstanding theoretical debate on the 
authenticity of the disorder and current diagnostic perceptions. General background is 
provided regarding etiology, conceptualization and use of diagnostic criteria, the study of 
developmental trajectories, and efforts to bring together ideas on impairment from a 
variety of research, clinical, and measurement perspectives. Information related to 
ADHD treatment practices, predictors of impairment and treatment use is also provided. 
An analysis of research following individuals with subclinical forms of ADHD over time 
will offer the reader an understanding of what is known about functional impairment 
associated with insufficient symptoms to receive a diagnosis of ADHD, the main focus of 
this research. Analyzing ADHD developmental trajectory studies (that include a 
subclinical group) helped pinpoint gaps in the literature and formulate research questions 
that are explored in manuscripts I and II (see Chapter 4). 
This review is a systematic examination in that it: 1) makes a concerted effort to 
identify and methodically draw together the findings of the studies that are judged to be 
of acceptable quality for inclusion in the analysis; 2) categorizes studies in order to 
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narrow and elucidate what has and has not been explored to date, and 3) provides an up-
to date summary of the research investigating issues surrounding subclinical ADHD and 
impairment trajectories. 
Publications reviewed here were found by internet-based literature searches in 
PubMed, EBSCOhost, PsycLit, and Google Scholar. In addition, literature references of 
relevant papers, books, or other sources were explored. The focus of the review is mainly 
on papers published within the last 20 years, emphasizing recent findings. However, 
earlier work is referenced that highlights relevant historical or theoretical points. 
ADHD:  BACKGROUND, DIAGNOSTIC CONCEPTUALIZATION, & DEVELOPMENTAL 
PERSPECTIVE 
Debate:  Does ADHD exist? 
Attention-deficit/hyperactivity disorder (ADHD) is considered by some to be an 
“unsatisfactory umbrella term applied to children with widely differing temperaments and 
functional problems, but sharing certain core features” (Halasz & Vance, 2002). That 
sentiment reflects a longstanding theoretical debate over whether ADHD is a real 
disorder or a social catch-all construct with a poorly identified biological threshold 
(Amaral, 2007). In a letter to the editor, Amaral argues that “it is in defining such a 
diagnostic threshold that lies the social construction, as the boundaries of normality in a 
given region are set by psychiatrists (by choosing and applying diagnostic criteria) and 
society (by recognizing symptoms as deserving of medical care)” (Amaral, 2007). In 
reply, Polanczyk and Rohde maintain that while diagnostic criteria for mental disorders 
are based on theoretical concepts, the validity of ADHD is supported by empirical 
evidence (Polanczyk & Rohde, 2007a). 
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Evidence Suggests ADHD is Underdiagnosed 
There is a common public perception and media portrayal that ADHD is 
overdiagnosed (Sciutto & Eisenberg, 2007). A review of prevalence studies shows there 
is not sufficient evidence to suggest that ADHD is systematically over-diagnosed (Sciutto 
& Eisenberg, 2007). While that may occur in some cases, there is stronger evidence that 
ADHD is often under-diagnosed (Adler, Spencer, Stein, & Newcorn, 2008), and 
consequently, under-treated (Cuffe, Moore, & McKeown, 2009; Vierhile, Robb, & Ryan-
Krause, 2009). For example, one study, using 2001-2004 National Health and Nutrition 
Examination Survey (NHANES) data, found among the children who met ADHD DSM-
IV criteria at the time of the survey, only 47.9% had a previous diagnosis and only 32.0% 
had been treated with ADHD medications over the past year (Froehlich et al., 2007). 
Using data from the National Health Interview Survey, Cuffe et al. (2009) found that 
although children with a probable diagnosis of ADHD saw a mental health provider or 
general doctor significantly more often than children without ADHD, 40% of children 
with ADHD saw neither health professional in the last year and only 48% of males and 
41% of females were reported to have taken medication for ADHD in the last 3 months. 
ADHD Etiology 
ADHD is a disorder of multifactorial (e.g., neurological and genetic) etiology 
(Nigg, 2006). Differences in functional trajectories are shaped by the dynamic and 
continuous interplay between biology and environmental factors (e.g., individual, family, 
and social experiences) over a lifetime (Halfon & Hochstein, 2002). A brief overview of 
neuro-biological factors (including genetics) of ADHD followed by a discussion of 
psychosocial and environmental factors in the expression of ADHD is provided below. 
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ADHD is the most heritable of all psychiatric conditions (Stephen P. Hinshaw & 
Blachman, 2005). ADHD clusters in families (Rowland, Lesesne, & Abramowitz, 2002) 
and twin and adoption research indicates that genetic factors contribute to the etiology 
and continuity of ADHD symptoms (Thapar, Langley, Owen, & O'Donovan, 2007). Due 
to the heterogeneity of ADHD it is thought that a strong genetic component exerts 
influence over the expression of ADHD symptoms (Swanson et al., 2001). It seems likely 
that genetic vulnerability is caused, not by one or two genes, but by the small 
contributions of many genes (Steinhausen, 2009). 
There are differences in brain structure and functioning in children with and 
without ADHD. Structurally, overall brain volume is lower and specific brain areas (e.g. 
the pre-frontal cortex, part of the frontal lobe involved in weighing alternatives and 
inhibiting responses or impulses) appear to be smaller in children with ADHD compared 
to children without ADHD (Castellanos et al., 2002; Krueger & South, 2009). Regarding 
functioning, recently published findings provide evidence for multiple and persistent 
neural processing deficits in ADHD (Doehnert, Brandeis, Imhof, Drechsler, & 
Steinhausen, 2010). Such findings do not support the developmental lag theory (where 
attention problems in ADHD become smaller and disappear as the brain matures) (Shaw 
et al., 2007) and instead suggest a persistent developmental lag that is not outgrown 
(Steinhausen, 2009). 
While clarity regarding etiology of ADHD is emerging, data is lacking to support 
the use of diagnostic tests or biomarkers to diagnosis ADHD (McGough & Barkley, 
2004). Until such tests and biomarkers are established, ADHD will remain what Halasz 
calls a “nosological conundrum” and McGough a “clinical diagnosis” (McGough & 
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Barkley, 2004). The Diagnostic and Statistical Manual of Mental Disorders (4th edition-
Text Revision (DSM-IV-TR)) (American Psychiatric Association, 2000) is a classification 
system utilizing evidence-based criteria, is designed to establish a reliable and valid 
diagnosis, (Rohde, 2008) and offers a temporary solution for diagnoses until the causes of 
ADHD are better understood (Lollar, 2008). Some argue that, because ADHD is 
classified as a neurobiological condition, functional impairment should be assessed and 
considered an outcome but not included in the diagnostic criteria (Lollar, 2008; Stein, 
2007). However, until the DSM is able to classify ADHD on the basis of etiology, the 
DSM is limited to using symptoms and functioning to distinguish between wellness and 
illness (McIntyre, Fallu, & Konarski, 2006). 
Differences in Clinical Expression 
While uncovering physiological and biological underpinnings of ADHD 
symptoms is of utmost importance, psychosocial and environmental variables deserve 
greater consideration in research (Wolf & Wasserstein, 2001). It is these critical variables 
that interact with biological vulnerability to shape symptom expression (Brassett-
Harknett & Butler, 2007), impairment (Biederman et al., 1995), and comorbidity (S. 
Hinshaw, 1999). Gene expression, for example, is considered dynamic in nature, not 
static; that is, reacting to and interacting with environmental experiences (Kendler, 1995) 
and significant associations of genes thought to be linked to ADHD account for less than 
5% of explained behavioral differences (Steinhausen, 2009). 
There is ample research evidence demonstrating environmental influences on 
ADHD expression. One intervention study demonstrated improvements in children’s 
ADHD symptoms, when parents were coached in parenting skills (Sonuga-Barke, Daley, 
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Thompson, Laver-Bradbury, & Weeks, 2001). Findings from gene/environment studies 
provide evidence suggesting environmental factors such as family adversity moderates 
the impact of genotype on the expression of ADHD symptoms (Laucht et al., 2007). 
Environmental factors are often critical in promoting or diminishing the risk to a child’s 
academic and social functioning and eventual outcome (Halasz & Vance, 2002). 
Clinical expression of ADHD is also influenced by associations with comorbidity, 
gender effects, and the impact of the disorder on psychosocial functioning (also known as 
impairment) (Steinhausen, 2009). A brief discussion of comorbidity and gender effects is 
provided here. Later, an analysis of the literature pertaining to patterns of change between 
symptom change and functional impairment among youth with ADHD, youth with 
subclinical ADHD and youth without ADHD is provided (the main focus of this literature 
review). 
ADHD Comorbidity 
ADHD is often correlated with and exists alongside other psychiatric conditions 
at greater than chance levels, especially in adolescents (Biederman et al., 2006; Gordon, 
et al., 2006). The probability of having oppositional-defiant disorder (ODD), conduct 
disorder (CD), anxiety, antisocial, obsessive-compulsive disorder, post-traumatic stress 
disorder, mood disorder, cognitive performance and learning disorders, tic disorder, or 
substance use disorder is significantly enhanced in the presence of ADHD (Biederman, et 
al., 2006; Gordon, et al., 2006). Approximately 50% of children with ADHD develop 
either ODD or CD.(Pliszka, 1998). Conduct Disorder (CD) is characterized by a pattern 
of aggression toward others and or serious violations of rules, laws, and social norms and 
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ODD is a pattern of behaving negatively and defiantly toward adults or others (American 
Psychiatric Association, 1994). 
Youth with ADHD tend to experience more functional impairment if comorbid 
disorders are present (Biederman et al., 1996). In a recent review, it was noted that 
children with both conduct problems and ADHD show a worse course than children with 
either disorder alone (Waschbusch et al., 2002). Youth with ADHD and comorbid ODD 
or CD tend to have more severe social impairment than children with ADHD alone 
(Nijmeijer et al., 2008). 
ADHD & Gender 
Gender may affect vulnerability to ADHD, as boys are diagnosed with ADHD 2.4 
times more often than girls (Polanczyk & Jensen, 2008). There are fewer females than 
males with ADHD represented in epidemiological and clinical samples (Steinhausen, 
2009), and research involving community samples of females of varying ages is an area 
in need of further research (Rohde, 2008). Girls, especially those with inattention 
problems are more likely to be under-referred, and less likely to be diagnosed and treated 
than boys (Stephen P. Hinshaw & Blachman, 2005; Staller & Faraone, 2006). 
Evidence suggests that girls with ADHD, similar to boys with ADHD, exhibit 
high levels of social, cognitive, academic, and personal impairment, across multiple 
domains (Stephen P. Hinshaw & Blachman, 2005; Staller & Faraone, 2006). Results from 
a meta-analysis of clinic referred and non-referred children found no gender differences 
in social and peer and academic performance (Gaub & Carlson, 1997). More research is 
needed to better understand symptom and impairment trajectories of girls with ADHD 
(S.P. Hinshaw, Owens, Sami, & Fargeon, 2006). 
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Among the three ADHD subtypes, girls are most likely to present with inattentive 
type, compared to boys (Staller & Faraone, 2006), and children often do not present 
clinical levels of impairment for inattention until middle school or later (Barkley & 
Biederman, 1997). For girls, problems may be pronounced by the time they are referred, 
and levels of impairment may increase through adolescence (Stephen P. Hinshaw & 
Blachman, 2005). This is concerning, because if impairment is not detected until late 
elementary or middle school, they may not receive a diagnosis because of the age seven 
onset diagnostic requirement (diagnostic criteria discussed below) (Stephen P. Hinshaw 
& Blachman, 2005). 
Current Diagnostic Criteria 
A diagnosis of ADHD is often made using guidelines outlined in the DSM-IV-TR 
which specifies five diagnostic criteria (criteria A-E) for ADHD (American Psychiatric 
Association, 2000). Criterion A categorizes symptom presentation into inattention and 
hyperactivity/impulsivity dimensions, from which three ADHD ‘types’ or ‘subtypes’ are 
derived. The first dimension includes nine symptoms of inattention and makes up the 
ADHD Predominantly Inattentive Type (ADHD-I). It includes behaviors such as “often 
fails to give close attention to details,” “often loses things,” and “often forgetful in daily 
activities” (American Psychiatric Association, 2000). The second dimension contains six 
symptoms of hyperactivity (e.g., “often “on the go”” and “often talks excessively”) and 
three symptoms of impulsivity (e.g., “often has difficulty awaiting turn” and “often 
interrupts”) (American Psychiatric Association, 2000). This dimension makes up the 
ADHD Predominantly Hyperactive-Impulsive Type (ADHD-HI). The ADHD Combined 
Type (ADHD-C), includes all 9 ADHD-HI and all 9 ADHD-I symptoms (18 in total). 
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ADHD diagnosis requires endorsement of six (or more) of the nine symptoms for 
ADHD-I and ADHD-HI diagnosis and 12 (or more) for ADHD-C diagnosis. Diagnostic 
criteria requires that symptoms have persisted for at least 6 months that are maladaptive 
compared to individuals of similar developmental stage (American Psychiatric 
Association, 2000). 
Criterion B-E states the following:  “B: Some hyperactive-impulsive or inattentive 
symptoms that caused impairment were present before age 7; C:  Some impairment from 
the symptoms is present in 2 or more settings (e.g., at school [or work] and at home); D:  
There must be clear evidence of clinically significant impairment in social, academic, or 
occupational functioning;” and E:  Symptoms are not better accounted for by another 
mental disorder (American Psychiatric Association, 2000). 
Categorical vs. Dimensional ADHD Model 
Identifying an individual as having or not having ADHD is an oversimplification 
of a dimensionally complex disorder. The DSM-IV adopts a categorical (“by kind”) 
rather than a dimensional (“by degree”) model of ADHD with subtypes being considered 
qualitatively distinct symptom domains (Sonuga-Barke, 1998; Wilson, 1993). In the 
general population, hyperactive, inattentive and impulsive behaviors are continuously 
distributed with no clear distinction between behavior that is normal or abnormal 
(Buitelaar & Rothenberger, 2004). Epidemiological evidence supports the dimensional 
view of ADHD, with symptoms and impairments lying at the upper end (Shaw et al., 
2011). However, for practical clinical decision making and research considerations, 
categorical distinctions are often used (Rohde, 2008). This is similar to the identification 
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of hypertension where blood pressure is thought to be a dimensional construct, yet use of 
a clinical cut-off point is standard practice (Rohde, 2008). 
Subtype Information 
The purpose of subtypes is to clarify the heterogeneous nature of ADHD to aid 
clinical and research practice (Lahey & Willcutt, 2010). Recent studies challenge current 
subtype classifications (Rohde, 2008). Longitudinal evidence suggests high levels of 
subtype diagnostic instability, temporal instability, and an inability to distinguish 
subtypes on the basis of treatment response and separable factors for inattention and 
hyperactivity/impulsivity and functional impairment (Lahey, Pelham, Loney, Lee, & 
Willcutt, 2005; Riley et al., 2008; Todd et al., 2008; Valo & Tannock, 2010). Several 
researchers have recently called for the need to replace the categorical subtypes with a 
focus on dimensional case identification of ADHD using severity or counts of symptoms 
and resultant impairment (Lahey & Willcutt, 2010; Lubke, Hudziak, Derks, van 
Bijsterveldt, & Boomsma, 2009; Rowland et al., 2008; Valo & Tannock, 2010). 
Information related to subtype instability is discussed in greater detail in the symptom 
trajectory studies section. 
Evolution of Diagnostic Criteria 
Since the first publication in 1952, the DSM went from listing 106 to 182, to 265 
to 292, and to 297 diagnostic categories with each successive edition (DSM-I to DSM-II, 
DSM-III to DSM-III-R, to DSM-IV, respectively) (Wikipedia contributors, 2012). 
Diagnostic conceptualization of ADHD has changed substantially over time when it was 
first included in the DSM-II as ‘hyperkinetic reaction of childhood’ (American 
Psychiatric Association, 1968). DSM-III was the first version to include inattention as a 
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diagnostic component for what was then called attention deficit disorder (ADD) 
(Biederman, Petty, Evans, Small, & Faraone, 2010). 
In the 80’s and 90’s, large epidemiological studies such as the National 
Comorbidity Survey (NCS) demonstrated that DSM diagnostic criteria at the time (DSM-
III-R) did not differentiate well between people with and without impairment who met 
symptom count criteria (less severe disorder from more severe disorder) (Regier, 2003). 
This finding affirmed the need to reconsider and revise diagnostic criteria for mental 
disorders and the assessment of clinical significance (Regier, 2003). While increasing the 
number of symptoms required for an ADHD diagnosis was suggested by some, the DSM-
IV (published in 1994), required “clinically significant” impairment in addition to the 
required number of symptoms (Regier, 2003). 
DSM-III and DSM-IV (but not DSM-III-R) versions include an ADHD "residual 
type" that could be assigned to an individual who previously had ADHD and currently 
have significant impairment but do not meet the full symptom count criteria (Biederman, 
et al., 2010). These subclinical  categories are important because considering only full-
syndrome ADHD may overlook an important group of children and be an 
oversimplification of a more nuanced problem (Barnow, Schuckit, Smith, & Freyberger, 
2006). To be clinically important, any reduced definition of ADHD should be associated 
with impairment (Mick, Faraone, & Biederman, 2004). 
Other DSM reduced ADHD definitions include ADHD in Partial Remission 
(ADHD-IPR) and ADHD Not Otherwise Specified (ADHD-NOS). ADHD-IPR (similar 
to ADHD ‘residual type’) is assigned when symptoms no longer meet full criteria for any 
of the subtypes but some symptoms or signs of ADHD remain (American Psychiatric 
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Association, 2000). ADHD-NOS, is defined in the DSM-IV as “prominent symptoms of 
inattention or hyperactivity-impulsivity that do not meet criteria for ADHD” (American 
Psychiatric Association, 2000). Examples included for the use of ADHD-NOS include 
the following: 1.  For individuals meeting symptom and impairment criteria but not 
meeting the age of onset criteria and, 2. For individuals who present with clinically 
significant impairment but do not meet symptom count criteria (American Psychiatric 
Association, 2000). 
According to the vague descriptions provided in the DSM, it is not clear how to 
determine if a child meets criteria for these reduced ADHD definitions (Leslie, 2002). 
For example, “the number of symptoms required for 'prominence' or the degree of 
impairment necessary” are not provided (Bauermeister et al., 2011). Nor is it clear from 
the literature if there is a distinct difference between terms such as ADHD-NOS and 
ADHD-IPR; or if they can be used interchangeably. 
This review provides a consideration of timely topics as the research and clinical 
community awaits the publication of the fifth edition of the DSM in 2013. Discussions 
such as how to treat and define subsyndromal ADHD continue as the new DSM edition is 
prepared (Bauermeister, et al., 2011). Despite decades of research and scientific strides 
that have improved our understanding of ADHD, Barkley writes of the new manual, 
“Much work remains to be done as we seek to identify more rigorous diagnostic criteria 
for ADHD that amend the already considerable and useful work that has gone into prior 
DSMs” (Barkley, 2007). 
 
30 
Inconsistencies in Adoption and Use of DSM Diagnostic Criteria 
Conceptually, measurement of ADHD in children and adolescents is 
straightforward. Based on the DSM-IV diagnostic criteria, measurement requires a 
certain number of symptoms, the presence of impairment, age and duration criteria, and 
assessment from multiple perspectives and in multiple contexts. Methodologically, 
however, diagnosing ADHD is challenging and ambiguous (Stein, 2007). Measurement 
variability, subjective interpretations, and controversy regarding measurement approach 
abound in the literature. Understanding current diagnostic measurement obstacles is 
important both for illuminating the challenges that clinicians and researchers face given 
the diagnostic limitations of the DSM-IV and to cover salient measurement topics related 
to this study. 
Variation in the use of DSM-IV diagnostic criteria exists across practitioners, 
research and geographic areas and may result in missed or inappropriate diagnosis 
(Magyary & Brandt, 2002). After finding wide variations in clinical treatment of ADHD 
in 1998, an expert panel on the diagnosis and treatment of ADHD concluded that there 
was a real need for improved ADHD assessment and follow-up (Health, 1998 Nov 16-
18). Evidence based practice guidelines (based on DSM-IV criteria) for diagnosis and 
treatment of ADHD were published by both The American Academy of Child and 
Adolescent Psychiatry (AACAP; 1997)
 
and the American Academy of Pediatrics (AAP; 
2000) (Dulcan, 1997; Homer et al.). Years after the National Institute of Health (NIH) 
expert panel call for improvements, literature on ADHD measurement is far from 
standardized (Rushton, Fant, & Clark, 2004) and comprehensive assessments are often 
not provided to children (Rosenblatt & Rosenblatt, 2002; Stein, 2007). 
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Equally disconcerting is the fact that since 1980, when guidelines requiring the 
consideration of impairment were adopted and the Global Assessment of Functioning 
(GAF) (an impairment measure) included in the DSM-III, symptom criteria alone are still 
used to diagnose ADHD by some researchers and clinicians (Gathje, et al., 2008). 
Impairment instruments are not routinely used in research and clinical practice (Gordon, 
et al., 2006), in spite of the DSM-IV diagnostic requirement that “there must be clear 
evidence of clinically significant impairment in social, academic, or occupational 
functioning” (American Psychiatric Association, 1994). The lack of adherence to 
diagnostic standards has treatment implications. One community study documented that, 
while 72% of children received stimulant medication during a four year period, parents 
did not report any impairing ADHD symptoms for the majority of those children 
(Angold, Erkanli, Egger, & Costello, 2000). 
The reason for inconsistencies in the adoption and use of DSM diagnostic criteria 
related to impairment is likely due to several reasons. Barkley pinpointed one reason 
when he wrote, “for many years, we have erroneously assumed that higher scores on our 
tests and absence or reduction in symptoms equated with less impairment and better 
quality of life” (Goldstein & Naglieri, 2009). Other reasons could be a belief that there is 
no difference between symptoms and impairment (Mannuzza et al., 2011) or a lack of 
clarity on identifying and measuring impairment (Gathje, et al., 2008). 
Examples of inconsistencies in the adoption, use, and understanding of DSM 
diagnostic criteria abound in the literature. As recently as the late 90’s, researchers wrote, 
“Indeed, when the symptoms of ADHD remit, the functioning of the child normalizes” 
(Biederman, Mick, & Faraone, 1998) and “impairment can be captured through careful 
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measurement of symptom severity” (Scahill, et al., 1999). Disparate definitions for all of 
the subsyndromal ADHD categories are widespread in the literature. ADHD-IPR in one 
study was defined as “reserved for adults who met the criteria for ADHD in childhood 
and continue to have significant symptoms and impairment that fell below the threshold 
for the full diagnosis” (McGough & Barkley, 2004) whereas another study defined 
ADHD-IPR as “continuing impairment, but failure to meet full diagnostic criteria based 
on ADHD symptoms” (Sciberras, Roos, & Efron, 2009). 
SUBCLINICAL ADHD 
Some researchers concerned with studying subclinical ADHD syndromes have 
relied on the DSM-based classifications of ADHD (those described above), while others 
have adopted the APA definition of subthreshold ADHD. Subthreshold ADHD is a 
category proposed by the AAP in 1997 that, like the DSM definitions, provides an 
alternative to narrowly dichotomizing ADHD (Scahill, et al., 1999). This “subclinical 
syndrome” is typically defined as having a “chronic history” of three-to-five ADHD-HI 
or ADHD-IA symptoms (using the DSM-IV diagnostic criteria) (S. Faraone, Kunwar, 
Adamson, & Biederman, 2009). Researchers considering subthreshold ADHD have 
employed various definitions, differing on the number of inclusionary symptoms, 
inclusion or exclusion and degree of impairment. For example, some have included 
“without substantial functional impairment” in the definition (Rogers, Hwang, Toplak, 
Weiss, & Tannock, 2011; Scahill, et al., 1999). 
Subthreshold ADHD is more prevalent than ADHD (Lewinsohn, Shankman, Gau, 
& Klein) with up to 22% of youth exhibiting subclinical inattentive and hyperactive 
subthreshold symptoms (Scahill et al., 1999), yet there are very few follow-up studies on 
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the longitudinal course of subthreshold ADHD. Subthreshold ADHD is a risk factor for 
developing ADHD (Shankman et al., 2009) and expressed from the same set of genes as 
ADHD (Levy, Hay, McStephen, Wood, & Waldman, 1997). Further, youth with 
subclinical ADHD may have less (Galéra, Melchior, Chastang, Bouvard, & Fombonne, 
2009) or just as much impairment as youth who meet ADHD diagnostic criteria 
(Bagwell, Molina, Pelham Jr, & Hoza, 2001) and were as likely to develop later 
psychopathology as children meeting symptom count but not impairment (Angold, et al., 
1999; Shankman, et al., 2009). 
While some have raised questions about the validity of subthreshold ADHD (S. 
Faraone, et al., 2006), clinical research evidence shows this milder form of ADHD 
(Mason, Walker, Wine, Knoper, & Tercyak, 2007) to be a “clinically meaningful” and 
“valid” target population (Costello & Shugart, 1992; Scahill, et al., 1999) and deserving 
further research attention (S. V. Faraone et al., 2006). Identifying children with 
subthreshold levels of ADHD allows for examination of psychosocial correlates and 
comparisons with children who meet full ADHD criteria and with children who do not 
have ADHD. From a public health standpoint, subthreshold ADHD may have similar risk 
factors as ADHD and be a useful designation for targeted interventions and for 
preventing “further functional decline” (Scahill, et al., 1999). 
METHODS AND MEASUREMENT 
Diagnostic Retention Studies 
Since the early 70’s, the temporal stability of ADHD has been extensively 
explored through both epidemiological community samples and clinic-referred samples 
in the United States (S. V. Faraone, Biederman, & Mick, 2006; Mannuzza, Klein, & 
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Moulton, 2003; Willoughby, 2003). The first longitudinal studies of ADHD persistence 
were clinic-based, diagnostic retention studies, identifying youth meeting diagnostic 
criteria for ADHD at one point in time and seeing what proportion still met criteria at a 
later point in time (Willoughby, 2003). The results of these studies have since been called 
into question, as critics often attribute the wide variance in reported prevalence over time 
to differences in early study methodology (S. V. Faraone, J. Biederman, & E. Mick, 
2006; Polanczyk & Rohde, 2007b). While diagnostic continuity of ADHD has been 
studied using different diagnostic criteria and assessment procedures, ADHD is 
considered to be a persistent disorder (Bauermeister, et al., 2011).  
One study, comparing different diagnostic approaches found that childhood 
ADHD persists into young adulthood in 58% of the cases when DSM-IV criteria (parent 
report) are used and in 66% of the cases when developmentally relative criteria (+2 SDs 
above the normal mean) (parental report) (Barkley, Fischer, Smallish, & Fletcher, 2002). 
These findings are higher than Lara et al. (2009) who found approximately 50% of 
childhood cases, across 10 countries, continued to meet full diagnostic criteria for ADHD 
into adulthood. Diagnostic stability is higher for younger (4-6) children than for late 
childhood to early adolescence (Steinhausen, 2009).  
Diagnostic retention studies have several significant drawbacks. They do not 
clarify changes in ADHD as a function of development (Willoughby, 2003). They apply 
diagnostic criteria (DSM) that is continually revised and was developed for children 
(males specifically) to adolescents and adults (Willoughby, 2003). And, they are 
categorical in nature and provide a narrow view of development (Willoughby, 2003). 
Studies showing marked ADHD remission rates (loss of full diagnostic status) over time 
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may be deceptive because they do not distinguish levels of subclinical ADHD symptoms 
and impairment (Biederman, 2011; Willoughby, 2003). As one researcher writes, “It is 
technically correct that those diagnosed with ADHD in childhood who reach adulthood 
with one less symptom of the disorder may no longer satisfy criteria for ADHD, but it is 
clinically dubious to equate the absence of full syndromic status with full recovery” 
(Biederman, 2011). 
Symptom Trajectory Studies 
There has been an emergence of interest in ADHD symptom trajectory research 
over the past two decades and a shift away from a focus on solely identifying diagnostic 
retention or outcomes. Symptom trajectory studies determine the number of ADHD 
symptoms exhibited across repeated assessment time points (Willoughby, 2003). 
Symptom trajectory studies of ADHD are less common than diagnostic retention studies 
and often use clinic-based samples; however, they may be more useful than diagnostic 
retention studies in establishing the developmental course of ADHD (Willoughby, 2003). 
Hart et al, (1995) undertook the first longitudinal symptom trajectory study using 
DSM-III-R diagnostic criteria, and structured diagnostic interviews in both baseline and 
follow-up assessments. One hundred and six clinic-referred boys (aged 7 to 12 years at 
baseline) were assessed annually for four years and results showed a decline in symptoms 
of ADHD-HI over time with increasing age, whereas symptoms of ADHD-I declined 
from the first to the second assessment period but remained stable after that (Hart, Lahey, 
Loeber, Applegate, & Frick, 1995). Since then, other follow-up studies have shown that 
inattention symptoms are more likely to persist into adolescence and adulthood (S.P. 
Hinshaw, et al., 2006; Lara et al., 2009; Holbrook, 2012). 
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Biederman et al. reanalyzed study data using symptom trajectories as a function 
of chronological age and, similar to Hart (Hart, 1995), found hyperactivity/impulsive 
symptom mean declined with age, whereas the inattentive symptom mean remained 
stable (from age 8 to 15 years) (Biederman, et al., 2000). This was a change from their 
previous analysis which “modeled outcome variables as a function of group (ADHD 
versus control), age (child versus adolescent), and their interaction” and found no 
difference in the mean number of ADHD symptoms between children and adolescents 
with ADHD (Biederman et al., 1998). 
Studies also show persistence rates increase when subclinical diagnoses are 
included in the follow-up criterion (Bauermeister, et al., 2011; S. V. Faraone & 
Biederman, 2005). A meta-analysis showed ADHD persistence rates varied from 4% to 
more than 86% (S. V. Faraone, J. Biederman, & E. Mick, 2006). They demonstrated that 
rates of diagnostic persistence are dependent on how persistence is defined (S. V. 
Faraone, J. Biederman, & E. Mick, 2006). Including 32 prospective studies of 
“syndromic persistence” (maintaining full ADHD criteria) and “symptomatic 
persistence” (maintaining partial ADHD symptom criteria), results showed that if only 
diagnostic retention (syndromic persistence) criteria were used only about 15% of adults 
retained a diagnosis of ADHD whereas the rate increased to approximately 65% if 
symptomatic persistence (ADHD-IPR) criteria were employed (S. V. Faraone, J. 
Biederman, & E. Mick, 2006). Study findings since the 2006 review have been mostly 
consistent (Sciberras, et al., 2009).  
Hinshaw et al. (2006) prospectively assessed a sample of 126 preadolescent girls 
with ADHD 5 years after their diagnosis. While the overall diagnostic retention rate was 
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92%, they found a majority of girls (63%) with ADHD-IA retained that status at the 5 
year follow-up. In contrast, most girls with ADHD-C at baseline either reverted to 
ADHD-I subtype at follow-up due to a loss of HI symptoms (24%) or to a nonclinical 
ADHD status (34%) rather than retaining the ADHD-C subtype (39%) (S.P. Hinshaw, et 
al., 2006). 
One study found 37% of children with ADHD-C and 50% of children with 
ADHD-I met criteria for a different subtype at least twice during six years (baseline age 
4-6) of follow-up assessments and almost all children with ADHD-HI either remitted or 
changed to another subtype by year eight (Lahey, et al., 2005). A longitudinal study of 
twins with ADHD found that the 5-year subtype stability (using DSM-IV criteria) from 
childhood to adolescence was poor; 11.1% for ADHD-HI, 17.7% for ADHD-IA, and 
24.0% for ADHD-C (Todd, et al., 2008). Riley et a., found no significant subtype 
differences between ADHD-IA and ADHD-C for social skills or academic functioning 
(Riley, et al., 2008) supporting suggestions that ADHD-HI may be a precursor to ADHD-
C rather than a distinct subtype (Lahey, et al., 2005; Riley, et al., 2008) 
Methodological Variations Impacting ADHD Prevalence & Persistence 
In addition to methodological variation resulting from the use of different 
definitions for outcome terms such as persistence and remission (as discussed above in 
the diagnostic retention studies section), variability in prevalence and persistence 
estimates may be caused by other methodological issues such as the use of clinic versus 
community samples (Woo & Rey, 2005); sample ascertainment (who is interviewed (e.g., 
parent, child, teacher); type of assessment (e.g., rating scale, observational); evaluator 
status (e.g., blind to ADHD status) (Mannuzza, et al., 2003) and variation in diagnostic 
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criteria (S. V. Faraone, J. Biederman, & E. Mick, 2006; Ramtekkar, Reiersen, Todorov, 
& Todd, 2010). It is often not possible to determine if changes in diagnostic retention or 
symptom trajectory levels are due to a combination of measurement issues and 
developmental variation or to one or the other alone (Willoughby, 2003). 
Treatment of impairment is an especially important methodological factor to 
consider. While they differ across studies, some researchers include a definition of 
impairment when assessing ADHD estimates and some do not (Polanczyk & Rohde, 
2007a). Also, the treatment of impairment affects prevalence and persistence rates 
(Canino et al., 2004; McKeown, 2004). One study of ADHD prevalence rates (using 
DSM-IV criteria and different definitions of impairment) found ADHD rates varied from 
3.7% to 8.9%, with higher rates associated with less stringent impairment criterion 
(Canino, et al., 2004). Utilizing data (sample included over 10,000 children aged 4-17) 
from the National Health Interview Survey, Mckeown et al. found 12.2% of boys and 
5.6% of girls met criteria for ADHD using only the symptom-count criteria. The 
prevalence dropped to 5.6% of boys and 2.3% of girls when the “impact” (impairment) 
requirement was included (McKeown, 2004). 
Measuring Magnitude of Treatment Effect (Symptom Improvement) 
Several approaches are used to measure clinically important or significant level of 
ADHD symptom improvement (magnitude of treatment effect or symptom remission) (P. 
Hazell, Lewin, & Sly, 2005). One is to use continuous outcome measures. (P. Hazell, et 
al., 2005). For example, results from a review by Swanson, et al. (2003) of 3 meta-
analyses found pooled effect size estimates (of stimulant medication compared with 
placebo) ranged from .75 to .90 standard deviations (considered moderate to large effect) 
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(Cohen, 1988). If related to changes in units on a rating scale, effect size estimates mean 
more clinically , like the approach described next, however, cut points for what are 
considered normal and deviant are often arbitrary regardless of approach (P. Hazell, et 
al., 2005). 
Some researchers report the pre- and post- percentage change in symptoms or a 
variant of this; number of youth who achieved a score in the range as youth without 
ADHD (Ramos-Quiroga & Casas, 2011). In ADHD clinical trial research, definitions of 
treatment effect commonly include a mean cutoff score of ≤1 on standardized symptom 
scales (e.g. Swanson, Nola and Pelham, Version IV (SNAP-IV) (Steele, 2006). This 
indicates minimal or no symptoms for DSM-IV diagnosis (matching similar scores of 
children without ADHD) and often assumes that functioning is similar to the average 
optimally functioning child without ADHD (Steele, et al., 2006). Severity of symptoms 
are not taken into consideration when one only looks at the percentage of symptom 
reduction and children who are classified as symptom remitters may continue to have 
clinical difficulty (Ramos-Quiroga & Casas, 2011). 
While approaches utilizing clinically significant change or effect size magnitude 
(Greenland, 2001) are valuable, they mainly offer group level rather than individual level 
information about patterns of symptom and impairment change (J. S. Owens, et al., 
2009). Further, treatment effect data, not considering impairment, may overstate 
treatment success for those that would not be included as successes if functioning ratings 
were also considered (J. S. Owens, et al., 2009). 
Study methodological improvement can be seen in a comparison of two examples. 
The Wisconsin study (Barkley, et al., 2002) reassessed 126 of the initial cohort of 158 
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clinically referred children with hyperactivity and controls in adolescence. In an attempt 
to examine ADHD persistence as a function of parent versus self-reported symptoms, 
they created age-based referenced ADHD criteria (Barkley, et al., 2002). Using age-
matched controls, they identified the mean number of DSM-III-R symptoms and created 
thresholds 2 standard deviations above that mean (Barkley, et al., 2002). They identified 
significantly more impaired individuals using the developmentally referenced criteria 
than they did using the DSM-III-R based criteria (Barkley, et al., 2002). The New York 
Study, used an improved methodology by using “probably” (fewer symptoms than 
required for diagnosis and clinically significant impairment) and “definite” levels of 
ADHD (meeting DSM ADHD diagnostic criteria) with both categories requiring 
impairment by the individual’s ADHD symptoms (Mannuzza, et al., 2003). The 
categories were not dependent on a comparison group (like the Wisconsin study), which 
may not be representative (Mannuzza, et al., 2003). 
Measuring Persistence/Remission 
ADHD developmental trajectory studies concerned with persistence and 
remission should include a consideration of changes in symptoms and functional 
impairment -- two different aspects of a complex measurement issue. Measuring one 
without the other does not provide a complete clinical picture and may result in poor or 
inaccurate treatment decisions (e.g., length, type, or dose of treatment) (J. S. Owens, et 
al., 2009). In spite of a recognized need to improve nosology and adopt standard 
measurement practices, disparate definitions of persistence and remission are often used 
in the literature and no definitions have been widely adopted. As mentioned earlier, many 
studies do not include the measurement of impairment at all when considering remission 
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or persistence of ADHD. A review by Steele et al. concludes that a definition of 
remission should include optimal functioning in addition to minimal or no symptoms 
(Steele, et al., 2006). 
FUNCTIONAL IMPAIRMENT:  BACKGROUND, DOMAINS, MEASUREMENT, & PREDICTORS 
Functional Impairment Background 
The literature has only recently, over the last two decades, begun to consider 
functional impairment's role in diagnosis or treatment in ADHD (Ramos-Quiroga & 
Casas, 2011). This may be because, prior to the publication of DSM-IV, impairment 
criteria were implied rather than explicit (Fabiano & Pelham, 2009). According to the 
DSM-IV definition of ADHD, alongside symptom-count criteria, youth with ADHD must 
also exhibit functional impairment (American Psychiatric Association, 2000) in what are 
considered the most important “developmental contexts,” school and home (Deault, 
2010). 
One prominent ADHD researcher considers ADHD symptoms to be “the 
behavioral expressions associated with the disorder,” and impairment “the consequences 
that ensue for the individual as a result of these behaviors” (Gordon, et al., 2006). Canino 
et al. have explained Hoagwoods (1996) definition of functioning as “a continuously 
distributed characteristic, ranging from the highest levels of competence in adapting to 
demands posed by the child’s home, school, neighborhood, and peers, down to levels at 
which normal adaptation is not possible and functional impairment is diagnosed” 
(Canino, et al., 1999). Functional impairments have also been defined as “specific deficits 
in multiple domains of functioning developing subsequent to ADHD” (Winter, 2005). 
Impairment can include dysfunction or an absence of adaptation in daily functioning and 
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results in performance below that of normally developing peers (Fabiano & Pelham, 
2009). 
Similar to symptoms of ADHD which tend to change as children age, the same 
may be true for functional impairment (Nijmeijer, et al., 2008), and depend on 
environmental demands (Harpin, 2005). However, unlike symptoms, impairments tend to 
become more noticeable as children age as they acquire more autonomy (Adler, et al., 
2008). Impairment is thought to have an additive effect over time (Adler, et al., 2008; 
Wender, Wolf, & Wasserstein). For example, recent data show a negative impairment 
developmental cycle whereby peer rejection was related to impaired social skills, which 
in turn predicted later peer rejection, which then compromised functioning in additional 
areas across development (Murray-Close et al., 2010). 
Not all children and adolescents who meet ADHD symptom-count criteria are 
impaired (Gordon, et al., 2006). For example, evidence from one community follow up 
study of 140 girls with ADHD and 88 comparison girls, 16.4% (n=20) of girls with 
childhood ADHD were considered positively adjusted during adolescence, compared to 
86.4% of comparison girls as defined by meeting criteria for at least 5 of 6 impairment 
domains (5 met criteria in all 6 domains) (E. B. Owens, et al., 2009). However, impaired 
functioning is a very real eventuality for many (Molina et al., 2009). 
Children diagnosed with ADHD have been found to show larger global, social, 
academic and self-perception functional impairments compared to children without 
ADHD (S.P. Hinshaw, et al., 2006). Longitudinal studies have documented that children 
with ADHD have more impairment in multiple domains such as school, interpersonal, 
and family functioning at follow-up compared to children without ADHD (Biederman, et 
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al., 1996) While long-term outcomes are not the focus of this review, it is important to 
note that subsequent impairment is a strong predictor of long-term impairment (Gordon, 
et al., 2006). Youth with ADHD, compared to youth without ADHD, have poorer 
educational, job-related, financial, and social outcomes (e.g., not graduating, divorce, 
lower incomes) (Bussing, 2010; Klein, 2012). 
Studies assessing impairment have identified high-risk groups that would go 
undetected if only symptoms were assessed (Wille, Bettge, Wittchen, & Ravens-Sieberer, 
2008). For example, the Bella Study (2008) found 6% of the 2,863 surveyed families 
with children aged 7-17 suffered from “pronounced impairment” due to mental health 
problems but were not identified by symptom screening alone (Wille, et al., 2008). In a 
population-based study, 16.1% of the children who were screened were impaired but did 
not meet diagnostic symptom count criteria (Burns et al., 1995). 
Assessing impairment also adds important additional information about 
functioning that symptom assessment alone would not. For example, in the Bella study, 
twenty percent of the sample reported impairment (11-13% single domain; 4-7% two 
domains; and 1.5-3% 3 or 4 domains of impairment) and most families exclusively 
reported school (8-9%) or home life (1-3%) impairment, followed by both school and 
home impairment (1-4%) (Wille, et al., 2008). A population-based screening identified 
approximately a third of the children (those with a diagnosis and impairment (n=152) and 
those with no diagnosis but with impairment (n=193)) had significant functional 




Lahey et al. (2004) compared children with ADHD, children with "situational 
ADHD" (met symptom criteria but displayed impairment in only one setting), and 
children without ADHD over three years (baseline age 4-6) (Lahey, et al., 2004). 
Compared to 3.1% of children without ADHD, 34% of children with situational ADHD 
(children meeting symptom criteria for ADHD but not cross-situational impairment 
requirement) met full ADHD criteria in at least 2 of the 4 study waves and were more 
impaired (Lahey, et al., 2004). The authors point out that this may be due to the fact that 
school demands may not cause academic impairment to surface in early childhood 
(Lahey, et al., 2004). However, they question the multiple domain requirements for 
impairment and wonder why severe impairment in one domain should prevent a child 
from having a diagnosis (Lahey, et al., 2004). 
Domains of Functional Impairment 
It is clear from the literature that deficiencies in functional impairment occur in 
individuals with ADHD at all age levels across multiple domains (social, educational, and 
occupational) (Sciberras, et al., 2009). Academic, motor coordination, and social skills 
are the three domains of functioning most highly associated with ADHD symptoms 
(Sonuga-Barke, Daley, Thompson, & Swanson, 2003). This review focuses on social, 
classroom, home, leisure activity, and intrapersonal domains of functioning. An overview 
of the literature in each of these areas is provided below. 
Social Impairment (difficulties interfere with friendships) 
A review of prospective longitudinal studies indicates a range of social difficulties 
is persistent among children with ADHD compared to youth without ADHD (Sciberras, 
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et al., 2009). Social impairment can be evident in peer and friendship, parent-child, 
teacher, and other adult relationships, and can be related to ADHD itself, comorbid 
conditions, and the result of those two factors on the social environment (Wehmeier, 
Schacht, & Barkley, 2010). Compared to children without ADHD, children with ADHD 
exhibit poorer social and communication skills (Klimkeit et al., 2006), antisocial behavior 
(Biederman, et al., 2006), unstable friendships (Sciberras, et al., 2009), and are more 
involved with deviant peer groups (Gordon, et al., 2006). 
Over half of youth with ADHD have serious peer relationship impairment (Hoza 
et al., 2005; Wehmeier, et al., 2010) and by the third grade, up to 70% of children with 
ADHD have no close friends, especially if comorbid ODD or CD is present (Wehmeier, 
et al., 2010). Youth with ADHD often exhibit self-centered, intrusive, intimidating and 
adverse behavior toward other peers (Wehmeier, et al., 2010). Youth with ADHD are 
frequently ignored (e.g., not invited to parties or out to play), rejected (e.g., bullied or 
teased) by peers and seen by peers as being different (Fabiano & Pelham, 2009; Harpin, 
2005). As a result, they often lack mutual friendships and are unpopular with peers 
(Nijmeijer, et al., 2008). 
School Impairment (difficulties interfere with classroom learning) 
Inattention, impulsivity, and hyperactivity can lead to a number of difficulties for 
children in the school domain. ADHD is associated with school impairment such as 
disruptive classroom behavior, underperformance, need for tutoring, lowered 
standardized test scores, repeating grades in school, increased use of school-based 
services, and suspensions and expulsions (Barkley, 2004; Loe & Feldman, 2007). Several 
of the core ADHD symptoms (e.g., having difficulty with organizing tasks) impair one's 
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ability to study and the academic performance of children with ADHD may suffer from 
behaviors such as not turning in completed assignments (Sciberras, et al., 2009). Children 
with ADHD are more likely to struggle with tasks such as finishing seatwork and 
remembering things needed to do homework assignments compared to children without 
ADHD (Fabiano & Pelham, 2009). Comparing high school academic performance among 
male youth with and without ADHD, Kent et al. found youth who were diagnosed with 
ADHD in childhood continued to experience academic difficulties such as lower grades, 
failing classes, and being late or absent compared to youth who did not have a diagnosis 
of ADHD (Kent et al., 2011). 
Interpersonal Impairment (difficulties upset or distress the child) 
ADHD is associated with emotional impairment including poor self-regulation, 
demoralization, learned helplessness, low self-esteem, fear and anxiety, increased 
emotional expression (e.g., frustration and anger), and other emotional problems 
(Gordon, et al., 2006; Wehmeier, et al., 2010). Children with ADHD are significantly 
more likely to be upset or distressed by their difficulties than children without ADHD 
(Strine et al., 2006). Children with probable ADHD perceive themselves as receiving less 
social support from friends, classmates, and teachers compared to children without 
ADHD (Demaray & Elliot, 2001). Other domain impairment (e.g., social academic) 
caused by the adverse effects of ADHD symptoms likely contribute to the development 
of emotional impairment (Wehmeier, et al., 2010). Strained family relationships may also 
negatively affect a child’s emotional wellbeing (Harpin, 2005). 
Home Impairment (difficulties interfere with home life) 
Parent-child relationship impairment among ADHD youth may be apparent at 
home (Harpin, 2005). Children with ADHD may not comply with parent requests or 
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instructions or may exhibit argumentative behavior (Fabiano & Pelham, 2009). In one 
study, children with ADHD were nine times as likely to have a high level of home life 
impairment compared with children without ADHD (Strine, et al., 2006). A study by 
Cuffe et al. found the second most common parent reported impairment, after classroom 
impairment (94%), was impairment in the home setting (82.23% in males and 73.3% in 
females) (Cuffe, Moore, & McKeown, 2005). 
Leisure Impairment (difficulties interfere with leisure activities) 
There is little research related to the extent to which ADHD difficulties interfere 
with leisure activities. Strine et al. found children aged 4 to 17 with ADHD were 
significantly more likely than those without ADHD to have a medium amount or a great 
deal of impairment in their leisure activities (12.5% (ADHD) versus 1.5% (non-ADHD) 
(Strine, et al., 2006). Using data from a large, nationally representative sample including 
more than 10,000 children between the ages of 4 and 17, one study found about half of 
youth with probable ADHD were reported to have impairment in leisure activities (Cuffe, 
et al., 2005). 
Measuring Impairment 
The subject of impairment, while certainly not new to the field of mental health, 
arguably has been neglected in child/adolescent ADHD specific research literature 
(Goldstein & Naglieri, 2009). Little consensus seems to exist in the field of functional 
assessment on the definitions or measures of the constructs involved (Goldstein & 
Naglieri, 2009). The DSM-IV diagnostic criteria does not provide sufficient instructions 
on how to measure impairment (Gordon, et al., 2006). And, researchers and clinicians are 
assessing impairment in a variety of ways (Canino, et al., 1999). 
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Measures of impairment provide crucial information regarding developmental 
capacity, trajectory, and domain functioning. Measures of impairment also provide 
important information for treatment planning purposes and help distinguish clinically 
significant cases (Bird et al., 2000). Most measures of functioning concentrate on areas 
like social relationships at home, at school, and in leisure time, with parents, siblings, 
peers, etc. (Canino, et al., 1999). It is more clinically useful to assess multiple domain 
impairment information (e.g., family and academic) because it allows for a more 
comprehensive snapshot of current functioning (Fabiano & Pelham, 2009). Identifying 
domain specific impairments can lead to referral and can become outcomes to measure 
for targeted intervention aimed at improving long term functioning (Sayal, Goodman, & 
Ford, 2006). 
Impairment Measures 
Impairment measures should be reliable, capture multiple domains, and 
informative for clinicians and educators, but should not be costly or time consuming to 
administer  (Fabiano & Pelham, 2009). There are no standardized measures of 
impairment similar to the DSM-based symptom assessment checklists (Gordon, et al., 
2006). What does exist is a number of disparate measures, such as ratings, reports, and 
counts of negative life events, attempting to assess clinical impairment with varying 
degrees reliability and validity (Goldstein & Naglieri, 2009). Some potential 
measurement challenges are discussed here. 
Construct validity poses specific problems in the measurement of impairment 
(Canino, et al., 1999). For example, not all measures have clear cut-points for where 
impairment begins and ends (Canino, et al., 1999). It is also difficult to determine if the 
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cut-points of measures that exist correspond to what is considered “substantial 
impairment” which is required to satisfy criterion for access to services by federal 
agencies (Canino, et al., 1999).  
In a review of measures designed to capture functional impairment, Canino et el. 
distinguish between three measurement categories:  1.  global impairment measures, 2. 
domain-specific or multidimensional measures, and 3.  symptom- or diagnostic-specific 
impairment measures (Canino, et al., 1999). Rather than argue that one measurement 
category is better than another, the authors point out that each one has utility for different 
purposes (Canino, et al., 1999). 
The Global Assessment of Functioning Scale (GAF) (American Psychiatric 
Association, 1994) is an example of a global impairment measure. It is a measure of 
overall difficulties in daily functioning (Fabiano & Pelham, 2009) and is included in the 
DSM-IV-TR. The GAF allows clinicians to report an individuals highest level of 
functioning using 10 point ranges from 0-100, with 90-100 being prefect functioning 
(American Psychiatric Association, 2000). Global measures, unlike domain-specific 
measures which are discussed next, do not evaluate functioning in different areas such as 
home or school (Fabiano & Pelham, 2009). 
An example of a domain-specific measure is the Strengths and Difficulties 
Questionnaire (SDQ) (Goodman, 2001). The SDQ consists of 25 symptom items and 
seven items assessing difficulties in functioning (e.g., school and classroom settings) 
associated with reported symptoms (Goodman, 2001). The SDQ is one of a few measures 
of impairment that was specifically developed to assess impairment in relation to ADHD 
and other psychiatric symptomatology (Goodman, 2001). The SDQ measures difficulties 
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prompting caregivers to seek help for their children and is a helpful tool for pinpointing 
intervention needs (Ford, Hutchings, Bywater, Goodman, & Goodman, 2009). Domain 
specific measures often include measures of multiple disorders and differentiating 
impairment from specific disorders may not be possible (Canino, et al., 1999). Additional 
weaknesses of using domain specific measures include the following: they can to be 
lengthy, require multiple raters, or may only assess a single domain of functioning 
(Fabiano & Pelham, 2009). 
Symptom-specific measures assess impairment in relation to a specific symptom 
or diagnosis (Canino, et al., 1999). An example is the Diagnostic Interview Schedule for 
Children (DISC-IV) (Shaffer, et al.) which asks a series of impairment questions if 
diagnostic criteria, including enough ADHD symptoms are endorsed. One weakness of 
diagnostic specific measures is that the interviewee may not have a level of 
understanding needed to differentiate impairment caused by one type of symptom (or set 
of symptoms) versus another (Canino, et al., 1999). 
Another major shortcoming of symptom-specific measures such the DISC is that 
if the symptom criteria, duration criteria, or age of onset criteria for ADHD are not met, 
the impairment questions are never asked. Unless researchers use another source to 
identify functional impairment, this may result in under-identification of children and 
adolescents who experience subthreshold ADHD with clinically significant levels of 
impairment. Additionally, symptom-specific measures may not allow for a consideration 
of impairment in control children so that impairment norms can be established and used 




A number of features may predict impairment among youth and when considered 
together may have greater prognostic power (Steinhausen, 2009). In a prospective ADHD 
study (using DSM-III-R criteria), Biederman et al. found maternal psychopathology, 
larger family size, higher levels of comorbidity, and increased impulsive symptoms 
predicted lower rates of normalized functioning (Biederman, Mick, et al., 1998). 
Predictors of later adolescent functioning identified in the MTA study include symptom 
severity, conduct problems, intellect, social advantage, and strength of symptom response 
to treatment; and, to a lesser extent, type of treatment received during the 14 months 
intervention (Molina, et al., 2009). CD also predicts poor academic outcomes and 
relationship difficulties (Gordon, et al., 2006). Early peer problems is a predictor of 
relationship difficulties in adolescence (Gordon, et al., 2006). 
Mota and Schachar (2000) used the receiver-operating characteristic (ROC) 
approach (combining symptoms most associated with impairment) to predict impairment 
(Mota & Schachar, 2000). The algorithm used fewer symptoms than the DSM-IV criteria 
and improved diagnostic sensitivity and specificity. Mota and Schachar point out that 
other studies attempting to determine which symptoms best predicted ADHD impairment 
often use factor analysis where symptom combinations were based on their correlation 
with other symptoms rather than impairment (Mota & Schachar, 2000). For that reason, 
symptom prevalence or subtype distinctions, are inadequate in predicting impairment 
(Mota & Schachar, 2000). 
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STUDYING PATTERNS OF SYMPTOM AND FUNCTIONAL IMPAIRMENT CHANGE 
Research has demonstrated that measures of impairment generally have a 
relatively modest correlation with symptom reports (Gathje, et al., 2008). These findings 
supporting the argument that symptoms and impairment are two related, yet separate, 
aspects of the ADHD diagnosis (Gathje, et al., 2008). Impairment is only partially 
predicted by symptom severity (Barkley, 2010), accounting for only 25% of the variance 
in impairment in one study (Gordon, et al., 2006). 
Measurement indicators of functioning are more meaningful to patients, their 
families, and teachers than measurement indicators of symptoms (J. S. Owens, et al., 
2009). Parents and teachers are less likely to consider a resulting treatment change 
meaningful if the child does not show improvement in functioning (Hoagwood, Jensen, 
Petti, & Burns, 1996). Research and clinical data present a strong case for using 
impairment over symptom measures because, in the majority of the cases, when 
impairment improves symptoms improve, where as the converse is less likely (J. S. 
Owens, et al., 2009; Young & Gudjonsson, 2008). Impairment, such as declining grades, 
rather than symptoms often results in referral for services (J. S. Owens, et al., 2009). 
Still, recent intervention studies have shown that significant change in functioning 
occurs without symptom change and visa versa (Karpenko, et al., 2009; J. S. Owens, et 
al., 2009). There is value in knowing if a symptom change is associated with meaningful 
change in specific domains of functioning (J. S. Owens, et al., 2009) and it is important to 




Analytic Approaches to Studying Patterns of Symptoms and Impairment Change 
When considering patterns of individual ADHD developmental change over time, 
it is important to employ fitting analytic approaches (Willoughby, 2003). Jacobson and 
Traux’s methods are most often utilized in treatment and intervention studies, however, 
developmental trajectory research is an ideal forum this methodological approach. One 
part of Jacobson and Traux’s formula for defining “clinically significant” (CS) change, 
the Reliable Change Index (RCI) (Jacobson & Truax, 1991), is one frequently used 
analytical approach that is useful in considering change over time and helping to better 
understand the developmental course of ADHD. RCI is a statistical approach to 
measuring an individual’s change (e.g., symptomatology, impairment) in performance on 
a standardized outcome measure (Jacobson & Truax, 1991). While the RCI does not 
calculate clinically significant change, it is valuable because it categorizes individuals by 
the direction and magnitude of change (e.g., increasing symptoms counts, decreasing 
symptom counts, no change in symptoms), regardless of functioning status (the second 
part of the Jacobson and Truax formula) (J. S. Owens, et al., 2009).  
Using the two-part formula, CS change occurs when an individual had achieved 
reliable change (using the reliable change index (RCI) from pre- to post- measurement 
points and when the post-assessment score reaches the normative range (Jacobson & 
Truax, 1991). Employing CS change rather than using the RCI alone, may be overly 
conservative and less useful for ADHD research because, while declines in symptoms 
and improvement in functioning occur, normative scores may only be achievable for a 
small number of individuals (J. S. Owens, et al., 2009). Even if someone does not return 
to the normal range of functioning, there is value in calculating the magnitude and 
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direction of the impairment change (J. S. Owens, et al., 2009). While other comparable 
methods exist, use of the Jacobson and Truax RCI method is encouraged to allow for 
cross-study comparability (Karpenko, et al., 2009; J. S. Owens, et al., 2009).  
SYMPTOM & FUNCTIONAL IMPAIRMENT TRAJECTORY STUDIES REVIEW ANALYSIS 
A search for studies including the following five criteria yielded only three reports 
(Biederman, et al., 2000; Bussing, et al., 2010; S. Faraone, et al., 2006):  1.  DSM-III, III-
R or IV diagnostic criteria were used via a structured diagnostic interview or through a 
validated ADHD rating scale, using parent report; 2. ADHD children were compared to a 
well-matched control group; 3.  Most participants were ≥4 and ≤12 years of age  at the 
start of the study and were followed prospectively for at least 1 year after the initial 
assessment; 4. A subthreshold ADHD, ADHD NOS, subclinical ADHD, Residual Type, 
ADHD in-partial remission, syndromatic remission, functional persistence, or 
subsyndromal group was considered separately from the ADHD group and non-ADHD 
group; and 5. Impairment status was measured and considered in relation to symptom 
status. Eight additional studies are included in the review analysis because they met a 
number of the inclusion criteria and offer important insight or methodological 
perspectives related to the study of the patterns of symptom and impairment change 
comparing youth with ADHD, subclinical ADHD and children without ADHD. 
Studies included in the review analysis were examined in order to assess the 
following dimensions of research and evaluation: type of study; 
populations/communities/levels of focus; location of study; problem/areas of 
focus/objectives; underlying theories & principles used in 
design/implementation/evaluation of study; evaluation approaches; design and methods 
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for evaluation; instrumentation; data collection methods; data analysis and reporting 
procedures; dissemination of results; conclusions; other comments. This strategy was 
used to organize the information into specific content areas and also, later, to acquire a 
sense of the gaps in the literature.  
The following section first discusses studies that are relevant to the current study 
but which did not meet all of the inclusion criteria listed above. Next, the three studies 
meeting all of the inclusion criteria are presented followed by a summary of gaps and 
shortcomings and importance of the reviewed literature. 
Subclinical Group Not Considered Separately 
Studies prior to Biederman et al. (1998) did not inquire if functional impairment 
could normalize for youth with persistent ADHD (Mick, et al., 2004). Biederman et al. 
analyzed data from a 4 year longitudinal study of referred boys (aged 6-17) with 
persistent ADHD (compared to youth without ADHD to assess levels of school, social, 
and emotional functioning (Biederman, Mick, et al., 1998). Normalized functioning was 
defined as attaining scores above the fifth percentile of scores in the non-ADHD group 
(Biederman, Mick, et al., 1998). At follow-up they found one-fifth of the children with 
persistent ADHD functioned poorly in all 3 domains, one fifth did well in all domains, 
and three-fifths were impaired at follow up in one or two areas, suggesting the 
developmental trajectory of ADHD is associated with inconsistent functioning 
(Biederman, Mick, et al., 1998). 
Biederman et al., included subthreshold cases with ADHD cases when defining 
persistent ADHD and defined subthreshold as fewer symptoms than was required for 
ADHD (at least 5 versus at least 8 using DSM-III-R criteria) and with significant 
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impairment using the GAF. They included impairment because of Barkley’s idea that the 
DSM criteria for ADHD may not be developmentally appropriate for adolescents [certain 
symptoms may no longer be endorsed as children age](Biederman, Mick, et al., 1998). 
Since subthreshold cases were included in persistent ADHD cases, it is not known how 
many of the 85 individuals classified as persistent ADHD cases were subthreshold, and 
distinguishing subthreshold functional trajectories is not possible. In an earlier study 
(using the same cohort), Biederman et al. (1996) found “early and late remitters” at the 
four-year follow-up were less academically and socially impaired compared to 
individuals with persistent ADHD. Here too, the subthreshold group (those not meeting 
symptom count criteria for DSM-III-R (at least 5 symptoms) but having severe 
impairment) was included with the ADHD group (Biederman, et al., 1996). 
In a similar methodological study, Mick et al. found a 5-year persistence rate of 
71% (N=99) among a referred sample of girls with (123) and without (112) ADHD (6 to 
17 years of age at baseline ADHD screening) (Mick et al., 2011). Persistence was defined 
as meeting full DSM-IV ADHD diagnostic criteria or residual criteria defined as 3-5 
ADHD symptoms (fewer than full diagnostic criteria but more than half the required 
symptoms) and associated impairment (i.e., GAF score, 60) (Mick, et al., 2011). 
According to the researchers, that definition of persistence was used because, in line with 
clinical practice, a disorder is not necessarily considered in remission when full 
diagnostic criteria are not met (Mick, et al., 2011).  
Findings showed girls with persistent ADHD had more functional impairment 
than girls with ADHD in remission (N=44), yet remitted ADHD was associated with 
more functional impairment (e.g., academic tutoring) compared to girls without ADHD 
 
57 
(Mick, et al., 2011). This study, like the Biederman study above, was limited by using a 
global assessment of impairment and for its inability to distinguish functional trajectories 
of the residual group (as they were included with individuals meeting full DSM-IV 
ADHD diagnostic criteria in the persistent ADHD group). 
Retrospective Adult Study 
Young & Gudjonsson compared adults in partial remission (IPR; n=43) or in full 
remission (IR; n=22) to adults with ADHD (n=88) and without ADHD (n=33) and found 
symptom remission is associated with improvement in psychosocial functioning (Young 
& Gudjonsson, 2008). In partial remission was defined as having met criteria for ADHD 
in childhood and rating fewer symptoms of ADHD on the DSM-IV checklist (1 SD above 
the mean for a normal control group) (Young & Gudjonsson, 2008). While adults with 
ADHD fared the worst, individuals with partial remission and full remission continued to 
have difficulties with making and managing friendships compared to those who had 
never had ADHD (Young & Gudjonsson, 2008). Additionally, while individuals with 
IPR had fewer symptoms than the ADHD group, they had a greater number of visits to 
health services compared to adults who had never had ADHD (Young & Gudjonsson, 
2008). While this study used retrospective recall of clinically referred patients and 
focused on adult functioning, findings show individuals continued to experience 
functional impairment even though they no longer meet full diagnostic symptom criteria 




Cross Sectional Data 
Using cross sectional data, Scahill et al. examined functioning correlates of 
ADHD in a community sample of children using the Children’s Global Assessment Scale 
(CGAS) (Scahill, et al., 1999). They found children with subthreshold ADHD were 
significantly less impaired than children with ADHD, but significantly more impaired 
than children without ADHD (Scahill, et al., 1999). The researchers defined subthreshold 
ADHD by a symptom score of 13-18 using the Parent Diagnostic Interview Schedule for 
children (DISC-R; based on the DSM-III-R criteria) and impairment was not used to 
define ADHD, subthreshold, or non-ADHD categories (Scahill, et al., 1999). Findings 
suggested it is beneficial to consider ADHD dimensionally in terms of severity of 
disorder rather than categorically (Scahill, et al., 1999). 
Symptom/Functioning Correspondence Studies 
One of the first symptom/functioning correspondence studies examined the 
interrelationship between the Child Behavior Checklist (CBCL) (symptom measure) and 
the Child and Adolescent Functional Assessment Scale (CAFAS)(impairment measure) 
using Jacobson and Truax’s RCI methodology (Rosenblatt & Rosenblatt, 2002). 
Psychosocial domains assessed using a sum score from the CAFAS included Role 
Performance, Behavior Toward Others/Self, Moods/Emotions, Substance Use, and 
Thinking (Rosenblatt & Rosenblatt, 2002). The sample included 3,008 referred youth 
(mean age was 12.5 years at intake) with various diagnoses, including ADHD ODD/CD, 
and mood disorder receiving mental health services and “a coordinated care plan” 
following intake. At follow-up, findings showed 13% of disagreement in outcomes 
between symptoms (CBCL) and functioning (CAFAS). Researchers found minimal 
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correspondence between reliable change in symptoms and functioning with 197 (45%) 
achieving reliable positive change in functioning (CAFAS) while 59 (13%) of the 432 
youth’s scores on the CBCL did not change (Rosenblatt & Rosenblatt, 2002). On the 
other hand, 50 (15%) youth showed negative change and 103 (30%) showed positive 
symptoms change while 329 youth did not show any reliable functioning change 
(Rosenblatt & Rosenblatt, 2002). These findings suggest that a consideration of the 
correspondence between symptom and functioning change has value over a consideration 
of symptom change alone. 
Drawing methodologically from the Rosenblatt study, Karpenko et al. analyzed 
data from the Multimodal Treatment Study of Children with ADHD (MTA) to study the 
correspondence between clinically significant (CS) change in symptoms and reliable 
change in functioning (Karpenko, et al., 2009). Participants included 417 children (aged 
7-9) with ADHD-C who received treatments (i.e., medication and/or behavioral 
treatment). Using parental report, they found that children with CS symptom change were 
two times more likely than children who did not reach CS symptom change to have 
reliable improvement in social, academic, home, and global levels of impairment 
(Karpenko, et al., 2009). Of note, functioning did improve for 14-52% of children who 
did not have CS change in symptoms, depending on the measure (Karpenko, et al., 2009). 
From the client’s standpoint, the researchers suggest, reliable change in impaired 
functioning alone (without significant symptom change) may hold meaning (J. S. Owens, 
et al., 2009).  
Because the study was limited to the MTA dataset, there was no control group 
and a clinical population was used (Karpenko, et al., 2009). A subclinical ADHD group 
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was not identified and individuals who had worsening impairment (a small percentage) 
were combined with “no-changers” (Karpenko, et al., 2009). The researchers justified the 
use of measuring CS change for symptom outcomes and RCI for functional impairment 
outcomes because CS change has been mainly applied to analysis of symptom change 
and it may be “helpful to begin studying change in functioning by applying the less 
stringent criterion (reliable change)” (Karpenko, et al., 2009). Other than to maintain 
consistency with previous MTA analyses, it is not clear why they chose to treat 
symptoms using the more conservative approach for symptom change. 
Owens et al. studied the relationship between reliable change in symptoms and 
reliable change in functioning in 64 girls with ADHD enrolled in a school-based 
parent/teacher intervention program (J. S. Owens, et al., 2009). A comparison of group 
and individual level analysis revealed that while both analyses indicate statistically 
significant correspondence between reliable change in symptoms and reliable change in 
functioning, individual analysis revealed a substantial number of children with ADHD 
experienced a “change in one dimension without change in the other” (J. S. Owens, et al., 
2009). Depending on informant and functional domain, up to 40% achieved reliable 
symptom change without reliable improvement in functioning and up to 16% achieved 
reliable change in functioning without reliable change in symptoms (J. S. Owens, et al., 
2009). Of note, less than 50% of girls with symptom improvement showed reliable 
improvement in the six domains of functioning that were assessed (symptoms, peers, 
parent/teacher, academics, family/classroom/ self-esteem). This study did not include a 
subclinical ADHD group nor did it include a comparison group. 
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Studies Meeting all Inclusion Criteria 
Biederman et al. considered three categories of remission:  syndromatic (loss of 
full diagnostic status; (DSM-III-R criteria), symptomatic (not meeting symptom count 
criteria (36% of symptoms), regardless of impairment), and functional (not meeting 
symptom count criteria (36% of symptoms), plus no impairment (GAF score higher than 
60) (Biederman, et al., 2000). Measuring 128 clinically referred boys (ranging in age 
from less than 6 to 20 years) at the four year follow-up, they found the following rates of 
remission:  syndromatic (60%), symptomatic (30%), and functional remission (10%) 
(Biederman, et al., 2000). In spite of the large percentage of syndromatic remission 
(60%) these individuals who no longer met symptom count criteria continued to suffer 
from impairment (Biederman, et al., 2000). The 30% who fell into the symptomatic 
remission category had fewer than the number of symptoms for a subthreshold diagnosis, 
regardless of impairment, and no findings are presented on the levels of impairment 
experienced by these individuals(Biederman, et al., 2000). Information related to domain 
specific impairment was not collected. Results of this study emphasize that reported 
remission rate is more a function of the definition of remission used, rather than course of 
the disorder. 
Faraone et al. (S. Faraone, et al., 2006) compared four adult groups: full ADHD 
(127), late onset ADHD (all criteria met except onset age of 7) (79), subthreshold (never 
having had ADHD using DSM-IV criteria and having a chronic history of 3 or more 
ADHD-HI or ADHD-IA symptoms (41), and comparisons (123) (S. Faraone, et al., 
2006). The subthreshold group was significantly impaired compared to the comparison 
group but presented with less impairment than individuals with late-onset and full ADHD 
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diagnosis (S. Faraone, et al., 2006). Impairment items assessed included the need for 
academic tutoring in childhood, traffic citations received, grade achieved in school, and 
occupational status (S. Faraone, et al., 2006). The subthreshold group in Faraone’s study 
“does not provide insight into the problems faced by adolescents and adults who are 
“growing out” of the disorder by experiencing symptom remission of childhood ADHD 
and/or associated lessening of functional impairment” (Young & Gudjonsson, 2008). 
Bussing at al. (Bussing, et al., 2010) provide observational outcome data related 
to functioning and quality of life from a diverse, prospective, longitudinal community 
study. They compared 94 children at baseline (age 5–11) with full ADHD (using DSM-
IV criteria) to 75 children with subthreshold, and 163 low-risk peers at an 8-year follow-
up assessment (Bussing, et al., 2010). Based on combined parent and child reports using 
the Columbia Impairment Scale, youth with ADHD, but not children without ADHD in 
childhood, was associated with increased functional impairment and lower quality of life 
at follow-up (Bussing, et al., 2010). ADHD and subthreshold ADHD in childhood were 
associated with lower average grades compared to children without ADHD (Bussing, et 
al., 2010). Both ADHD and subthreshold ADHD were associated with increased risk of 
juvenile justice system involvement and failure to graduate and subthreshold but not full 
ADHD was associated with being held back in school (Bussing, et al., 2010). 
GAPS SHORTCOMINGS AND STRENGTHS OF THE ANALYSIS REVIEW LITERATURE 
It was not possible to distinguish functional trajectories of the subclinical groups 
in the Biederman and Mick Studies, as they were included with individuals meeting full 
DSM-IV ADHD diagnostic criteria (Biederman, et al., 1996; Mick, et al., 2011). 
Additionally, global assessment of impairment did not allow for domain specific 
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assessment of functional impairment. The researchers did inquire if functioning could 
normalize for youth with persistent ADHD and learned the developmental trajectory of 
ADHD is often associated with inconsistent functioning.  
Young & Gudjonsson retrospectively demonstrated individuals continued to 
experience functional impairment even though they no longer meet full diagnostic 
symptom criteria (Young & Gudjonsson, 2008). Using cross-sectional data, Scahill found 
children with subthreshold ADHD were significantly less impaired than children with 
ADHD, but significantly more impaired than children without ADHD and demonstrated 
the usefulness of treating ADHD dimensionally rather than categorically(Scahill, et al., 
1999). In line with both Young & Gudjonsson and Scahill, all three studies that did meet 
inclusion criteria also demonstrated that youth with subclinical ADHD who no longer 
met symptom count criteria continued to suffer from impairment (Biederman, et al., 
2000; Bussing, et al., 2010; S. Faraone, et al., 2006). Further, Biederman et al., 
emphasize that reported remission rate is more a function of the definition of remission 
used, rather than course of the disorder. 
Methodologically, the symptom/functioning correspondence studies provide 
detailed information related to percentages of individuals who make reliable 
improvement in functioning but not symptoms and visa versa and make a compelling 
case for using similar methodology to uncover symptom and/or functioning 
developmental trajectories (Karpenko, et al., 2009; J. S. Owens, et al., 2009; Rosenblatt 
& Rosenblatt, 2002) among youth with subclinical ADHD to compared to youth with and 
without ADHD. The Owens et al. study, highlighted a need for research that considers 
profiles of children who show no change in symptoms or a reduction in symptoms (J. S. 
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Owens, et al., 2009). The Karpenko study pinpoints a need to compare nontreated 
individuals with treated individuals when considering corresponding symptom and 
impairment, as they did not consider nontreated individuals (a limitation of using the 
MTA dataset) (Karpenko, et al., 2009). These studies also contribute to an understudied 
area in ADHD research; the relation between patterns of change in symptoms and 
functioning (J. S. Owens, et al., 2009). Given the potential importance of subclinical 
ADHD and the almost complete absence of longitudinal research on this subcategory of 
ADHD, further research is in this area is warranted. 
ADHD AND SUBCLINICAL ADHD TREATMENT SEEKING 
Medication Treatment and Developmental Trajectories 
Research evidence shows that early identification and treatment can improve 
developmental trajectories (Magyary & Brandt, 2002). Recommended treatment for 
ADHD includes medication and/or behavior therapy (Adler, et al., 2008) to improve 
targeted outcomes (Vierhile, et al., 2009). There are a variety of ADHD medications and 
stimulant medications thought to be better than nonstimulant medications (Vierhile, et al., 
2009). Stimulant medications such as methylphenidate (the active ingredient in Ritalin) 
and mixed amphetamine salts (Adderall) are a first-line treatment for ADHD, with 
methylphenidate being the best-studied (Ramos-Quiroga & Casas, 2011). When stimulant 
medication is ineffective, atomoxetine, a non-stimulant medication, is recommended 
(Vierhile, et al., 2009). Behavior therapy includes various interventions designed to 
modify the physical and social environment in order to reward achievement of desired 
goals or assign consequences for not meeting goals (Perrin et al., 2001). Other 
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psychosocial interventions do not have evidence-based support (W. Pelham & Fabiano, 
2008). 
In 2007, 66% of youth (ages 4-17) were treated with medication for a current 
ADHD diagnosis (Visser & Lesesne, 2005). Youth aged 11-17 had higher mediation rates 
compared to children aged 4-10 and boys were more likely than girls to take medication 
(Visser & Lesesne, 2005). Medication treatment compliance may be as low as 50% in 
children with ADHD (Johnston & Fine, 1993). Regarding behavioral intervention, recent 
findings suggests that treatment effects from school-based intervention and parent 
training for young children with ADHD symptoms was not sustained two years following 
treatment (Shelton et al., 2000). 
The ultimate goal of treatment for ADHD is to achieve remission (Steele, et al., 
2006). Remission should include reducing impairment in emotional, academic, and social 
domains, not just reducing ADHD core symptoms (Adler, et al., 2008; Steele, et al., 
2006). The efficacy of stimulant medication in reducing core symptoms of ADHD (P. L. 
Hazell et al., 2010) as well as improving function in a number of domains is well 
documented in the literature (Perrin, et al., 2001). In fact, in about 70% of cases, ADHD 
medication reduces ADHD symptoms (e.g., interrupting and fidgeting) as well as 
improves impairment (e.g., relationships at home with parents) (Action, 2002). 
Steele et al. (2006) reviewed studies and found achievement of symptomatic 
remission rates in ADHD children treated with methylphenidate (highest remission rates) 
and atomoxetine, but did not find remission rates in the literature for amphetamines. Most 
clinical trials, they found, define remission by taking symptoms, but not impairment, into 
account(Steele, et al., 2006). They reviewed various studies that have assessed 
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improvements in functioning and found medication use versus no medication use is 
associated with greater rates of symptom remission and increased social and academic 
functioning (Steele, et al., 2006). 
Improved functioning was greater with medication that offered higher symptom 
remission rates (Steele, et al., 2006). Perwein et al., found children with ADHD who 
received atomoxetine showed significantly greater improvement in psychosocial 
functioning compared to those children taking a placebo (Perwien et al., 2004). Academic 
impairments have been shown to be effectively treated with stimulants, while social 
impairment have been shown to be effectively treated with nonstimulant medication 
(Wehmeier, et al., 2010). Quality of life research has shown medication treatment 
resulted in improvements in family functioning as well as improvements in social and 
self esteem (Harpin, 2005). 
Treating Children with Subclincial ADHD 
The subject of treating children with subclinical ADHD is a controversial one. 
Data suggests that compared to children meeting full ADHD symptom counts, fewer 
children meeting subthreshold symptoms counts are treated with medication (Bussing, et 
al., 2010). One study looking at community treatment data considered four subgroups 
(full ADHD/subthreshold/last-onset ADHD/controls) and found among the subthreshold 
group 19% had received psychotropic medication for ADHD (lifetime), and 15% were 
currently taking medication (S. Faraone, et al., 2006). In another study, 25% of youth 
with subthreshold ADHD reported ever being treated with medication for ADHD, 
compared to 50% of youth with ADHD (Bussing, et al., 2010). While one would expect 
lower rates of medication treatment among individuals with diminished forms of ADHD 
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compared to ADHD, some question the appropriateness of treating this group (S. 
Faraone, et al., 2006) while others reason that increasing medication rates among 
subthreshold cases may reduce the risk for negative functional outcomes (Bussing, et al., 
2010). 
Family Impairment 
Research evidence indicates family functioning difficulties are associated features 
of ADHD (Barkley, 2004; Deault, 2010; Johnston & Mash, 2001; Schroeder & Kelley, 
2009) and many parents find parenting a child with ADHD to be difficult and 
psychologically distressing (Harrison & Sofronoff, 2002).  A recent community-based 
study found parents of children with ADHD or CD/ODD (though CD/ODD with or 
without ADHD had a greater influence) were more likely to report problems with 
parental support, involvement, communication, and limit-setting compared to parents of 
children without those disorders (Geryk et al., 2012). An eight-year follow-up study of 
interaction patterns of 100 children with hyperactivity and 60 comparison children found 
among families with a hyperactive child, negative parent-child interactions predicted 
continuing parent-teen conflicts, and parents of hyperactive children reported more 
personal distress at outcome compared to parents without a child with hyperactivity 
(Barkley, Fischer, Edelbrock, & Smallish, 1991). 
Predictors of Treatment Seeking 
Several studies (Angold, et al., 1998; Farmer, Stangl, Burns, Costello, & Angold, 
1999; Sayal, et al., 2006; Sayal, Taylor, & Beecham, 2003) and data from the National 
Health Interview Survey (NHIS) (Simpson, Cohen, Bloom, & Blumberg, 2009) suggest a 
strong relationship between the impact of youth’s behavioral difficulties and mental 
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health service use. Other findings suggest burden resulting from a child’s mental health 
condition strongly predicts mental health service use (Angold, et al., 1998) and 
continuing care (Farmer, et al., 1999). Results from the NHIS survey found families were 
almost two times as likely to have contact with a mental health provider if the child’s 
difficulty was considered a “burden on the family” (Simpson, et al., 2009). Hispanic, 
black, and younger children (aged 4-7 years), with emotional or behavioral difficulties 
were less likely to use mental health services compared to white and older children 
(Simpson, et al., 2009). 
Children with ADHD compared to children without ADHD are more likely to 
utilize health care services (e.g., visit mental health professionals, take medication, and 
have frequent visits) (Pastor & Reuben, 2008). Research shows referral for treatment or 
services for ADHD is usually a result of functional impairment rather than symptoms 
(Angold, et al., 1999). Angold et al. found that children, regardless of meeting symptom 
criteria or not, who had impaired function were likely receiving services (Angold, et al., 
1999). One study found more “costly and restrictive treatment” was associated with a 
child and adolescents severity of impairment in multiple domains (McDermott, 
McKelvey, Roberts, & Davies, 2002). In a study by Bourdon et al. comparing four 
Strengths and Difficulties Questionnaire (SDQ) scoring methods, scoring method using 
parent perceived severity of difficulties identified the highest percentage of children with 
“service contact/use” (Bourdon, Goodman, Rae, Simpson, & Koretz, 2005). Parent’s 
perception of problems and report of impairment are strong predictors of child mental 
health service use (Sayal, et al., 2003). Sayal et al, collected data from 232 parents of 
children with ADHD and found rather than severity of disorder and comorbidity, impact 
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of the disorder on caregivers best predicted recognition of problems (perceived burden) 
which were the main correlate of service contact(Sayal, et al., 2006). 
Additional predictors of treatment seeking and service use have been identified in 
the literature. In a study of 268 clinic referred and 137 community-based children with 
ADHD and 268 controls, aged 6-15, Gau et al. found the most associated variables for 
psychiatric referral were male gender (OR=3.58), maternal education level as college or 
higher (OR=2.46), and interfering with friendship (OR=2.28). Interestingly, among 
community-based children with ADHD, data did not show differences in symptom 
severity and degree of impairment between those seeking medical services and those who 
did not (Gau et al., 2010). A study of Puerto Rican children aged 4-17 found ADHD, 
ADHD-NOS, impairment and male gender predicted stimulant medication use during the 
past year (Bauermeister, et al., 2003). Similarly, another study found ADHD, ADHD-
NOS and male gender was associated with stimulant medication use, as well as younger 
age (Leslie, et al., 2005). After controlling for symptom severity, Jensen at al. found 
parental mental health history, level of stress, family size, and marital status predicted 
service use (Jensen, Bloedau, & Davis, 1990). 
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Chapter 3  
METHODOLOGY 
PURPOSE 
The overall purpose of this study is to investigate developmental ADHD symptom 
and functioning profiles in a community sample of children and adolescents participating 
in the South Carolina Project to Learn about ADHD in Youth (SCPLAY) using data from 
baseline and follow-up assessments. This study employs the Jacobson & Traux reliable 
change index (RCI) methodology to examine patterns of Attention-Deficit/Hyperactivity 
Disorder (ADHD) functioning change. This method is clinically relevant in that it allows 
for a determination of the proportion of youth who improve or do not improve 
functionally, and who improve in one area but not the other. This research is also 
concerned with subthreshold ADHD as having potential risk for having or developing 
subsequent impairment problems as children age and demands on attention and 
performance increase. Patterns of symptom and functioning change are considered for 
children with ADHD, children with subthreshold ADHD and children without ADHD, as 
well as for children with ADHD and subthreshold ADHD who are and are not medicated. 
This study examines functional impairment in five individual domains of functioning, as 
well as overall impairment. Additionally, predictors of impairment severity and service 
utilization are examined. It is hoped that through improved understanding of the 
correspondence between these constructs, resources can be targeted to help children and 




Developmental psychopathology is a multidisciplinary framework used to 
understand symptoms and functional impairments associated with mental disorders in the 
context of change over time and in relation to normal development (Cicchetti, 1990; 
Cicchetti & Toth, 1995). This perspective emphasizes a longitudinal perspective as 
essential to understanding development, as well as an appreciation of underlying 
biological predisposition and environmental contexts (Hinshaw & Blachman, 2005). 
While there is ample research stemming from the developmental perspective focusing on 
associations between aspects of the family and symptomatology, there is a lack of 
research conceptualizing ADHD in terms of ongoing difficulties that children and 
adolescents with ADHD experience in multiple domains of functioning at different points 
in time (Deault, 2010). 
The developmental perspective is also a useful framework to invoke when asking 
questions such as “What factors contribute to the development of more severe forms of 
impairment?” and “Are the predictors of treatment-seeking the same for children 
experiencing subthreshold ADHD as for children with ADHD?”- questions this research 
seeks to answer. Answers to these questions provide guidance for interventions in clinical 
practice and enhance parents’ efforts to help their children reduce social and academic 
impairments (Deault, 2010). A developmental psychopathology approach also helps 
clarify the developmental course and diversity in course of ADHD and subclinical 
ADHD (Cicchetti & Toth, 1995). 
Stemming from developmental psychopathology, developmental epidemiology is 
the study of patterns of disease distribution (in this case, ADHD) over time as a tool for 
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understanding specific aspects of the developmental course (Costello et al., 2006). It is 
specifically concerned with individual trajectories and requires researchers to take 
symptoms and impairment, as well as developmental stage, into account when 
considering the line between normal and abnormal behavior (Costello & Angold, 1993). 
This research is guided by that principle and, as an example, does not apply strict DSM-
IV diagnostic criteria to youth of differing ages. Developmental epidemiology is both a 
descriptive and an analytic approach (Costello, Foley, & Angold, 2006). This framework 
is useful for attempting to understand developmental trajectories of impairment 
associated with ADHD over time because it is based on the premise that core features of 
ADHD change over time, and stresses the importance of interpreting aspects of that 
change (e.g. symptom expression) in relation to normal development (Mick, et al., 2004). 
Developmental epidemiology emphasizes the need to use consistent methodology when 
analyzing change over time (Youngstrom, Meyers, Youngstrom, Calabrese, & Findling, 
2006). 
Finally, impairment resulting from having ADHD extends beyond the individual, 
and should be conceptualized through an ecological perspective (Goldstein & Naglieri, 
2009). This research considers both individual and social environmental functional 
domains that can help with targeted planning and treatment for individuals with ADHD 
and subthreshold ADHD. Such an approach is similar to the DSM-IV-TR, which uses a 
multi-axial classification system designed to consider biological and psychosocial aspects 
(in addition to ADHD diagnostic criteria) that are related to diagnosing an individual (e.g. 
medical conditions that are relevant to the disorder, co-morbidity, and relevant 
psychosocial and environmental problems). 
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The International Classification of Functioning, Disability, and Health Model 
(ICF) was developed by the WHO working group, and classifies functioning and 
disability according to three levels of functioning (impairments at the body function 
level, limitations at the personal activity level, and participation restrictions at the societal 
level). The ICF is useful for describing children’s behavior and functioning (Lollar, 
2008). These three levels in the ICF model are all affected by aspects of the environment 
(Lollar, 2008) and relate directly to the domains of functioning that are targeted in this 
study. 
This study uses the ICF-CY perspective, along with developmental 
psychopathology and developmental epidemiology frameworks to consider patterns of 
change in ADHD symptoms and functioning and predictors of impairment and ADHD 
medication use. Taken together, these perspectives provide a developmental framework 
that guides this research, and offer perspective on conceptualizing research questions and 
conducting analysis. 
SPECIFIC STUDY RESEARCH AIMS/QUESTIONS 
MANUSCRIPT 1: 
The purpose of this study is to examine patterns of change between symptoms and 
functioning among youth with ADHD, with subthreshold ADHD (having three to five 
symptoms of ADHD), and without ADHD across two time-points, and to evaluate 
predictors of impairment. 
Manuscript 1 Aim 1 (M1A1): To examine patterns of change between symptoms 
and functioning among youth with ADHD, with subthreshold ADHD, and without 
ADHD across two time-points. 
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Research Question 1 (M1A1RQ1):  How do youth with subthreshold ADHD, 
youth with ADHD, and youth without ADHD change from baseline to follow-up 
with regard to patterns of change in symptoms and domains (both specific and 
aggregate) of functioning? The 5 domains of functioning include social 
(friendships), school (classroom learning), home (home life), intrapersonal (self), 
and free time (leisure activities). 
Manuscript 1 Aim 2 (M1A2):  To examine baseline demographic and psychiatric 
variables associated with severe levels of functional impairment at follow-up. 
Research Question 2 (M1A2RQ2): Are the risk factors (child factors: age, gender, 
comorbidity, medication; family factors: exposure to parental psychopathology, 
primary parents educational attainment, marital status) that are associated with 
more severe forms of ADHD impairment similar for youth with ADHD, youth 
with subthreshold ADHD, and youth without ADHD? 
MANUSCRIPT 2: 
The purpose of this study is to examine patterns of symptom and functional 
impairment change from baseline and follow-up for youth with subthreshold ADHD and 
youth with ADHD based on treatment status, and to evaluate predictors of treatment 
utilization for youth with subthreshold ADHD compared to youth with ADHD. 
Manuscript 2 Aim 1 (M2A1):  To examine patterns of symptom and functioning 
change from baseline to follow-up for youth with subthreshold ADHD and youth with 
ADHD based on treatment status [taking ADHD medication versus not taking ADHD 
medication (within the last year)]. 
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Research Question 1 (M2A1RQ1):  How do youth with subthreshold ADHD, 
and youth with ADHD change from baseline to follow-up with regard to patterns 
of change in symptoms and functioning (both specific domains and aggregate), 
based on treatment status (taken medication within the last year versus not taken 
medication in the last year)? The 5 specific domains of functioning include social 
(friendships), school (classroom learning), home (home life), intrapersonal (self), 
and free time (leisure activities). 
Manuscript 2 Aim 2 (M2A2):  To examine baseline demographic and psychiatric 
variables that are associated with ADHD medication use at follow-up. 
Research Question 2 (M2A2RQ2):  Are the risk factors (child factors: 
impairment, gender, race, age, comorbidity; family factors: parent reported 
burden, insurance, parent educational level, exposure to parental 
psychopathology) of ADHD medication use (past year) similar for youth with 
subthreshold ADHD compared to youth with ADHD? 
RESEARCH DESIGN 
This South Carolina Project to Learn about ADHD in Youth (SCPLAY) utilized a 
two-phase research design involving school district-wide, voluntary teacher and parent 
screenings (phase I), and in-person assessments including a structured diagnostic 
interview with participants and parents/caregivers (phase II). Study procedures were 
reviewed and approved by the Institutional Review Board of the University of South 
Carolina and the Centers for Disease Control and Prevention. Informed consent was 
obtained from parents for children under the age of 18. Assent forms were read aloud and 
signed by children and parents. 
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SCREENING (PHASE I) 
Research Population 
In Phase I, the sampling population included all 15 elementary schools in a large 
school district in SC. At the time of the screening, the school district had approximately 
8,700 elementary school students attending Pre-K through grade 5. The school district 
population was culturally and racially diverse, and included rural, suburban, and some 
urban neighborhoods. The behavioral screening was conducted in classrooms (excluding 
special education classes) during the 2003-2004 school years. Teachers and/or parents 
(n=4606) completed Phase I screens. 
Screening Overview 
Participating parents and teachers answered two questions, one about previous 
ADHD diagnosis (teacher question:“To your knowledge, has this child been diagnosed 
with ADHD?”; parent question: “Has a doctor or health professional ever told you that 
your child had ADHD or ADD?”) and one question about current ADHD medication 
treatment (teacher question:“Is this child on stimulant medication such as 
methylphenidate (Ritalin)?”; parent question: “Is your child currently taking medication 
for ADHD/ADD?”). Additionally, teachers completed the Vanderbilt ADHD Diagnostic 
Teacher Rating Scale (VADTRS) (M. L. Wolraich, Feurer, Hannah, Baumgaertel, & 
Pinnock, 1998), and rated associated functioning by completing the “impact supplement” 
of the Strengths and Difficulties Questionnaire (SDQ) (Goodman, 1999). These two 
measures are explained in greater detail below. 
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Vanderbilt ADHD Diagnostic Teacher Rating Scale (VADTRS), teacher version 
(Wolraich, Feurer, Hannah, Baumgaertel, & Pinnock, 1998) 
The VADTRS scale is a DSM-IV based rating scale used to assess children for 
symptoms of ADHD (includes all 18 symptoms), ODD (eight symptoms), CD (12 
symptoms), and anxiety/depression (7 symptoms). For the present study, only items 
assessing ADHD symptoms were utilized. Teachers were asked to rate the 18 items 
using a Likert scale (“Never”; “Occasionally”; “Often”; and “Very Often”) reflecting the 
child’s behavior “since the beginning of the school year.” (M. L. Wolraich, et al., 1998) 
The Strengths and Difficulties Questionnaire (SDQ) (Goodman,
 
2001) 
The SDQ is a screening tool for multiple behavioral disorders and includes a 
rating of functioning (impact supplement). For the present study, the impact supplement 
was used to identify impaired functioning. The SDQ is described in more detail in the 
Interviews (Phase II) section below. The teacher version of the SDQ differs from the 
parent version only in terms of wording referencing "your child" versus "this child," and 
the teacher version does not have the family life or leisure impairment items (as teachers 
often cannot report on those domains of functioning) (Goodman, 1999). 
Classification of High and Low Screen 
Children were categorized as probable ADHD cases (high-screen): (1) if teachers 
rated six or more ADHD symptoms in either or both inattentive and hyperactive-
impulsive ADHD subtype domains on the VADTRS with intermediate impairment 
ratings on the SDQ, or (2) if parents or teachers reported the child had received an 
ADHD diagnosis or were taking medication for ADHD. Otherwise, children were 
considered probable non-ADHD cases (low screen). All high screens and a sample of low 
 
78 
screens, frequency matched on gender, were randomly selected (n=2206) and eligible for 
Phase II. A letter from the school district was sent home to eligible families asking for 
permission to have study recruitment staff contact them. If a letter was returned, 
indicating consent to be contacted for the study, interested families (n=633) were then 
invited for an in-person structured assessment of ADHD, other mental disorders, 
treatment history, demographics, and other factors. 
INTERVIEWS (PHASE II) 
Baseline and follow-up (Phase II) in-person interviews were conducted with 
consenting families (n=481 baseline; n=292 follow-up). Baseline interviews were 
administered 13 months (mean time) following the screening (from 9/03 to 1/06 and 
follow-up interviews began 20 months later (9/07-2/09). The participating caregiver was 
often the child’s mother. Interviews (baseline and follow-up) were completed primarily 
in-person; written questionnaires for parents were sent home in advance of the interview 
and collected and checked for completeness during the interview. Interviews were 
conducted via telephone and parent measures returned by mail if families moved away, 
did not wish to meet at the study interview site or the child’s school, or have interviewers 
come to their home. Participants were given an incentive (gift cards at baseline or cash at 
follow-up) for participation in the study. Following each interview, diagnostic data were 
independently reviewed by a project child psychiatrist. Parents were sent a findings letter, 
and referral information was provided if findings suggested a probable diagnosis. 
Protocols were followed when parents or children reported “risks of harm to self or others 
or reported abuse.” 
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Baseline/Follow-up Measures (Detailed) 
Measures were selected to assess ADHD, CD, and ODD symptomatology and 
associated functional impairment (core domains of functioning), along with other 
disorders and measures related to treatment history, demographics, and other factors. 
Diagnostic Interview Schedule for Children, Parent Version (NIMH DISC-IV-P; 
Shaffer, Fisher, Lucas, Dulcan, & Schwab-Stone, 2000) 
Parents completed selected modules of the Diagnostic Interview Schedule IV 
(DISC-IV) (Shaffer, et al., 2000), a highly-structured computer-based investigation of 
child psychopathology during the past 12 months. Selected modules included generalized 
anxiety disorder, separation anxiety disorder, obsessive compulsive disorder, post-
traumatic stress disorder, major depression/dysthymic disorder, mania/hypomania, 
ADHD, ODD, and CD. The DISC-IV interview is based on DSM-IV diagnostic criteria 
and was administered to the parent by a trained project staff member during baseline and 
all follow-up assessments. If stem questions (symptom questions) were endorsed, 
contingent questions followed which determined if a participant met frequency, duration, 
and intensity criteria as specified by DSM diagnostic criteria (Grills-Taquechel & 
Ollendick, 2008). If enough stem questions were answered positively and DSM 
diagnostic criteria symptom counts met, further questions were asked assessing DSM-IV 
impairment criteria. However, if not enough DSM symptoms were endorsed by parents 
through the DISC-IV stem questions, the impairment questions were not asked. For this 
reason, the DISC-IV was only used to assess past year ADHD symptom counts and not to 
assess functional impairment. For all other psychiatric disorders assessed, past year 
 
80 
categorical probable diagnoses were obtained using the DISC-IV scoring algorithm based 
on DSM-IV diagnostic criteria. 
The DISC is a reliable and valid interview with clinical value (Grills-Taquechel & 
Ollendick, 2008). The DISC has excellent inter-rater reliability (Shaffer, et al., 2000) and 
the test-retest reliability (k statistic) of the ADHD DISC-IV module (parent report) in a 
clinical sample and community sample (past year) among children aged 9-17 years is 
k=.79 and k=.60, respectively (Shaffer, et al., 2000). The sensitivity of the DISC is found 
to be excellent (range = 0.73 to 1.0) and one community-based study shows DISC 
correspondence to clinically meaningful ADHD symptomatology (ADHD; k =.72) 
(Schwab-Stone, Shaffer, Dulcan, & Jensen, 1996). The DISC showed moderate to good 
validity across a number of diagnoses, including ADHD (Schwab-Stone, et al., 1996). 
Parent interview was used because research has shown test-retest is unreliable on the 
child DISC interview (Schwab-Stone, et al., 1996). 
The Strengths and Difficulties Questionnaire (SDQ) (Goodman,
 
2001) 
The Strengths and Difficulties Questionnaire (SDQ) (Goodman, 2001), comprised 
of 25 symptom items, was developed for parents, teachers, and youth to assess emotional, 
social, and behavioral
 
difficulties and prosocial strengths. The symptom/difficulty 
subscales include symptoms of ADHD, conduct disorder, emotional problems, peer 
problems,
 
and prosocial behavior. Parents are asked about their child’s 
symptoms/behavior during the past six months and response variables include a three-
point Likert scale (“not true,” “somewhat true,” and “certainly true”) that indicates 
applicability of each symptom to the child (Goodman, 1999). The extended version of the 
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Strengths and Difficulties Questionnaire includes a rating of the impact of those 
symptoms/difficulties on specific areas of functioning (Goodman, 1999). 
Only the eight items assessing “impact” or impairment associated with the 
symptom items from the extended version of the SDQ were examined in these analyses. 
The parent version of this measure was completed at baseline and follow-up. The SDQ 
impairment section contains one item related to parental perceived severity of problems 
(“Overall, do you think that your child has difficulties in one or more of the following 
areas: emotions, concentration, behavior or being able to get on with other people?”) with 
responses including “no,” “yes, minor difficulties,” “yes, definite difficulties,” and “yes, 
severe difficulties,” and one item assessing the length of time the difficulties have been 
present (Goodman, 2001). Additionally, the impairment section consists of six items 
related to functioning associated with the reported difficulties with Likert scale responses 
ranging from “not at all” to “a great deal” . The five areas (or domains) of functioning 
assessed related to the child include child distress, home life, friendships, classroom 
learning, leisure activities. The last item asks about the difficulties being a burden to the 
caregiver or family.  
For these analyses, the parent perceived burden item was treated dichotomously, 
coded as “present” (“medium amount” or “great deal”) = 1, and, “absent” (“not at all” or 
“a little”) = 2. The five functioning items (also referred to as impairment items) were 
summed to derive
 
a “total impairment score,” categorizing impairment as 
abnormal/severe (high) if at least two impairment items were endorsed as a “medium 
amount” or one item was endorsed as a “great deal” (total impairment score ≥2) or 
normal/low/moderate (total impairment score ≤1). Total impairment scores were used to 
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consider predictors of service utilization, as an outcome variable, and to assess change 
from baseline to follow-up in relation to change in symptom categories. Individual 
functioning items were used to assess reliable change in functional impairment from 
baseline to follow-up using a reliable change index (described in detail below). 
Normative data on the SDQ parent version have been obtained for both child 
(Stone, Otten, Engels, Vermulst, & Janssens, 2010) and adolescent (Bourdon, et al., 
2005) populations. The SDQ is well-validated and was selected because it is widely used 
in both research and practice, and assesses domains of functioning in children and 
adolescents with ADHD. Reliability and validity data are summarized in two reports by 
the SDQ author (Goodman, 1999, 2001), and indicate that the parent version has high 
internal consistency for the total impact/impairment score (Cronbach alpha coefficient 
=.85), good four- to six-month retest stability for the parent version (Impact/impairment 
score; .57), and good validity for the impact/impairment score (negative predictive value 
(NPV) = .95; positive predictive value (PPV) = .53). Internal reliability has been reported 
to be .82 (Goodman, 2001). 
Medication Status & Service Use 
The DISC-IV was used to ascertain use of ADHD medication, including stimulant 
and non-stimulant medication, during the preceding year. The parent-reported mental 
health history questionnaire was used to identify if the parent has ever been told by a 




Socio-demographic information (age, gender, race, insurance status, primary 
parent’s educational attainment, and marital status) was obtained from parent self-report 
on a demographic questionnaire. 
STATISTICAL PROCEDURES FOR RESEARCH QUESTIONS 
SAS version 9.2 was used for data management and, when necessary, analyses 
were conducted using SAS-callable SUDAAN 10.0. 
Procedures for Research Questions 1 for Manuscript 1 
Part I:  JT Method: Looking for Reliable Change 
The data used to analyze question 1 for manuscript 1 were drawn from parent 
DISC-IV and SDQ data from baseline and follow-up assessments. Procedures outlined in 
Jacobson and Traux’s (1991) methodology for creating a reliable change index (RCI) 
were used to determine which children met criteria for reliable change in functioning 
(using the five functional domains from the SDQ data) in relation to symptom category 
(non-ADHD, subthreshold ADHD, and probable ADHD) change from baseline to follow-
up. While other comparable statistical methods exist, researchers are encouraging the use 
this method for comparability purposes (Karpenko, et al., 2009). The following formula 
for reliable change (RC) as outlined by Jacobson and Traux was used: 
 ;  
  
Xpost = individual’s score at follow-up  
Xpre = individual’s score at baseline 
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rxx = test-retest reliability of the measure 
Sdiff = standard error of the difference between the two scores 
SD1 = standard deviation of the sample at baseline 
SE = standard error of measurement 
Categories of change: 
Scores ≥ to 1.96 = positive change (e.g. impairment increased/worsened) 
Scores ≤ to -1.96 = negative change (e.g. impairment decreased/improved) 
Scores between 1.96 and -1.96 = no change 
Scores ≥ to 1.96 are unlikely to be due to chance (p<.05) (Karpenko, et al., 2009). 
Follow-up data for each measure of functioning was subtracted from the baseline data to 
find the difference scores for each of the 5 domains of functioning that are included in 
question 1. For each measure of functioning a participant was classified as having 
increased, decreased, or stayed the same. Total impairment scores were used when 
considering change in overall functional impairment from baseline to follow-up with 
abnormal/severe (high) impairment being at least two impairment items were endorsed as 
a “medium amount” or one item was endorsed as a “great deal.” These criteria were used 
because they follow the DSM-IV impairment criteria, yet may be overly stringent 
considering that situational ADHD (severe impairment in only one domain) may be an 
equally valid measure of impairment.(Lahey, et al., 2004) 
This first step, using the RCI, distinguished individuals who made a statistically 
reliable change from those who had not. It was performed to account for any error in 
measurement when analyzing change from the pre- to the post-time point (Rosenblatt & 
Rosenblatt, 2002). “Reliable change” is achieved when the “magnitude of change 
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sufficiently exceeds the random fluctuation associated with measurement error” 
(Rosenblatt, 2002). 
Part II:  Chi-square tests 
Next, to analyze the correspondence between symptoms (parent report using the 
DISC-IV) and functioning (parent report using SDQ), the two categorical variables of 
interest, Chi-square tests were conducted on the symptom groups (increase in symptoms 
(symptom deterioration), no change in symptoms, and decrease in symptoms (symptom 
improvement)) and functioning (increase in functional impairment (functional 
deterioration), no change in functioning, and decrease in functional impairment 
(functional improvement)) for each domain of functioning (i.e., friendships/classroom 
learning/home life/intrapersonal/leisure activities) and overall impairment (question 1, 
manuscript 1) for youth with ADHD, youth with subthreshold ADHD, and youth without 
ADHD. At baseline, participants were categorized into one of three main groups: those 
identified as having six symptoms from either the inattentive or hyperactive/impulsive 
symptom list (probable ADHD), those as identified as having three-to-five symptoms 
from either list (probable subthreshold ADHD), and those individuals identified as having 
none-to-two from either list (probable non-ADHD). Overall impairment was categorized 
as abnormal (high/severe impairment), borderline (moderate impairment), and normal 
(no/low impairment). The domains considered together for overall impairment were 
social, school, home, intrapersonal, and free time. 
Procedures for Research Question 1 for Manuscript 2 
The same methods described above were utilized to answer research question 1 
for manuscript 2. Two differences, however, are noted here. Participants were further 
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categorized by ADHD medication status (medicated versus not medicated during the 
previous year) and individuals with probable subthreshold ADHD were compared to 
individuals with probable ADHD. 
Procedures for Research Questions 2 for Manuscripts 1 & 2 
Predictors of More Severe forms of Functional Impairment 
Research question 2, manuscript 1, examined the predictors (or risk variables) of 
more severe forms of impairment at baseline, to see if they were similar for youth with 
ADHD, youth with subthreshold ADHD, and youth without ADHD. The outcome 
variable, “severe” (abnormal/high) impairment was met if at least two functional domain 
items were endorsed as a “medium amount” or one item was endorsed as a “great deal.” 
Five of the functional impairment questions above were summed and a total impairment 
score was treated dichotomously, with “severe impairment present” = 1, and, “absent” = 
2. The predictor variables included in the regression analysis include child factors (age, 
gender, comorbidity, and medication use) and family factors (exposure to parental 
psychopathology, primary parent’s educational attainment, marital status). Age 
(calculated from the DISC-IV interview date and date of birth) was treated as a 
continuous variable. Gender was treated dichotomously (male versus female). Two of the 
risk variables, co-morbid mental disorders and exposure to parental psychopathology 
were dichotomously coded as “present” (1) or “absent” (2). Co-morbid conditions are 
listed in the DISC-IV section above and were considered dichotomously. Medication use 
was considered dichotomously [if parent/caregiver reported that their child had or had not 
taken any ADHD medication in the last 12 months (prior to the baseline interview)]. 
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Parental psychopathology was considered dichotomously and included any parent 
report of previous diagnosis (12 of the most common mental disorders were reported, 
with depression reported most frequently). Primary parent’s educational attainment was 
considered dichotomously, as college degree or higher educational attainment versus 
some college education without a degree or lower education attainment. Marital status 
was considered dichotomously as a parent endorsing a family history of divorce or not. 
Predictors of Treatment Utilization 
Research question 2, manuscript 2, examines the predictors of treatment 
utilization (taken ADHD medication within the last year) for youth with subthreshold 
ADHD, compared to youth with ADHD. Data regarding medication use within the last 
year were obtained from the DISC-IV. Predictor variables included child factors [total 
impairment score (including social, academic, home, intrapersonal and leisure), gender, 
race, age, comorbidity] and family factors (parent reported burden, insurance, parent 
educational level, exposure to parental psychopathology). Individual functioning items 
were summed to create a total impairment score and treated dichotomously, with 
abnormal/severe (high) impairment = 1 if at least two functional impairment items were 
endorsed as a “medium amount” or one item was endorsed as a “great deal,” and less 
than that as “absent” = 2. Specific demographic characteristics (gender, race, age, 
insurance) were also considered as predictors, with gender treated dichotomously (male 
versus female); age (calculated from the DISC-IV interview date and date of birth) 




Parent reported burden (“do the difficulties put a burden on you or the family as a 
whole”) scores were treated dichotomously coded as either “present” (1) or “absent” (2). 
Insurance was considered in the following three categories: Medicaid vs. private 
insurance vs. no insurance. Primary parent’s educational attainment was considered 
dichotomously, as college degree or higher educational attainment versus some college 
education without a degree or lower education attainment. Exposure to parental 
psychopathology was treated dichotomously coded as either “present” (1) or “absent” (2).  
Logistic regression was used to explore the predictor variables explained above 
and the binary outcome variables (more severe impairment and ADHD medication use 
within the last year). Variables were selected for inclusion in a regression analysis based 
on literature indicating they are significantly related to the outcome variables for youth 
with ADHD compared to youth without ADHD. Participants were categorized into one of 
three main symptom groups: those identified as having six symptoms from either the 
inattentive or hyperactive/impulsive symptom list (probable ADHD), those as identified 
as having three to five symptoms from either list (probable subthreshold ADHD) and 
those individuals identified as having zero to two symptoms from either list (probable 
non-ADHD). Based on those categories, the baseline sample consisted of 211 non-
ADHD, 84 subthreshold, and 186 probable ADHD cases. All models were analyzed for 
goodness of fit, and statistically sound models were retained. 
Demographic and psychosocial characteristics of the interviewed sample, 
symptom count categories, symptom patterns, distribution of impairment item selection, 





Table 3.1 Demographic and Psychosocial Variables of Sample by Data Collection 
Wave (raw frequencies and weighted percents) 
 
  Baseline Follow-up 
  n % N % 
Total 481 100.0 292 100.0 
Gender     
 Boys 323 49.1 191 49.3 
 Girls 158 50.9 101 50.7 
Race/Ethnicity     
 Non-Hispanic White 269 44.2 169 46.3 
 Non-Hispanic Black 184 50.6 114 51.4 
 Other 28 5.2 9 2.4 
Age in years (mean, range) 9.1 (5-13) 11.8 (7-15) 
Insurance     
 None 49 11.8 20 6.6 
 Private insurance 305 69.9 203 76.6 
 Medicaid 100 18.3 58 16.7 
CD/ODD     
 Yes 90 11.5 40 7.8 
 No 389 88.5 252 92.2 
Any psychiatric comorbidity     
 Yes 123 17.4 54 12.4 
 No 356 82.6 238 87.6 
ADHD medication     
 Yes 141 14.4 92 17.1 





Table 3.2 Representation of Symptom Count Categories by Data Collection  
                 Wave 
 
Symptom Category Baseline Follow-up 
Probable ADHD cases (≥6 IA symptoms or 
≥6 HI symptoms) 
186 106 
Subthreshold ADHD cases (not a probable 
case, but had 3-5 IA symptoms or 3-5 HI 
symptoms) 
84 57 
Non-ADHD cases (<3 IA symptoms and <3 
HI symptoms) 
211 129 
Total 481 292 
Symptom count categories   by data collection wave (only including those 
who were re-interviewed at the follow-up) 
Symptom category Baseline Follow-up 
Probable ADHD cases (≥6 IA symptoms or 
≥6 HI symptoms) 
113 106 
Subthreshold ADHD cases (not a probable 
case, but had 3-5 IA symptoms or 3-5 HI 
symptoms) 
46 57 
Non-ADHD cases (<3 IA symptoms and <3 
HI symptoms) 
133 129 
























Probable ADHD cases (≥6 IA 
symptoms or ≥6 HI symptoms) 
113 34 66 - 
Subthreshold ADHD cases (not 
a probable case, but had 3-5 IA 
symptoms or 3-5 HI symptoms) 
46 28 33 39 
Non-ADHD cases (<3 IA 
symptoms and <3 HI symptoms) 
133 - 77 23 





Table 3.4 Distribution of Item Selection within Strengths and Difficulties 











Difficulties upset/distress child 62.2 21.9 10.9 5.0 
Difficulties interfere with home life 64.0 20.2 11.0 4.9 
Difficulties interfere with friendships 74.9 17.1 6.3 1.8 
Difficulties interfere with classroom 
learning 62.5 13.2 11.4 13.0 
Difficulties interview with leisure 




 Table 3.5 Impairment Changes for SDQ Domains of Functioning by Baseline  
                 ADHD Symptom Status 
 





























































































































Chapter 4  
RESULTS 
This chapter includes two manuscripts based on the analyses described in Chapter 
3. The first manuscript: Developmental differences in patterns of symptom and 
impairment change among a community sample of youth with ADHD, subthreshold 
ADHD and without ADHD; has been formatted for submission to the Journal of Child 
Psychology and Psychiatry and focuses on research questions 1 and 2. The second 
manuscript: Medication use within the context of ADHD and subthreshold ADHD: 
Developmental course and predictors in a community sample; focuses on research 
questions 3 and 4 and has also been formatted for submission to the Journal of Child 




MANUSCRIPT I:  DEVELOPMENTAL DIFFERENCES IN PATTERNS OF SYMPTOM AND 
IMPAIRMENT CHANGE AMONG A COMMUNITY SAMPLE OF YOUTH WITH ADHD, 
SUBTHRESHOLD ADHD, AND WITHOUT ADHD1 
                                                             
1 Lorie L. Geryk, MPH, Ken W. Watkins, PhD, Joseph R Holbrook, PhD, Steven P. 
Cuffe, MD, Daniela B. Friedman, PhD, Robert E. McKeown, PhD. Formatted for 




Background:  Despite a substantial prevalence of subthreshold Attention-
Deficit/Hyperactivity Disorder (ADHD) and research indicating that many youth with 
this disorder have impaired functioning and negative outcomes, few studies have 
considered patterns of symptom and functioning change for youth with probable ADHD, 
subthreshold ADHD and youth without ADHD transitioning from childhood to 
adolescence. Methods:  A community-based sample composed of children at high-risk 
for ADHD and low-risk peers (frequency-matched on gender) were identified through 
screening and invited to in-person interviews. At two assessment periods, baseline 
(N=481) and follow-up (N=292) (starting 20 months after baseline), parents/caregivers 
completed measures related to the youths’ psychiatric symptom and impairment status,  
and supplemental questionnaires examined socio-demographic information and child and 
family risk factors. At baseline, children were identified who met symptom criteria for 
subthreshold ADHD (N=84), probable ADHD (186), and non-ADHD (n=211) and 
patterns of change in symptoms and impairment were examined at follow-up using a 
Reliable Change Index (RCI) and Chi Square tests. A supplementary analysis 
investigated predictors of severe impairment. Percents are weighted to reflect the 
complex sampling design. Results:  Subthreshold ADHD symptoms were seen in as 
many as 18% (N = 84) of the youth studied at baseline. Youth who were non-ADHD at 
baseline who were probable cases at follow-up were significantly more likely to decline 
functionally in four of the five impairment domains and total impairment (62% overall 
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impairment decline) compared to youth who were non-ADHD at baseline and either non-
ADHD or subthreshold ADHD at follow-up (4% and 9% decline in overall impairment, 
respectively). Thirty three percent of youth who were subthreshold at baseline remained 
in that category at follow-up and 15%-27% of those individuals showed significant 
decline in at least one domain of functioning and 47% declined in overall impairment at 
follow-up. Conclusions:  The findings show the importance of examining symptom and 
impairment constructs separately in the consideration of their unique contributions to 
ADHD and subthreshold ADHD diagnoses and of acknowledging the need to examine 
nuanced changes in diagnostic status during development; especially functional declines. 
These findings may be relevant to efforts to intervene earlier in childhood and to help 
identify high-risk individuals who may be good candidates for targeted interventions. 
Key words: Attention Deficit Hyperactivity Disorder, Subthreshold ADHD, symptom 
and impairment trajectories, predictors of impairment. Abbreviations: RCI, reliable 
change index; ADHD, attention-deficit/hyperactivity disorder; DISC-IV, Diagnostic 
Interview Schedule for Children version IV; SDQ, Strengths and Difficulties 
Questionnaire; DSM-IV, Diagnostic and Statistical Manual-IV; OR, odds ratio; 95% CI, 




Health professionals and educators who consider Attention-Deficit/Hyperactivity 
Disorder (ADHD) syndrome only in the context of full presentation of symptoms may 
overlook an important group of subclinical children, and oversimplify nuanced problems 
(Barnow, et al., 2006). Recent studies have challenged the validity of current diagnostic 
criteria including ADHD subtype classifications (hyperactive-impulsive, inattentive, and 
combined) (Lahey, et al., 2005; Riley, et al., 2008; Todd, et al., 2008; Valo & Tannock, 
2010), age of onset criteria (Applegate, et al., 1997; Barkley & Biederman, 1997), and the 
need to have impairment present in two or more settings (Lahey, et al., 2004). 
Researchers have called for the replacement of categorical subtypes with a focus on 
dimensional case identification of ADHD using severity or counts of symptoms (Lahey & 
Willcutt, 2010; Lubke, et al., 2009; Rowland, et al., 2008; Valo & Tannock, 2010), for 
elimination or extension of the age of onset criteria (Barkley & Biederman, 1997; Bell, 
2011; McGough & Barkley, 2004), and for focus more on impairment type and severity 
than on number of settings (Lahey, et al., 2004; Ramsay & Rostain, 2006). 
Subthreshold ADHD 
A growing body of evidence indicates that a sizable number of youth who meet 
less than full symptom criteria for a diagnosis of ADHD experience significant functional 
impairment that may require intervention (Mick, et al., 2011). This subthreshold group 
has been shown to express the same set of genes as ADHD (Levy, et al., 1997) and to be 
at increased risk of developing ADHD (Bussing, et al., 2010). Subthreshold ADHD is 
more prevalent than ADHD (Lewinsohn, et al.), with up to 22% of youth exhibiting 
inattentive and/or hyperactive subthreshold symptoms (Scahill, et al., 1999), yet little 
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research has been devoted to understanding developmental trajectories of youth with 
subthreshold ADHD. To be clinically meaningful, any reduced form of ADHD (e.g. 
meeting fewer than the required DSM-IV symptoms for a full diagnosis) should include 
consideration of impairment (Mick, et al., 2004). 
ADHD Associated Impairment 
Similar to symptoms of ADHD, functional impairment may tend to change as 
children age, and such change may be affected by environmental demands (Harpin, 
2005). However, unlike symptoms which tend to diminish over time (Biederman, et al., 
2000), impairment tends to become more noticeable as children age and acquire more 
autonomy, and is thought to have an additive effect (Adler, et al., 2008; Wender, et al.), 
with impairment in one domain predicting later compromised functioning in other 
domains (Murray-Close, et al., 2010).  
Measuring Patterns of Symptom and Impairment Change 
Research has demonstrated that measures of impairment generally have a 
relatively modest correlation with symptom reports, supporting the argument that these 
are two related yet separate aspects of the ADHD diagnosis (Gathje, et al., 2008) and 
cannot be validly equated (Bell, 2011). Measuring either impairment or symptoms 
without the other does not provide a complete clinical picture and may result in poor or 
inaccurate treatment decisions (e.g. length, type, or dose of treatment) (J. S. Owens, et al., 
2009). Further, research shows that decreasing symptom burden is not always associated 
with improved functional status, whereas increasing symptom burden is more likely to be 
associated with functional decline (J. S. Owens, et al., 2009).  
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Recently, in the ADHD literature, two studies have emerged focusing on the 
poorly understood connection between reliable change in symptoms relative to reliable 
change in functioning (E. B. Owens, et al., 2009; Rosenblatt & Rosenblatt, 2002). Using 
a reliable change index (RCI) (Jacobson, 1991) studies confirm that change in 
functioning (both improved functioning and worsened functioning) often occurs when 
there is no reliable or significant change in symptoms (Karpenko, et al., 2009; E. B. 
Owens, et al., 2009; Rosenblatt & Rosenblatt, 2002). Heterogeneity in patterns of change 
is an understudied area, (Willoughby, 2003) and Jacobson and Traux’s RCI method, 
while most often utilized in treatment and intervention studies, is an ideal method for 
exploring patterns of symptom and impairment change among community-based youth 
with ADHD, subthreshold ADHD, and without ADHD. 
Predictors of Impairment 
There is a large body of research considering predictors of ADHD persistence, but 
few studies have explored predictors of impaired functioning. Though not well 
understood, a number of child and family risk factors may contribute to impairment 
among ADHD youth (Healey, 2010). Child-related factors including gender (Gathje, et 
al., 2008), higher levels of comorbidity, increased impulsive symptoms (Biederman, 
Mick, et al., 1998) and treatment (Molina, et al., 2009) were found to be associated with 
functioning. Researchers analyzing ADHD symptoms most associated with impairment 
showed symptom prevalence or subtype distinctions are inadequate for predicting 
impairment (Mota & Schachar, 2000).  
Family factors associated with functioning among ADHD youth include: maternal 
psychopathology (Biederman, Mick, et al., 1998), social advantage (Molina, et al., 2009), 
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and marital status (Healey, Gopin, Grossman, Campbell, & Halperin, 2010). No study 
was found examining predictors of impairment for youth with subthreshold ADHD. This 
is a needed area of study, given that subthreshold ADHD may follow a similar, persistent 
impairment trajectory as ADHD. 
Study Purpose 
The main purpose of this study is to consider the complex processes through 
which impairment trajectories unfold in relation to symptoms. This study is a novel 
extension to previous RCI studies, and examines the relationship between change in 
symptoms and reliable change in functioning in children and adolescents with ADHD, 
subthreshold ADHD, and children without ADHD who participated in the South Carolina 
Project to Learn about ADHD in Youth (SCPLAY). Additionally, predictors associated 
with more severe forms of ADHD impairment will be explored to see if they are similar 
for youth with ADHD and youth with subthreshold ADHD. 
Methods 
Recruitment and Sampling 
SCPLAY utilized a two-phase research design involving school district-wide, 
voluntary teacher and parent screenings (phase I) and in-person assessments (phase II). 
In-person assessments involved (structured diagnostic interviews with youth and 
parents/caregivers at baseline and four follow-up points. The sampling population 
included 15 elementary schools (pre-k through grade five) in SC with approximately 
8,700 students from culturally and racially diverse rural, suburban, and urban 
neighborhoods. Children in non-self-contained classrooms were screened for risk of 
ADHD through two approaches: 1. teacher rated symptoms of inattention, hyperactivity, 
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and impulsivity using the Vanderbilt ADHD Diagnostic Teacher Rating Scale 
(VADTRS) (M. L. Wolraich, et al., 1998), impairment ratings by using the “impact 
supplement” of the Strengths and Difficulties Questionnaire (SDQ) (Goodman, 1999), 
and reported history of ADHD diagnosis and ADHD medication use; and, 2. parent-
reported history of ADHD diagnosis and ADHD medication use. The behavioral 
screening was conducted during the 2003-2004 school years and 4606 teachers and/or 
parents completed Phase I screens. 
All high-risk children (high-screen for ADHD) and a sample of low-risk children 
(low-screen for ADHD), frequency matched on gender, were randomly selected (n=2206) 
and invited, along with their parent/caregiver, by letter to participate in Phase II in-person 
structured assessments. Six hundred and thirty-three families returned forms indicating an 
interest in being contacted about Phase II assessments. Baseline interviews were 
conducted with consenting parents/caregivers and children 13 months (mean time) 
following the screening.  
A detailed description of the SCPLAY study population, design, sampling frame, 
and methods are described elsewhere (M. L. Wolraich, et al., 2012). SCPLAY study 
procedures were approved by the Institutional Review Board of the University of South 
Carolina and the Centers for Disease Control and Prevention, and informed parental 
consent was obtained for all interviews. The institutional review board of the University 
of South Carolina determined this study exempt from its review. 
Participants 
Data for these analyses were obtained from SCPLAY baseline (n=481; 9/03-1/06) 
and follow-up 1 parent assessments (n=292; 9/07-2/09). Parent/caregiver, a biological 
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parent in 426 out of 481 (89%) baseline families, provided family demographic and 
psychosocial information, mental health history, information about the selected child 
related to ADHD symptoms and impairment, other psychiatric disorders, and treatment 
history via computer-based (interviewer administered) interview and paper and pencil 
(self-administered) questionnaires. The final sample for this report is 292 of the original 
481, with 285 parents/caregivers completing the SDQ impact supplement at follow-up. 
Comparison of the retained sample versus those lost to attrition revealed no statistically 
significant differences related to baseline demographic variables.  
Using the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) 
(American Psychiatric Association, 2000) symptom criteria for ADHD, youth were 
categorized into two symptom groups: probable ADHD cases (≥ 6 Inattentive (IA) 
symptoms or ≥ 6 hyperactive/impulsive (HI) symptoms) and subthreshold ADHD cases 
(3-5 IA symptoms or 3-5 HI symptoms). After categorization, 39% of the sample met 
inclusion criteria for probable ADHD, 18% for subthreshold, and 44% for non-ADHD at 
baseline; at follow-up, 36% of the sample met inclusion criteria for probable ADHD, 
19% for subthreshold, and 44% for non-ADHD. The baseline samples are introduced in 
Table 4.1. There were no significant differences between the probable ADHD, 
subthreshold ADHD, and non-ADHD groups on demographic characteristics at baseline. 
Measures 
The Diagnostic Interview Schedule for Children (DISC-IV; Shaffer et al., 
2000). The DISC-IV, based on the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV-TR) (Association & DSM-IV., 2000), is a well-validated, fully-structured 
diagnostic interview developed to diagnosis psychopathology in children (Shaffer, et al., 
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2000). Parents were administered the DISC-IV by a trained interviewer during baseline 
and the first follow-up annual assessment to obtain past year ADHD symptom counts and 
past year categorical probable diagnosis for generalized anxiety disorder, separation 
anxiety disorder, social phobia, post-traumatic stress disorder, obsessive compulsive 
disorder, major depression/dysthymic disorder, mania/hypomania, oppositional defiant 
disorder, and conduct disorder. The test-retest reliability of the ADHD DISC symptom 
count (parent report) in a community sample (past year) among children aged 9-17 years 
was ICC=.84 (Shaffer, et al.). The DISC showed moderate to good validity across a 
number of diagnoses, including ADHD (Schwab-Stone, et al., 1996). Parent interview 
was used because research has shown low test-retest reliability in the child disc interview 
(Schwab-Stone, et al., 1996). 
ADHD Medication Status. One dichotomous medication status variable was 
coded (1 (yes) or 0 (no)) from the following item on the DISC-IV interview, “In the past 
twelve months, has your child taken any medicine for being overactive, being 
hyperactive, or having trouble paying attention?” Based on a subsample on whom we 
have detailed medication data (n=458), 14.6% of the subthreshold ADHD sample at 
baseline were taking stimulant medication and 4.3% were taking non-stimulant 
medication. 32.6% of the probable ADHD sample at baseline were taking stimulant 
medication and 13.6% were taking non-stimulant medication. 
The Strengths and Difficulties Questionnaire (SDQ) (Goodman, 2000). The 
SDQ (extended version) is a domain-specific behavioral screener consisting of 25 
symptom items assessing five subscales (behavioral problems, emotional problems, 
hyperactivity, peer-problems, and prosocial behavior) and seven “impact questions” 
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assessing difficulties in functioning (i.e. school and classroom settings) associated with 
reported symptoms (Goodman, 1999). The SDQ is one of a few measures that was 
specifically developed to assess impairment in relation to ADHD and other psychiatric 
symptoms. For these analyses, only the parent version impact questions of the SDQ 
extended version were examined (baseline and follow-up).  
For the first impact question “Overall, do you think that (child’s name) has 
difficulties in any of the following areas: emotions, concentration, behavior, or being able 
to get along with other people?” (responses included ‘no,’ ‘minor,’ ‘severe,’ and 
‘definite’), if respondents reported at least “minor” problems, then further impact 
questions related to five domains of functioning were asked. The impairment variables 
were defined by using parent responses to the following questions: 1. “Do the difficulties 
upset or distress the child?”; 2-5. “Do the difficulties interfere with the child’s life in the 
following areas: 2. Home life?; 3. Friendships?; 4. Classroom learning?; leisure 
activities?; and 6. “Do the difficulties put a burden on you or the family as a whole?” 
Response options for these items were coded (“not at all”=0; “a little”=0; “a medium 
amount”=1; “a great deal”=2). . Individual impairment items were used to assess reliable 
change in functioning from baseline to follow-up using a reliable change index (RCI; 
described below) (Jacobson & Truax, 1991).  
The SDQ is well-validated, and reliability and validity data are summarized in 
two reports by the author (Goodman, 1999, 2001). For the impact supplement, the parent 
version has high internal consistency (Cronbach alpha coefficient =.85), good 4-6 month 
retest stability (Impact/impairment score; .57), good validity (negative predictive value 
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(NPV) = .95; positive predictive value (PPV) = .53), and internal reliability has been 
reported to be .82 (Goodman, 2001). 
Predictors of Impairment 
Outcome Variable: The five impairment items were summed to derive
 
a “total 
impairment score,” and dichotomously treated as abnormal/severe if at least two 
impairment items were endorsed as a “medium amount” or one item was endorsed as a 
“great deal” (total impairment score ≥2) or normal/low/moderate (total impairment score 
≤1). Predictor Variables: Several baseline factors were examined as predictors of severe 
impairment. Child demographic and psychosocial variables included age and gender 
(ascertained from parental reports on the demographic questionnaire), comorbidity 
[considered dichotomously as either having or not having had a comorbid disorder 
(baseline, past year) as reported on parent DISC-IV report], and medication use, 
considered dichotomously [parent/caregiver report that their child had or had not taken 
any ADHD medication in the last 12 months (prior to the baseline interview)]. 
Additionally, the following family factors were examined as predictors of severe 
impairment: marital status (dichotomized into married or divorced); primary caregiver’s 
education level (dichotomized into less than a bachelor degree or a bachelor degree or 
higher); and, history of parent psychopathology (considered dichotomously and 
ascertained from parent report on a mental health history questionnaire). 
Procedures/Analysis 
All analyses were performed using SAS-callable SUDAAN version 10.0 software 
to adjust for the complex sampling design. Basic descriptive statistics were calculated 
and prevalence of treatment utilization reported. Raw frequencies and weighted 
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percentages are reported for all results. Procedures outlined in Jacobson and Traux’s 
(1991) methodology for creating a reliable change index (RCI) were used to determine 
which youth met criteria for reliable change in impairment (using the five domains of 
functioning from the SDQ data) in relation to symptom category (non-ADHD, 
subthreshold ADHD, and probable ADHD) change from baseline to follow-up. While 
other comparable statistical methods exist, researchers are encouraging the use this 
method for comparability purposes (Karpenko, et al., 2009). The following formula for 
reliable change (RC) as outlined by Jacobson and Traux was used: 
 ;  
  
The RCI method described by Jacobson and Traux (1991) was used to divide the 
baseline by follow-up differences for each participant by the standard error (SE) of the 
difference score for each domain of functioning. This allowed for the identification of 
individual change (significance level set to p ≤ 0.05) that is greater than what would be 
attributed to chance or measurement error (Jacobson, Roberts, Berns, & McGlinchey, 
1999). 
Descriptive percentages were used to compare proportions of change (i.e., 
improvement, no change, and decline) in symptom categories and functional impairment 
measures (five domains and overall impairment) among symptom groups (Jacobson, et 
al., 1999). SDQ scores ≥ to 1.96 reflected positive change (i.e., impairment increased), 
scores ≤ to -1.96 reflected negative change (e.g. impairment decreased), and scores 
between 1.96 and -1.96 reflected no impairment change. Participants were then classified 
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as “functionally improved” (i.e. changed statistically significantly in a positive direction), 
“no changers” (i.e. did not change statistically significantly), and “functionally declined” 
(changed statistically significantly in a negative direction). Further, chi-square tests were 
used to determine if there was a significant association between improvement in 
symptoms and improvement in functioning. 
A multivariable logistic regression analysis was used to examine the relative 
impact of all covariates on the likelihood of having severe impairment at follow-up. Odds 
ratios and 95% confidence intervals (CIs) were computed to investigate the strength of 
the relationships between risk factors and severe impairment. All covariates were initially 
screened through interaction models and those that were poorly associated with ADHD 
medication use were excluded in the final multiple logistic regression models. 
Results 
The baseline sample was ethnically and gender diverse, with non-Hispanic blacks 
and girls being well-represented, 38% and 33%, respectively. At baseline, youth ranged 
in age from 5-13 (mean 9.1) and at follow-up youth ranged in age from 7-15 (mean 11.8). 
Twenty six percent of youth had one or more comorbid psychiatric disorder at baseline 
and 19 of youth had one or more comorbid psychiatric disorder at follow-up. Twenty 
nine percent of youth were taking ADHD medication at baseline and 32% at follow-up. 
Twenty six percent of youth had co-occurring mental disorder(s) at baseline and 18% at 
follow-up. 
Patterns of Symptom and Functioning Change 
After establishing symptom category change form baseline to follow-up, RCI was 
used to distinguish individuals who made a statistically reliable change in each domain of 
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functioning (and overall impairment) from baseline to follow-up. The relation between 
symptom category change (decrease, no change, and increase) for individuals with 
probable ADHD, subthreshold ADHD, and non-ADHD and impairment change 
(individual domains of functioning and overall impairment) was analyzed through a 
series of chi-square tests. The percentage of children demonstrating patterns of symptom 
change (increased, no change, and decreased) and impairment change (five domains of 
functioning and overall impairment) is shown in Tables 4.2 (functional decline) and 4.3 
(functional improvement). 
Youth who were non-ADHD at baseline, who were probable ADHD cases at 
follow-up, were significantly more likely to decline functionally than either subthreshold 
ADHD or non-ADHD at follow-up in 4 domains of functioning and total impairment: 
distress/intrapersonal, x
2
 (2, N = 14) = 53.10, p < 0.001; friendships, x
2
 (2, N = 13) = 
46.20, p < 0.001; classroom learning, x
2
 (2, N = 14) = 32.93, p < 0.001; leisure activities, 
x
2
 (2, N = 10) = 50.90, p < 0.001; total impairment, x
2
 (2, N = 14) = 41.71, p < 0.001. 
Youth who were subthreshold ADHD at baseline, who were probable ADHD at follow-
up, were significantly more likely to decline functionally than subthreshold ADHD at 
follow-up in classroom learning, x
2
 (2, N = 13) = 14.74, p < 0.001. Youth who were 
subthreshold ADHD at baseline, who were subthreshold at follow-up, were significantly 
more likely to decline functionally than probable ADHD youth in total impairment, x
2
 (2, 
N = 15) = 8.78, p < 0.02. Youth who were probable ADHD at baseline, were not 




Youth who were non-ADHD at baseline who were probable ADHD cases at 
follow-up were significantly less likely to improve functionally than either subthreshold 
ADHD or non-ADHD at follow-up in 4 domains of functioning: distress/intrapersonal, x
2
 
(2, N = 94) = 23.37, p < 0.001; friendships, x
2
 (2, N = 96) = 21.62, p < 0.001; classroom 
learning, x
2
 (2, N = 91) = 28.92, p < 0.001; and leisure activities, x
2
 (2, N = 97) = 20.32, 
p < 0.001. Youth who were subthreshold ADHD at baseline who were probable ADHD 
cases at follow-up were significantly less likely to improve functionally than either 
subthreshold ADHD or non-ADHD at follow-up in distress/intrapersonal functioning, x
2
 
(2, N = 22) = 7.13, p < 0.05. Finally, youth with probable ADHD at baseline who 
remained probable ADHD at follow-up were significantly less likely to improve 
functionally compared to youth with non-ADHD and subthreshold youth at follow-up in 
two areas:  distress/intrapersonal, x
2
 (2, N = 45) = 8.90, p < 0.02; friendships, x
2
 (2, N = 
31) = 7.66, p < 0.05; and significantly less likely to improve functionally compared to 
youth with subthreshold ADHD at follow-up in two areas: classroom learning, x
2
 (2, N = 
51) = 9.40, p < 0.01; and leisure activities, x
2
 (2, N = 42) = 16.99, p < 0.001. 
Predictors of Severe Impairment 
Multivariable Models – Non-ADHD, Subthreshold ADHD and Probable ADHD 
Covariates that were found to be associated with severe impairment include the 
following: male gender, taking ADHD medication, psychiatric comorbidity, and having a 
primary parent with a psychiatric history. Marital status and age were not significantly 
related to severe impairment at follow-up and were dropped from the final logistic 
regression models. Table 4.4 presents results of the 3 multivariable logistic regression 
models. In model 1, among non-cases, ADHD medication use (OR = 9.8; 95% CI: 1.8–
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54.6) was the strongest significant predictor of severe impairment, followed by primary 
parent psychiatric problem history (OR = 4.1; 95% CI: 1.4–12.3).  
In model 2, among subthreshold cases, females (OR = 0.3; 95% CI: 0.1–1.0) were 
significantly less likely than males to have severe impairment at follow-up. Though not 
statistically significant, those whose parent/s had less than a college bachelors degree 
(OR = 3.0; 95% CI: 0.9-10.6) were more likely to be severely impaired at follow-up than 
those youth whose parents had a bachelors degree or higher education. In model 3, 
among probable ADHD cases, severe impairment at follow-up was more likely in those 
who met criteria for a comorbid psychiatric disorder (OR 5.2; 95% CI: 2.2-11.9) 
compared to those who did not. Non-cases, subthreshold cases, and probable ADHD 
cases did not share any of the same significant predictors. 
Discussion 
This study is one of the relatively few prospective community-based studies 
following subthreshold cohorts of youth to examine patterns of change in symptoms and 
functional impairment. This was achieved by following a diverse sample of youth with 
subthreshold ADHD, probable ADHD, and without ADHD over a period of 
approximately 3 years to study the course of ADHD functional impairment in five areas – 
intrapersonal, home life, friendships, classroom learning, and leisure activities, with the 
majority of children entering adolescence at follow-up. In an attempt to consider the 
ADHD syndrome in a more nuanced way, this study considered symptom and 
functioning change without narrowly defined DSM subtype, age of onset, and 
impairment (two or more settings) diagnostic criteria. 
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Findings  show that decreasing symptom burden is not always associated with 
improved function, whereas increasing symptom burden is more likely to be associated 
with functional decline. A portion of youth who were probable ADHD cases at baseline 
and decreased symptoms (subthreshold ADHD at follow-up), 21% (N=22) experienced 
significant functional decline in at least one functional domain; whereas, 39% (N=18) of 
youth with baseline subthreshold ADHD whose  symptoms increased  (probable ADHD 
at follow-up) declined functionally at follow-up. These findings are in line similar 
methodological  research (J. S. Owens, et al., 2009) and show the importance of 
examining both symptom and functioning constructs in the consideration of their unique 
contributions to ADHD and subthreshold ADHD diagnoses. 
Subthreshold ADHD symptoms were seen in as many as 17% (N = 84) of the 
youth studied here at baseline. This is similar to the Scahill et al. (1999) study finding 
that 22% of youth exhibited subthreshold symptoms. The prevalence of subthreshold 
ADHD increased slightly at follow-up to 20% (N = 57). Thirty three percent of youth 
who were subthreshold at baseline remained in that category at follow-up (compared to 
77% and 66% of youth remaining in non- and probable ADHD categories, respectively); 
whereas, 28% decreased to non-ADHD, and 39% increased into the ADHD category. 
These findings have important implications. First, they support research showing youth 
with subthreshold ADHD are at increased risk of developing ADHD (Bussing, et al., 
2010). Second, the subthreshold ADHD category was not as stable as the non-ADHD and 
probable ADHD symptom categories (at follow-up).  
Among the 33% of youth (baseline and follow-up subthreshold ADHD), 33% 
declined functionally at follow-up in at least on of the five domains of functioning and 
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47% declined in overall impairment. This finding supports recent research showing a 
sizable number of subthreshold ADHD youth had significant functional impairment that 
may require intervention (Mick et al., 2011; Young & Gudjonsson, 2008; Scahill, et al., 
1999; J. S. Owens, et al., 2009; Biederman, et al., 2000; Bussing, et al., 2010) 
Additionally, early identification of subthreshold ADHD with associated functional 
decline may help identify youth at high-risk for “converting” to full ADHD. 
Findings from the series of chi-square tests suggest that youth (both non-ADHD 
and subthreshold ADHD at baseline) who achieve probable ADHD status at follow-up 
are more likely to decline functionally than individuals achieving subthreshold ADHD or 
non-ADHD status at follow-up. This was especially true of youth with non-ADHD at 
baseline who were significantly more likely to decline functionally in total impairment 
and four of the five domains of functioning (all but home life). Baseline youth with 
subthreshold ADHD who were probable ADHD cases at follow-up were significantly 
more likely to decline functionally than subthreshold ADHD at follow-up in classroom 
learning and overall functioning. Baseline youth with non-ADHD and subthreshold 
ADHD who achieved probable ADHD status at follow-up were also significantly less 
likely to improve functionally at follow-up than youth with either subthreshold ADHD or 
non-ADHD at follow-up.  
Finally, baseline youth with probable ADHD who remained probable ADHD at 
follow-up were significantly less likely to improve functionally compared to youth with 
non-ADHD at follow-up in distress/intrapersonal and friendships and significantly less 
likely to improve functionally compared to youth with subthreshold ADHD at follow-up 
in classroom learning and leisure activities. This finding is expected as youth with 
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probable ADHD would likely exhibit elevated levels of impairment at baseline and 
follow-up, thus less likely to achieve functional improvement from baseline to follow-up 
assessments. 
Taken together it is clear that achieving probable ADHD status at follow-up is 
associated with the most functional decline. Achieving subthreshold status at follow-up 
was associated with less functional decline than probable ADHD status, but more 
functional decline than non-ADHD status at follow-up. This is in line with 
epidemiological evidence supporting a dimensional view of ADHD, where symptoms 
and impairments are continuously distributed in the general population, with more severe 
disorder lying at the upper end of the continuum (Buitelaar & Rothenberger, 2004; Shaw 
et al., 2011). 
The longitudinal data used here offered the opportunity to consider predictors of 
severe impairment among non-ADHD, subthreshold, and probable ADHD symptom 
categories. Most notable among the findings is that probable ADHD and subthreshold 
ADHD did not share any significant predictors in common; not an expected finding based 
on the supposition that subthreshold youth would share a similar impairment predictor 
profile as individuals with probable ADHD. Regression analysis, controlling for all other 
covariates, revealed four significant predictors for subsequent severe impairment: ADHD 
medication use and primary parent psychiatric history in the non-ADHD model; gender 
in the subthreshold model, and psychiatric comorbidity in the probable ADHD case 
model. 
The finding that ADHD medication use among the non-ADHD symptom group is 
a highly significant predictor of severe impairment is notable, but may be partially or 
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wholly explained by different  reasons including the following:1.treatment with ADHD 
mediation for another problem; 2. misdiagnosis; or 3. ADHD medication treatment is 
effective for reducing symptoms but not impairment. The subthreshold ADHD model 
showed being male significantly predicted severe impairment is not inline with results 
from a meta-analysis which found no gender differences in social and peer and academic 
performance functioning (Gaub & Carlson, 1997). Based on the lack of similar predictor 
findings for subthreshold and probable ADHD youth, it is reasonable to assume children 
with subthreshold ADHD tend not to be similar to children with ADHD with regard to 
risk profiles for severe impairment. The probable ADHD model results are consistent 
with prior findings showing comorbid psychopathology was negatively associated with 
normalized functioning (Biederman, Mick, et al., 1998). The identification of only one 
significant predictor for the probable ADHD group was not expected, since the predictor 
variables were selected based on prior study findings among individuals with ADHD. 
Study Limitations & Strengths 
As with any study, the current findings are not without limitations. The SDQ is a 
domain specific measure (assessing functional impairment in relation to symptoms of 
multiple disorders) (Canino, et al., 1999) so there is no way to know which symptoms, if 
any, are directly related to the reported impairment. However, using the DISC-IV (a 
symptom specific measure), was not possible because if the symptom criteria, duration 
criteria, or age of onset criteria for ADHD are not met, the impairment questions are 
never asked and subthreshold impairment and control children’s impairment could not be 
assessed. Symptom specific measures of impairment are needed that are not constrained 
by an inability to assess the impairment of youth with subthreshold ADHD and 
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comparison youth. Additionally, domains of functioning were measured using a single 
SDQ item. While this does not allow for complete detail, the SDQ is a well validated 
measure often used to assess functioning, is practical to administer, and provides 
information about multiple domains of functioning that can help inform developmental 
trajectory research as well as treatment and service decisions. 
The use of only parent/caregiver report is another limitation, as the DSM-IV 
recommends the use of multiple informants and the American Academy of Pediatrics 
recommends the need for both parent and teacher report of functional impairment 
(American Psychiatric Association, 2000; M. Wolraich, Brown, & Brown, 2011). 
Teacher reports of functional impairment were collected, but due to poor response rates, 
not used. Parent subjectivity may also be biased (e.g., underreport due to social 
desirability, over-report due to help-seeking, endorse symptoms that affect them the most, 
and may be more reliable reporters for younger children) (Barkley, 2006). While there is 
often disagreement among multiple informants and subjective bias in parent report, 
parents are thought to be crucial for a valid assessment of ADHD (Barkley, et al., 2002; 
Cantwell, Lewinsohn, Rohde, & Seeley, 1997). 
Symptom decreases over time might reflect true developmental changes, but also 
may be due to other things such as artifacts of repeated measurement (Hart, et al., 1995) 
and diagnostic inadequacies (e.g., applying symptoms that are not developmentally 
sensitive (Willoughby, 2003)). Additionally, the relationship between symptom change 
and impairment in specific domains of functioning may be a function of the treatment or 
care that individuals were provided, comorbidity, or other factors. While the impact of 
those things is not known, and the findings are constrained by unadjusted percents and 
 
117 
small numbers, this represents some of the only data available describing symptoms and 
functional impairment for youth in a community setting. 
Another limitation of this study is the proportion of baseline participants lost to 
follow-up. If those individuals were less likely to have ADHD symptoms or more likely 
to have ADHD symptoms, the findings are less likely to be representative of the initial 
sample. Finally, as the course of ADHD and subthreshold ADHD is continually 
changing, one’s symptom and impairment status at baseline and follow-up may not be 
static and future studies exploring changes in patterns of ADHD symptoms and 
impairment are needed that use repeated observations. 
This study adds to an absence of population-based longitudinal impairment data 
of children with subthreshold ADHD who are identified in early childhood and followed 
into adolescence. While most ADHD trajectory studies consider only patterns of 
symptom change over time, this study considered patterns of change for both symptoms 
and functioning. It utilized well validated instruments, trained data collectors, and 
extensive data quality control measures. Study sampling design increased case finding 
and analysis accounted for sampling design to give unbiased estimates. It used a 
prospective design with a retention rate of 61% at follow-up. In addition to being cross 
sectional in nature, most studies focus on children, and this study followed youth up to 
age 15. This was a community-based rather than clinic-based study, which is a strength, 
as clinic-based youth are likely to have more severe symptom and functional impairments 
than youth in the community (Gau, et al., 2010) and may result in higher treatment 
seeking rates (Rowland, Lesesne, & Abramowitz, 2002). White boys account for the 
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majority of research related to ADHD in youth (Hartung & Widiger, 1998 )and girls and 
African American youth are well represented in this study.  
Clinical Implications 
Based on current policies, individuals with subthreshold ADHD may not qualify for 
treatment and services (Canino, et al., 1999) yet it seems clinically questionable to 
disqualify individuals for services because they fall below symptom threshold for the 
recommended DSM criteria if they present with significant and developmentally 
inappropriate functional impairment. Current findings help inform our understanding of 
impairment persistence associated with symptom change and highlight the importance of 
considering subthreshold ADHD in efforts to understand the trajectories through which 
risk factors may affect the expression of, or impaired functioning associated with, 
ADHD. Evaluating the patterns between symptoms and impairment change provides 
direct comparisons between individuals for a better understanding of individual needs 
which can help in the treatment decision making process to continue or discontinue 
treatment/intervention or to focus on specific domains of impaired functioning. 
As part of the evaluation process, it is important to educate parents and youth that 
ADHD is a chronic condition shaped by biological and environmental factors (Halfon, 
2002) with associated impairments that may last into adulthood. ADHD education should 
stress that as the child/adolescent grows, develops and confronts different environmental 
challenges it is important to recognize that different symptoms and impairment may be 
exhibited. Targeted interventions should be tailored and flexible in addressing differences 
in individual symptom and impairment profiles. 
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Finally, the regressions revealed that severe impairment was significantly 
predicted by psychiatric comorbidity among probable ADHD cases, being male among 
subthreshold ADHD, and primary parent psychiatric problem history and psychiatric 
medication use among individuals without ADHD at follow-up. These findings may be 
relevant to efforts to intervene earlier in childhood and to help identify high-risk 
individuals who may be good candidates for targeted interventions. 
Clinically, pinpointing areas of individual need may help in the design of targeted 
treatment strategies, improve patient outcome, and aid the clinician’s ability to clearly 
and meaningfully inform caregivers and children. From a public health perspective, this 
knowledge can help focus scarce societal resources toward ADHD children at higher risk 
for persistent and severe impairment. This has implications for early intervention and 
secondary prevention initiatives, with the goal in mind of improving functioning of 
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Table 4.1 Demographics of Sample by Baseline ADHD Status; Raw Frequencies  
and Weighted Percents 
 
 
 Non-ADHD Cases Subthreshold Cases Probable 
ADHD Cases 
  N % N % N % 
Total  211 100.0 84 100.0 186 100.0 
Age in years (mean, range) 9.0 (5-12) 9.5 (5-12) 9.4 (5-13) 
Gender        
 Boys 136 41.9 59 65.0 128 60.2 
 Girls 75 58.1 25 35.0 58 39.8 
Race/Ethnicity       
 Non-Hispanic White 119 45.3 49 46.7 101 39.8 
 Non-Hispanic Black 81 48.6 34 51.4 69 55.6 
 Other 11 6.1 1 1.9 16 4.7 
Any psychiatric comorbidity       
 Yes 13 6.8 18 22.8 92 43.4 
 No 197 93.3 66 77.2 93 56.6 
ADHD medication       
 Yes 11 3.3 21 19.1 109 42.1 
 No 200 96.7 63 80.9 77 57.9 
Parent mental health history       
 Yes 32 12.1 14 18.6 53 24.3 
 No 176 87.9 69 81.4 122 75.7 
Parent education level       
 Less than bachelors degree 99 45.2 54 59.4 120 62.8 




Table 4.2 Percentages of Youth with Decrease in Symptoms, No change in 
Symptoms, and Increase in Symptoms Who Achieved Reliable Change 
DECLINE on SDQ Functional Measures (Increased Impairment) 
 
 Non-ADHD at baseline (n=130) 
 
No change in sx 
(non-ADHD at 
follow-up) 
Increase in sx 
(subthreshold ADHD 
at follow-up) 
Increase in sx 
(probable ADHD 
cases at follow-up) 
 (n=100) (n=17) (n=13) 
Baseline SDQ 
Impairment 
% who declined 
functionally (95% 
CI) 
% who declined 
functionally (95% CI) 
% who declined 
functionally (95% CI) 
Distress/intrapersonal** 4.0 (1.2, 12.3) 3.6 (0.6, 19.0) 69.1 (32.9, 91.0) 
Home life 4.6 (1.6, 12.7) 3.6 (0.6, 19.0) 7.9 (1.6, 31.6) 
Friendships** 3.8 (1.1, 12.2) 3.6 (0.6, 19.0) 62.4 (25.2 (89.1) 
Classroom learning** 5.7 (1.6, 17.7) 5.4 (1.4, 19.0) 57.9 (20.3, 88.1) 
Leisure activities** 1.8 (0.5, 7.1) 3.6 (0.6, 19.0) 57.2 (19.7, 87.9) 
Total impairment** 4.0 (1.2, 12.3) 9.0 (2.9, 25.0) 62.3 (25.0, 89.1) 
 Subthreshold ADHD at Baseline (n=46) 
 Decrease in sx (non-
ADHD at follow-up) 
No change in sx 
(subthreshold ADHD 
at follow-up) 
Increase in sx 
(probable ADHD 
cases at follow-up) 
 (n=13) (n=15) (n=18) 
Baseline SDQ 
Impairment 
% who declined 
functionally (95% 
CI) 
% who declined 
functionally (95% CI) 
% who declined 
functionally (95% CI) 
Distress/intrapersonal 3.5 (0.6, 18.6) 18.2 (6.7, 40.9) 37.2 (18.0, 61.4) 
Home life 1.7 (0.3, 9.6) 27.4 (6.4, 67.6) 19.6 (7.3, 42.9) 
Friendships 3.5 (0.6, 18.6) 19.2 (6.3, 45.8) 25.9 (10.4, 51.2) 
Classroom learning** 0.0 16.6 (5.5, 40.5) 59.7 (36.2, 79.5) 
Leisure activities 0.0 15.3 (5.0, 38.1) 28.7 (9.4, 60.8) 
Total impairment* 0.0 47.2 (21.1, 75.0) 43.8 (21.3, 69.1) 
 ADHD at baseline (n=103) 
 Decrease in sx (non-
ADHD at follow-up) 
Decrease in sx 
(subthreshold ADHD 
at follow-up) 
No change in sx 
(probable ADHD 
cases at follow-up) 
 (n=13) (n=22) (n=68) 
Baseline SDQ 
Impairment 
% who declined 
functionally (95% 
CI) 
% who declined 
functionally (95% CI) 
% who declined 
functionally (95% CI) 
Distress/intrapersonal 17.7 (5.3, 45.3) 31.4 (11.0, 62.9) 13.2 (7.5, 22.3) 
Home life 8.4 (1.9, 30.2) 4.9 (1.2, 17.6) 17.2 (8.6, 31.6) 
Friendships 18.1 (5.5, 45.8) 20.7 (7.3, 46.5) 19.6 (12.2, 29.9) 
Classroom learning 5.5 (0.9, 28.7) 1.6 (0.3, 9.0) 17.6 (9.8, 29.6) 
Leisure activities 18.1 (5.5, 45.8) 23.6 (8.9, 49.4) 14.5 (8.5, 23.8) 
Total impairment 7.8 (1.7, 29.0) 0.0 15.5 (8.1, 27.7) 
 
** p < .01 for Chi-square analyses 




Table 4.3 Percentages of Youth with Decrease in Symptoms, No Change in 
Symptoms, and Increase in Symptoms Who Achieved Reliable Change 
IMPROVEMENT on SDQ Functional Measures (Decreased Impairment) 
 
 Non-ADHD at Baseline (n=130) 
 No change in sx (non- 
ADHD at follow-up) 
Increase in sx 
(subthreshold ADHD at 
follow-up) 
Increase in sx (probable 
ADHD cases at follow-
up) 
 (n=100) (n=17) (n=13) 
Baseline SDQ Impairment 
% who improved 
functionally (95% CI) 
% who improved 
functionally (95% CI) 
% who improved 
functionally (95% CI) 
Distress/intrapersonal** 78.6 (66.5, 87.2) 76.3 (51.0, 90.9) 14.8 (3.8, 43.7) 
Home life 75.0 (63.2, 84.0) 55.1 (28.5, 79.0) 59.7 (22.2, 88.5) 
Friendships** 80.7 (69.6, 88.4) 76.1 (50.1, 91.0) 20.7 (5.8, 52.5) 
Classroom learning** 77.7 (65.8, 86.4) 74.5 (50.0, 89.5) 5.3 (0.8, 28.8) 
Leisure activities** 82.2 (72.6, 89.0) 70.6 (44.8, 87.7) 24.9 (7.2, 58.7) 
Total impairment 5.7 (2.7, 11.6) 5.1 (0.9, 25.0) 5.3 (0.8, 28.8) 
 Subthreshold ADHD at Baseline (n=46) 
 Decrease in sx (non-
ADHD at follow-up) 
No change in sx 
(subthreshold ADHD at 
follow-up) 
Increase in sx (probable 
ADHD cases at follow-
up) 
  (n=13) (n=15) (n=18) 
Baseline SDQ Impairment 
% who improved 
functionally (95% CI) 
% who improved 
functionally (95% CI) 
% who improved 
functionally (95% CI) 
Distress/intrapersonal* 73.5 (38.1, 92.6) 53.1 (26.4, 78.1) 25.7 (11.2, 48.6) 
Home life 56.7 (26.1, 82.9) 14.8 (4.4, 39.6) 30.7 (11.3, 60.7) 
Friendships 38.6 (13.5, 71.7) 56.7 (29.9, 80.1) 16.5 (5.6, 39.6) 
Classroom learning 59.7 (26.9, 85.6) 49.4 (23.1, 76.0) 28.6 (12.7, 52.5) 
Leisure activities 19.1 (7.0, 42.5) 56.3 (29.6, 79.8) 31.3 (14.4, 55.2) 
Total impairment 28.8 (9.7, 60.4) 21.3 (6.8, 50.3) 21.1 (8.7, 42.7) 
 Probable ADHD at baseline (n=103) 
 Decrease in sx (non-
ADHD at follow-up) 
Decrease in sx 
(subthreshold ADHD at 
follow-up) 
No change in sx 
(probable ADHD cases 
at follow-up) 
  (n=13) (n=22) (n=68) 
Baseline SDQ Impairment 
% who improved 
functionally (95% CI) 
% who improved 
functionally (95% CI) 
% who improved 
functionally (95% CI) 
Distress/intrapersonal* 75.0 (45.7, 91.4) 54.3 (27.1, 79.2) 33.8 (22.0, 48.1) 
Home life 44.6 (13.8, 80.3) 41.5 (17.1, 71.0) 42.9 (28.3, 58.8) 
Friendships* 62.3 (27.3, 87.9) 23.8 (9.4, 48.3) 25.2 (15.4, 38.6) 
Classroom learning** 49.0 (15.9, 83.0) 77.7 (56.9, 90.2) 40.1 (25.8, 56.4) 
Leisure activities** 80.1 (52.1, 93.7) 10.2 (3.8, 24.3) 42.9 (28.5, 58.7) 
Total impairment 35.0 (8.7, 75.3) 43.9 (18.7, 72.7) 32.1 (18.3, 50.1) 
** p < .01 for Chi-square analyses 




Table 4.4 Results of Multivariate Logistic Regression for Prediction of Impairment 
 
  OR (95% Confidence Interval) p value 
  Non-cases Subthreshold cases Probable cases 











 Males 1.0 - 1.0 - 1.0 - 











 No 1.0 - 1.0 - 1.0 - 











 No 1.0 - 1.0 - 1.0 - 
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Background. Despite a substantial prevalence of subthreshold ADHD and research 
indicating that many youth with subthreshold ADHD are being treated with ADHD 
medication, little is known about patterns of symptom and impairment change in relation 
to medication status and predictors of medication use. Methods. A community-based 
sample composed of children at high-risk for ADHD and low-risk peers (frequency-
matched on gender) were identified through screening and invited to in-person 
interviews. At two assessments periods, baseline (N=270) and follow-up (N=163) 
parents/caregivers of youth with probable ADHD or subthreshold ADHD completed 
measures related to the youth’s psychiatric symptom and functional impairment status 
and supplemental questionnaires examined socio-demographic information and child and 
family risk factors. At baseline, children were identified who met symptom criteria for 
subthreshold ADHD (N=84) and probable ADHD (186) and patterns of change in 
symptoms and functioning based on medication status were examined at follow-up 
(starting 20 months years later) using a Reliable Change Index (RCI) and Chi Square 
tests. A supplementary analysis investigated predictors of ADHD medication use. 
Results. ADHD medication data for this cohort showed that 19% (n=21) of youth with 
subthreshold ADHD at baseline and 27% (n=14) of youth with subthreshold ADHD at 
follow-up) and 42% (n=109) of youth with probable ADHD at baseline and 41% (n=65) 
of youth with probable ADHD at follow-up had taken medication in the year prior to 
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assessment. Thirty three percent (N=15) of youth who were subthreshold ADHD at 
baseline retained that status at follow-up and showed significant decline in function. 
When considering medication status among those individuals, 50% of the medicated 
youth declined in overall functioning at follow-up compared to 10% of those who where 
not medicated the year prior to follow-up. Baseline youth with probable ADHD who 
were not medicated the year prior to follow-up and who were non-ADHD cases at 
follow-up were significantly more likely than probable ADHD at follow-up to decline 
functionally in distress/intrapersonal and friendships; they were also more likely to 
decline in leisure activities compared to youth with subthreshold ADHD at follow-up. 
Parent perceived burden was predictive of ADHD medication use for youth with probable 
ADHD but significantly so for youth with subthreshold ADHD. Conclusions. The 
findings show the importance of examining symptom and functional impairment 
constructs separately in the consideration of their unique contributions to ADHD and 
subthreshold ADHD diagnoses and of acknowledging the need to more closely examine 
nuanced changes in diagnostic status and medication needs during development, taking 
impairment, more so than symptoms into account. These findings may be relevant to 
efforts to intervene earlier in childhood and to help identify high-risk individuals who 
may be good candidates for targeted interventions. Key words: Attention Deficit 
Hyperactivity Disorder, Subthreshold ADHD, symptom and impairment trajectories, 
predictors of impairment. Abbreviations: RCI, reliable change index; ADHD, attention-
deficit/hyperactivity disorder; DISC-IV, Diagnostic Interview Schedule for Children 
version IV; SDQ, Strengths and Difficulties Questionnaire; DSM-IV, Diagnostic and 




Inattention, hyperactivity/impulsivity, or the combination of the two impairs an 
individual's ability to adjust to a continually changing environment; and impairment may 
be a direct consequence (Nijmeijer et al., 2008). It is clear from the literature that 
deficiencies in functional impairment occur in individuals with ADHD at all ages across 
multiple domains (e.g. social, academic) (Sciberras, Roos, & Efron, 2009). ADHD is a 
persistent condition for many, and although symptoms tend to diminish and show 
different patterns over time (Holbrook, 2012), symptom declines do not necessarily result 
in a return to normal function (Willoughby, 2003). 
Children and adolescents who fail to achieve full ADHD diagnosis or full 
remission, a group referred to as subclinical, subsyndromal, or subthreshold(among other 
terms), are at risk for developing ADHD (Barnard-Brak, To, & Fearon, 2011; Bussing, 
Mason, Bell, Porter, & Garvan, 2010). While the literature lacks clear definitions of these 
terms, the ADHD literature often considers subthreshold ADHD to be three to five 
symptoms of either the inattentive or hyperactive/impulsive symptoms (using the DSM-
IV ADHD diagnostic criteria) and the current analyses adopts this specific definition. 
Subthreshold ADHD is more common than ADHD (Lewinsohn, Shankman, Gau, & 
Klein) with up to 22% of youth exhibiting subthreshold ADHD symptoms (Scahill, et al., 
1999). Compared to individuals without ADHD, individuals with subclinical ADHD have 
worse educational, occupational, economic, and social outcomes (e.g. grade retention, not 
graduating, divorce, lower incomes) (Bussing, et al., 2010; Klein et al., 2012). Further, 
children with subthreshold ADHD may be denied treatment and services based on current 
policies (Bussing, Mason, Bell, Porter, & Garvan, 2010; Canino, Costello, & Angold, 
 
134 
1999 1999). Recent ADHD treatment intervention studies have shown that change in 
function occurs in the absence of symptom change and vice versa (Karpenko, Owens, 
Evangelista, & Dodds, 2009; Owens, Johannes, & Karpenko, 2009). Further, research 
shows that decreasing symptom burden is not always associated with improved 
functional status, whereas increasing symptom burden is more likely to be associated 
with functional decline (Owens, et al., 2009). For research, referral, treatment, and 
intervention purposes it is important to identify children who make reliable change in 
both symptom and impairment change, as well as those who make change in only one 
area (Owens, et al., 2009). To date, research is lacking in this area and very little is 
known about longitudinal patterns of symptom and functional impairment change for 
youth with subthreshold ADHD. 
Symptom and impairment developmental trajectories can be improved through 
early identification and appropriate treatment of ADHD (Magyary & Brandt, 2002). A 
range of medication options exists for the treatment of ADHD, with stimulant 
medications [e.g. Ritalin (i.e., methylphenidate) and Adderall (i.e., dextroamphetamine)] 
generally considered superior to nonstimulant medications (e.g. Strattera (i.e., 
atomoxetine)) (Action; Vierhile, Robb, & Ryan-Krause, 2009). ADHD medication 
reduces ADHD symptoms (e.g., fidgeting and interrupting) as well as impairment (e.g., 
relationships at home with parents) in about 70% of youth (Action, 2002). In 2007, 66% 
of youth (ages 4-17) received medication treatment for a current ADHD diagnosis (Visser 
& Lesesne, 2005). Youth aged 11-17 had higher mediation rates than children aged 4-10, 
and boys were more likely than girls to take medication (Visser & Lesesne, 2005). 
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Treating Children with Subclincial ADHD 
The subject of treating children diagnosed as subthreshold ADHD is 
controversial. Data suggest that, compared to children meeting full ADHD symptom 
counts, fewer children meeting subthreshold symptoms counts are treated with 
medication (Bussing, et al., 2010). One study, using retrospective recall data among 
adults, considered four subgroups (full ADHD/subthreshold ADHD/late-onset 
ADHD/controls) and found among the subthreshold group, 19% had ever received 
psychotropic medication for ADHD, compared to 58% of the group with full ADHD 
(Faraone et al., 2006). In another study, 25% of youth with subthreshold ADHD reported 
ever being treated with medication for ADHD, compared to 50% of youth with ADHD 
(Bussing, et al., 2010). While one would expect lower rates of medication treatment 
among individuals with diminished forms of ADHD compared to ADHD, some question 
the appropriateness of treating this group at all (Faraone, et al., 2006), while others reason 
that increasing medication rates among subthreshold cases may reduce the risk for 
negative functional outcomes (Bussing, et al., 2010). 
Predictors of Service Use 
Several studies have examined predictors of treatment utilization for youth with 
ADHD and only a few studies have examined predictors of treatment utilization for youth 
with subthreshold ADHD. Research shows service contact for ADHD is often made 
because of parent’s perception of problems (perceived burden) or parental strain rather 
than child factors such as comorbidity (Angold et al., 1998; Bussing et al., 2003; Sayal, 
2006). Additional predictors of treatment seeking and service use for children with 
ADHD include male gender (Beuermeister, 2003; Gau et al., 2010; Bussing, 2005), 
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maternal education (college or higher) (Gau et al., 2010), parental mental health history, 
marital status (divorced) (Jensen, Bloedau, and Davis, 1990), and younger age (Leslie et 
al., 2005). 
Of the few studies that have considered a subclinical ADHD group, two studies 
found subclinical ADHD (defined three different ways, and not including individuals 
who met impairment criteria) predicted stimulant medication use (Bauermeister et al., 
2003; Leslie, et al., 2005). Reich et al. found that among comparison children, ADHD 
symptom counts and presence of impaired functioning were significant treatment 
correlates (Reich, Huang, & Todd, 2006). Similarly, Angold et al. found among the 
ADHD-NOS group, stimulant medication use was significantly related to number of 
symptoms and comorbid Oppositional Defiant Disorder (ODD) (Angold, Erkanli, Egger, 
& Costello, 2000). To our knowledge, no study has examined parent perceived burden as 
a predictor of medication use for youth with subthreshold ADHD. 
Study Purpose 
It is not clear from the literature if youth with subthreshold ADHD who are 
unmedicated fare particularly worse over time compared to individuals with subthreshold 
ADHD who are taking ADHD medication. To our knowledge, there are no published 
studies that have examined how medication use within the context of ADHD and 
subthreshold ADHD unfolds with regard to patterns of symptom and impairment change. 
The main purpose of this study is to discern prospective patterns of symptoms and 
functional impairment change in a community sample of youth with subthreshold ADHD 
and youth with ADHD, with regard to medication status (taking medication versus not 
taking medication). Additionally, this study evaluates predictors of ADHD medication 
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use for youth with subthreshold ADHD compared to youth with ADHD. This research 
adds to the existing understanding of subthreshold ADHD and explores symptom and 
functioning correspondence methodology that can be useful in identifying patterns that 
have important implications for conceptualizing treatment in research and practice for 
youth with subthreshold ADHD. It is also designed to identify more homogeneous 
subgroups with a higher likelihood of experiencing service utilization. 
METHODS 
Recruitment and Sampling 
SCPLAY utilized a two-phase research design involving school district-wide, 
voluntary teacher and parent screenings (phase I) and in-person assessments (phase II). In 
person assessments involved (structured diagnostic interviews with youth and 
parents/caregivers at baseline and four follow-up points. Baseline interviews were 
conducted with consenting parents/caregivers and children 13 months (mean time) 
following the screening. Further explanation of the SCPLAY study population, design, 
sampling frame, and methods can be found elsewhere (M. L. Wolraich et al., 2012). 
SCPLAY study procedures were approved by the Institutional Review Board of the 
University of South Carolina and the Centers for Disease Control and Prevention and 
informed parental consent obtained for all interviews.  
Participants 
Data for these analyses were obtained from SCPLAY baseline (n=481; 9/03-1/06) 
and follow-up parent assessments (n=292; 9/07-2/09). Parent/caregiver [a biological 
parent in 426 out of 481 (89%) baseline families] provided family demographic and 
psychosocial information, mental health history, information about the selected child 
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related to ADHD symptoms and impairment, other psychiatric disorders, and treatment 
history via computer-based (interviewer administered) interview, and paper and pencil 
(self-administered) questionnaires.  
Using the Diagnostic and Statistical Manual of Mental Disorders, 4
th
 edition, 
(DSM-IV-TR) symptom criteria for ADHD, youth were categorized into two symptom 
groups: probable ADHD cases (≥ 6 Inattentive (IA) symptoms or ≥ 6 
hyperactive/impulsive (HI) symptoms) and subthreshold ADHD cases (3-5 IA symptoms 
or 3-5 HI symptoms). After categorization, 69% (n=186) of the sample met inclusion 
criteria for probable ADHD and 31% (n=84)  met inclusion criteria for subthreshold 
ADHD. These categories only consider symptoms counts and do not correspond to 
previously published prevalence estimates that used a strict DSM-IV-TR ADHD case 
definition (Wolraich et al., 2012). The final baseline sample for these analyses is 270 of 
the original 481, with 260 parents/caregivers completing the SDQ impact supplement at 
follow-up. The baseline samples are introduced in Table 4.2.1. Comparison of the 
retained sample versus those lost to attrition revealed no statistically significant 
differences related to baseline demographic and psychosocial variables. 
Measures 
The Diagnostic Interview Schedule for Children (DISC-IV; Shaffer et al., 
2000). The DISC-IV, based on the Diagnostic and Statistical Manual of Mental 
Disorders, 4
th
 edition (DSM-IV-TR) (Association & DSM-IV., 2000), is a well-validated, 
fully-structured diagnostic interview developed to diagnosis psychopathology in youth 
(Shaffer, Fisher, Lucas, Dulcan, & Schwab-Stone, 2000). Parents were administered the 
DISC-IV by a trained interviewer during baseline and the first follow-up annual 
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assessments to obtain past year ADHD symptom counts and past year categorical 
probable diagnosis for ODD and CD. The test-retest reliability of the ADHD DISC-IV 
module (parent report) in a clinical sample and community sample (past year) among 
children aged 9-17 years was k=.79 and k=.60, respectively (Shaffer, et al.). The DISC 
showed moderate to good validity across a number of diagnoses, including ADHD 
(Schwab-Stone, Shaffer, Dulcan, & Jensen, 1996). Parent interview was used because 
research has shown low test-retest reliability in the child DISC interview (Schwab-Stone, 
et al., 1996).  
ADHD Medication Status. One dichotomous medication status variable was 
created from the following item on the DISC-IV interview, “In the past twelve months, 
has your child taken any medicine for being overactive, being hyperactive, or having 
trouble paying attention?” Based on a subsample on whom we have detailed medication 
data (n=458), 14.6% of the subthreshold ADHD sample at baseline were taking stimulant 
medication and 4.3% were taking non-stimulant medication; 32.6% of the probable 
ADHD sample at baseline were taking stimulant medication and 13.6 were taking non-
stimulant medication. 
The Strengths and Difficulties Questionnaire (extended version) (SDQ) 
(Goodman, 2000). The SDQ (extended version) is a domain-specific behavioral screener 
consisting of 25 symptom items assessing five subscales: behavioral problems, emotional 
problems, hyperactivity, peer-problems, and prosocial behavior and seven “impact 
questions” assessing difficulties in functioning (i.e., school and classroom settings) 
associated with reported symptoms (Goodman, 1999). The SDQ is one of a few measures 
of functional impairment that was specifically developed to assess impairment in relation 
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to ADHD and other psychiatric symptomatology. For these analyses, only the parent 
version impact questions from the extended version of the SDQ were examined (baseline 
and follow-up assessments). 
For the first impact question “Overall, do you think that (child’s name) has 
difficulties in any of the following areas: emotions, concentration, behavior, or being able 
to get along with other people?”, responses included ‘no,’ ‘minor,’ ‘severe,’ and 
‘definite’; if respondents reported at least “minor” problems, then the following impact 
questions related to five domains of functioning were asked: Question 1. “Do the 
difficulties upset or distress the child?”; Questions 2.-5. “Do the difficulties interfere with 
the child’s life in the following areas: 2. home life?; 3. friendships?; 4. classroom 
learning?; 5. leisure activities? One additional impact supplement item asked if the 
reported difficulties put a burden on the family (response options are the same as for the 
five functional impairment questions). The five impairment items scores were summed to 
create a total impairment score. Individual domains of functioning and total impairment 
were used to assess reliable change in functioning from baseline to follow-up using a 
reliable change index (RCI; described below) (Jacobson & Truax, 1991).   
The SDQ is well-validated, and reliability and validity data are summarized in 
two reports by the author (Goodman, 1999, 2001). For the impact supplement, the parent 
version has high internal consistency (Cronbach alpha coefficient =.85), good 4-6 month 
retest stability (Impact/impairment score; .57), and good validity (negative predictive 
value (NPV) = .95; positive predictive value (PPV) = .53)(Goodman, 2001). 
Predictors of taking ADHD medication during the last year. Predictor 
Variables:  Several baseline factors were examined as predictors of ADHD medication 
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utilization. Child demographic and psychosocial variables included age, gender, race 
(Non-Hispanic white vs. Non-Hispanic Black vs. Other) (all three variables ascertained 
from parental reports on the demographic questionnaire); comorbidity (ODD/CD were 
coded as separate dichotomous variables) (ascertained form parent DISC-IV report); and, 
severe impairment (present if at least one of the five SDQ domain question responses was 
“a great deal” or if two or more question responses were “a medium amount”) 
(ascertained using parent SDQ report). Additionally, the following family factors were 
examined as predictors of ADHD medication utilization: marital status (dichotomized as 
married or unmarried), primary caregiver’s education level (dichotomized as less than a 
bachelor degree or a bachelor degree and higher), insurance (none vs. private insurance 
vs. Medicaid), (all three variables ascertained from parental reports on the demographic 
questionnaire); parental psychopathology (coded as a dichotomous variable) (ascertained 
from parent report on a mental health history questionnaire); and, parent-reported burden 
based on the SDQ question (treated dichotomously coded as “present” (“medium 
amount” or “great deal”) or “absent” (“not at all” or “a little”). 
Procedures/Analysis: 
All analyses were performed using SAS-callable SUDAAN version 10.0 software 
to adjust for the complex sampling design. Basic descriptive statistics were calculated 
and prevalence of treatment utilization reported. Raw frequencies and weighted 
percentages accounting for the sampling scheme are reported for all results. Procedures 
outlined in Jacobson and Traux’s (1991) methodology for creating a reliable change 
index (RCI) were used to determine which youth met criteria for reliable change in 
impairment (using the five functional domains from the SDQ data) in relation to 
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symptom category (subthreshold ADHD and probable ADHD) change from baseline to 
follow-up (considering ADHD medication status). 
While other comparable statistical methods exist, researchers encourage use of 
this method for study comparison purposes (Karpenko, et al., 2009). The following 
formula for reliable change (RC) as outlined by Jacobson and Traux was used: 
 ;  
  
The RCI method described by Jacobson and Traux (1991) was used to divide the 
baseline by follow-up differences for each participant by the standard error (SE) of the 
difference score for each domain of functioning. This allowed for the identification of 
individual change (significance level set to p ≤ 0.05) that is greater than what would be 
attributed to chance or measurement error (Jacobson, Roberts, Berns, & McGlinchey, 
1999). 
Descriptive percentages were used to compare proportions of change (i.e., 
improvement, no change, and decline) in symptom categories and functional impairment 
measures (five domains and overall impairment) among symptom groups. SDQ scores ≥ 
to 1.96 reflected positive change (i.e., impairment increased); scores ≤ to -1.96 reflected 
negative change (e.g. impairment decreased); and, scores between 1.96 and -1.96 
reflected no impairment change. Participants were then classified as “functionally 
improved” (i.e., significant positive change), “no change” (i.e., no significant change), 
and “functionally declined” (significant negative change). Further, chi-square tests were 
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used to determine if there was a significant association between improvement in 
symptoms and improvement in functioning.  
A multivariable logistic regression analysis was used to examine which variables 
were independently predictive of ADHD medication use in multivariate models, using 
forward stepwise entry of variables of most interest to this study. Adjusted odds ratios 
and 95% confidence intervals (CIs) were computed to investigate the strength of the 
relationships. 
Results 
The sample was ethnically and gender diverse with non-Hispanic blacks and girls 
being well represented at baseline (38% and 31%) and follow-up (39% and 34% ), 
respectively. At baseline, youth ranged in age from 5-13 (mean 9.4) and at follow-up 
youth ranged in age from 7-15 (mean 11.8). Thirty two percent of youth had comorbid 
ODD and/or CD at baseline and 30% of youth had comorbid ODD and/or CD at follow-
up. Forty eight percent of youth were taking ADHD medication at baseline and 50% of 
the follow-up sample was taking ADHD medication. Among youth with subthreshold 
ADHD at baseline, 19% were taking ADHD medication the year prior to baseline 
compared to 42% of probable ADHD youth who where taking ADHD medication the 
year prior to baseline. At follow-up, 27% of youth with subthreshold ADHD and 41% of 
youth with probable ADHD were taking ADHD medication the year prior to follow-up. 
After establishing medication status and symptom category change from baseline 
to follow-up, RCI was used to distinguish individuals who made a statistically reliable 
change in each domain of functioning (and overall impairment) from baseline to follow-
up. The relation between symptom category change (decrease, no change, and increase) 
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for individuals with probable ADHD and subthreshold ADHD, and functional 
impairment change (individual domains and overall impairment) was analyzed through a 
series of chi-square tests. The percentage of children demonstrating patterns of symptom 
change (increased, no change, and decreased) (based on medication status) and 
impairment change (five domains of functioning and overall impairment) is shown in 
Tables 4.2.2 (functional decline/subthreshold at baseline), 4.2.3 (functional 
decline/probable ADHD at baseline), 4.2.4 (functional improvement/subthreshold at 
baseline), and 4.2.5 (functional improvement/probable ADHD at baseline). 
Baseline youth with subthreshold ADHD who were not medicated the year prior 
to follow-up and who were probable ADHD cases at follow-up were significantly more 
likely to improve functionally than subthreshold ADHD at follow-up in classroom 
learning. Baseline youth with subthreshold ADHD who were not medicated the year prior 
to follow-up and who were subthreshold ADHD cases at follow-up were significantly 
more likely to improve functionally than probable ADHD at follow-up in total 
impairment. Baseline youth with subthreshold ADHD who were not medicated the year 
prior to follow-up and who were non-ADHD cases at follow-up were significantly more 
likely to decline functionally than probable ADHD cases  and subthreshold cases at 
follow-up in distress/intrapersonal impairment. Baseline youth with probable ADHD who 
were not medicated the year prior to follow-up and who were non-ADHD cases at 
follow-up were significantly more likely to decline functionally than probable ADHD 
and subthreshold ADHD at follow-up in distress/intrapersonal impairment and 
friendships; they were also more likely to decline in leisure activities compared to youth 
with subthreshold ADHD and probable ADHD at follow-up. 
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PREDICTORS OF MEDICATION USE 
Multivariable Models – Subthreshold ADHD and Probable ADHD 
Multivariate regression models were used to identify whether any of the measured 
independent variables (overall impairment, parent perceived burden, conduct disorder 
and/or oppositional defiant disorder, gender, race/ethnicity, parent mental health history, 
age, primary parent education, and insurance) might predict ADHD medication use for 
youth with subthreshold ADHD and probable ADHD (Table 4.2.6). In the subthreshold 
ADHD model, parent perceived burden was positively associated with medication use. In 
the probable ADHD model, females were less likely than males to take medication. 
Overall impairment and comorbid CD/ODD were not significantly related to ADHD 
medication use. Race/ethnicity, parent mental health history, age, primary parent 
education, and insurance were also added to the models individually but were dropped 
due to lack of change in the point estimates of other variables before and after their 
addition to the models. 
Discussion 
In an attempt to consider ADHD dynamics in a more nuanced way, this study 
considered symptom and functioning change without using narrowly-defined DSM 
subtype, age of onset, and impairment (two or more settings) diagnostic criteria. This 
study is one of a relatively few prospective community-based studies following a diverse 
sample of youth with ADHD and subthreshold ADHD examining patterns of change in 
symptoms and functioning, considering ADHD medication status. Chi-square analyses 
showed that youth with subthreshold ADHD at baseline (and not medicated the year prior 
to follow-up) who were probable ADHD cases at follow-up were significantly more 
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likely to improve functionally in classroom learning compared to subthreshold ADHD 
cases at follow-up. Youth at baseline with subthreshold ADHD (and not medicated the 
year prior to follow-up who were subthreshold ADHD at follow-up were significantly 
more likely to improve functionally overall compared to youth with probable ADHD at 
follow-up. Considering medication status, one would expect individuals in the probable 
ADHD unmedicated group, who had increased symptoms from baseline subthreshold 
status) to show less improvement than individuals with unmedicated subthreshold ADHD 
at follow-up (no change from baseline); and this is evident in overall impairment 
(significant in chi square testing) and other measures of functioning (while not significant 
in chi-square testing), with more subthreshold youth (than probable ADHD youth) at 
follow-up showing greater positive change in improvement in the areas of home life and 
friendships. 
A different trend was seen among youth with probable ADHD at baseline who 
were not medicated the year prior to follow-up and non-ADHD cases at follow-up. Those 
individuals were significantly more likely to decline functionally than probable ADHD at 
follow-up in distress/intrapersonal and friendships domains and more likely to decline in 
leisure activities compared to youth with subthreshold ADHD and probable ADHD at 
follow-up. These findings, that decreasing symptoms are associated with functional 
decline may be explained by research suggesting that although symptoms tend to 
diminish over time, symptom declines do not necessarily result in a return to normal 
function (Willoughby, 2003). Further, impairment may increase over time as demands 
increase and through an additive process; with impairment becoming more noticeable as 
children age and acquire more autonomy (Adler, Spencer, Stein, & Newcorn, 2008). 
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In line with the declining symptom with increasing impairment trend, baseline 
youth with subthreshold ADHD who were not medicated the year prior to follow-up and 
who decreased symptoms (i.e., were non-ADHD cases at follow-up) were significantly 
more likely to decline functionally than probable ADHD cases at follow-up in 
distress/intrapersonal impairment. This group (N=11) of youth with non-ADHD at 
follow-up showed some functional decline in the areas investigated (e.g. 75% in 
classroom learning and 34% in overall impairment) which is concerning. It may be that 
these individuals, while they no longer meet symptom criteria for subthreshold ADHD, 
are suffering from remaining ADHD symptoms and/or other impairing disorders or 
psychosocial circumstances. 
Considering the medicated versus nonmedicated groups, the subthreshold baseline 
group who were probable ADHD at follow-up (and taking ADHD medication the year 
prior to follow-up) improved more functionally in the areas of intrapersonal, friendships, 
and classroom than those youth with probable ADHD at follow-up who were not 
medicated. The subthreshold baseline group who were subthreshold ADHD at follow-up 
and were taking medication the year prior to follow-up improved more functionally in the 
intrapersonal domain compared to those youth with subthreshold ADHD at follow-up 
who were not medicated. Youth who were probable ADHD at baseline and subthreshold 
ADHD at follow-up who were medicated the year prior to follow-up declined 14% in 
overall impairment at follow-up compared to those who were not medicated the year 
prior to follow-up (53% decline in overall impairment). This trend was similar for youth 
who were probable ADHD at baseline and remained probable ADHD at follow-up; 23% 
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of the medicated group declined in overall impairment compared to 44% of the 
unmedicated group. 
While most ADHD medication treatment studies only consider symptom change, 
a review of the literature including studies assessing improvements in functioning found 
medication use versus no medication use is associated with greater rates of symptom 
remission and increased social and academic functioning (Steele, Jensen, & Quinn, 
2006). While those findings show evidence of improvements in functioning with 
medication use, as described in the previous paragraph, this analysis showed youth with 
subthreshold ADHD at baseline and medicated the year prior to follow-up tended to 
decline functionally to a greater degree in four out of five domains of functioning and 
overall functioning compared to youth with subclinical ADHD at follow-up who were not 
medicated. Youth who were subthreshold ADHD who were probable ADHD at follow-up 
and medicated the year prior to follow-up also tended to decline functionally to a greater 
degree in three out of the five domains and overall functioning compared to youth with 
probable ADHD at follow-up who were not medicated. Individuals presenting with 
severe impairment may show less overall improvement in functional impairment 
measures over time. Additionally, medication treatment compliance may be as low as 
50% in children with ADHD (Johnston & Fine, 1993) which may result in poor 
management of symptoms and functional impairment (Perwien et al., 2004). 
In the present study we calculated a reliable change index (RCI) (Jacobson and 
Truax, 1991) to determine statistically significant functional impairment change. RCI has 
been applied to intervention and drug trial studies in the ADHD literature, and these data 
show the value of considering longitudinal community based symptom and functioning 
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trajectory data using the RCI method. RCI should not be confused with clinical 
significance which is often defined as a return to normal functioning (Jacobson, et al., 
1999). With the understanding that ADHD is a persistent neurobiological disorder, we 
did not calculate clinical significance. If, in fact, remission should be the goal of ADHD 
medication treatment (Steele, et al., 2006), future research should evaluate if the Jacobson 
& Traux CS method would be too stringent a criterion to use with medicated and non-
medicated youth with ADHD and subthreshold ADHD in community samples. 
Predictors of Medication Use 
The longitudinal data used here offered the opportunity to consider predictors of 
ADHD medication use among subthreshold ADHD and probable ADHD symptom 
categories. Self-referral in childhood is rare and only a small proportion of children with 
ADHD are receiving treatment, so having ADHD does not fully explain treatment 
seeking (Angold, et al., 1998). Most notable among the findings in this study was parent 
perceived burden was predictive of ADHD medication use for youth with probable 
ADHD but significantly so for youth with subthreshold ADHD. In these data, parent 
burden more so than youth clinical factors (i.e., comorbidity and overall impairment) 
predicted medication use. This finding for subthreshold ADHD is novel and in line with 
research showing parental strain or perceived burden more than symptoms (Angold, et 
al., 1998) or comorbid conditions (including ODD and CD) (Angold, et al., 1998; 
Bauermeister, et al., 2003) is a major reason for service contact for ADHD (Farmer, 
Stangl, Burns, Costello, & Angold, 1999). Additionally, the finding that overall 
impairment was not a significant predictor of medication use for either youth with 
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subthreshold ADHD or probable ADHD was surprising, and not in line with other 
research findings (Reich, et al., 2006; Zuvekas, Vitiello, & Norquist, 2006) 
Similar to other studies, these data show being male significantly predicted 
ADHD medication use for youth with probable ADHD (Bauermeister, 2003; Gau et al., 
2010; Bussing, 2005), however, while not significant, females with subthreshold ADHD 
were more likely to take ADHD medication than males with subthreshold ADHD. This 
finding was not expected as girls, especially those with inattention problems are more 
likely to be under-referred, and less likely to be treated than boys (Hinshaw & Blachman, 
2005; Staller & Faraone, 2006). 
Study Limitations & Strengths 
As with any study, the current findings are not without limitations. The SDQ is a 
domain specific measure (assessing impairment in relation to symptoms of multiple 
disorders) (Canino, et al., 1999) so there is no way to know which symptoms, if any, are 
directly related to the reported impairment. However, using the DISC-IV (a symptom 
specific measure), was not possible because if the symptom criteria, duration criteria, or 
age of onset criteria for ADHD are not met, the functional impairment questions are 
never asked and subthreshold ADHD impairment could not be assessed. Symptom 
specific measures of impairment are needed that are not limited by those constraints. 
Additionally, domains of functioning were measured using a single SDQ item. While this 
does not allow for extensive detail, the SDQ is a well validated measure, is practical to 
administer, and captures multiple domains of functioning that can help inform 
developmental trajectory research as well as referral and service decisions. 
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The use of only parent/caregiver report is another limitation, as the DSM-IV 
recommends the use of multiple informants and the American Academy of Pediatrics 
recommends the need for both parent and teacher report of functional impairment 
(American Psychiatric Association, 2000; M. Wolraich, Brown, & Brown, 2011). 
Teacher reports of functional impairment were collected, but not used due to poor follow-
up response rates. Parent subjectivity introduces bias (e.g., underreport due to social 
desirability, over-report due to help-seeking, endorse symptoms that affect them the most, 
and may be more reliable reporters for younger children) (Barkley, 2006). While there is 
often disagreement among multiple informants and subjective bias in parent report, 
parents are thought to be crucial for a valid assessment of ADHD (Barkley, Fischer, 
Smallish, & Fletcher, 2002; Cantwell, Lewinsohn, Rohde, & Seeley, 1997). 
Symptom decreases over time might reflect true developmental changes, but also 
may be due to other things such as artifacts of repeated measurement (Hart, Lahey, 
Loeber, Applegate, & Frick, 1995) and diagnostic inadequacies (e.g., applying symptoms 
that are not developmentally sensitive) (Willoughby, 2003). Additionally, the relationship 
between symptom change and impairment in specific domains may be a function of the 
treatment or care that individuals were provided, comorbidity, or other factors. While the 
impact of such factors is not known, and the findings are constrained by unadjusted 
percents and small numbers, this study provides some of the only data available 
describing symptoms and functional impairment for youth in a community setting. 
Another limitation of this study is the number of participants lost to follow-up. If 
those individuals were less or more likely to have ADHD symptoms or to take 
medication, the findings are less likely to be representative of the initial sample. Also, 
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due to the low prevalence rate of ADHD medication use in this sample the estimates of 
these predictor variables may not be precise. Finally, as the course of ADHD and 
subthreshold ADHD is continually changing, one’s symptom and impairment status at 
baseline and follow-up may not be static and future studies exploring changes in patterns 
of ADHD symptoms and functioning are needed that use repeated observations. 
This study adds to an absence of population-based longitudinal impairment data 
of children with subthreshold ADHD who are identified in early childhood and followed 
into adolescence. While most ADHD trajectory studies consider only patterns of 
symptom change over time, this study considered patterns of change for both symptoms 
and functioning. It utilized well validated instruments, trained data collectors, and 
extensive data quality control measures. Study sampling design increased case finding 
and analysis accounted for sampling design to give unbiased estimates. It used a 
prospective design with a retention rate of 61% at follow-up. In addition to being cross 
sectional in nature, most studies focus on children, and this study followed youth up to 
age 15. This was a community-based rather than clinic-based study, which is a strength, 
as clinic-based youth are likely to have more severe symptom and functional impairments 
than youth in the community (Gau, et al., 2010) and may result in higher treatment 
seeking rates (Rowland, Lesesne, & Abramowitz, 2002). White boys account for the 
majority of research related to ADHD in youth (Hartung & Widiger, 1998 )and girls and 
African American youth are well represented in this study.  
Clinical Significance 
Improved understanding of functional improvements and declines in the 
developmental characteristics related to symptom and impairment change in individuals 
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with ADHD and individuals with subthreshold ADHD will help clinicians who advise 
caregivers on matters related to treatment course and prognosis. Impairments are 
multidimensional in nature and not static. Assessing specific domains of functioning 
helps identify impaired areas to be used for referral, intervention starting points (Sayal, 
2006) and modifications in ongoing treatment plans. Considering overall impairment 
provides a global assessment of functioning which can be clinically beneficial (Fabiano 
& Pelham, 2009), especially when considering overall degree of improvement or decline 
over time. In addition to helping define intervention needs and to show functional change 
over time, the SDQ impact supplement is a useful measure of difficulties prompting 
caregivers to seek help for their children and their impact (Ford, Hutchings, Bywater, 
Goodman, & Goodman, 2009). This study highlights the need for clinicians to consider 
diagnosis in a nuanced way, paying particular attention to unique individual changes in 
both symptom and functioning over time. 
Logistic regression findings underscore the importance of understanding child and 
family factors associated with taking ADHD medication. Prior work has not included 
parent perception of burden when assessing risk factors of medication use for youth with 
subthreshold ADHD. Identifying parent burden provides an opportunity for clinicians to 
discuss parental perceptions of burden and address parent support needs alongside  
discussion and consideration regarding medication therapy need. Additionally the 
identified significant predictors of medication use are child and family factors that are not 
difficult for clinicians to ascertain and add to the small existing data available in the 
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Table 4.5 Demographics of Sample by Baseline ADHD Status; 
                 Raw Frequencies and Weighted Percents 
 
  Subthreshold Cases Probable cases 
  N % N % 
Total 84 100.0 186 100.0 
Age in years (mean, range) 9.5 (5-12) 9.4 (5-13) 
Gender     
 Boys 59 65.0 128 60.2 
 Girls 25 35.0 58 39.8 
Race/Ethnicity     
 Non-Hispanic White 49 46.7 101 39.8 
 Non-Hispanic Black 34 51.4 69 55.6 
 Other 1 1.9 16 4.7 
Insurance     
 None 12 16.7 13 8.1 
 Private insurance 45 54.1 113 66.2 
 Medicaid 24 29.2 45 25.8 
CD/ODD     
 Yes 13 17.9 72 34.6 
 No 70 82.2 114 65.5 
ADHD medication     
 Yes 21 19.1 109 42.1 
 No 63 80.9 77 57.9 
Parent mental health history     
 Yes 14 18.6 53 24.3 
 No 69 81.4 122 75.7 
Parent education level     
 Less than bachelors degree 54 59.4 120 62.8 




Table 4.6 Baseline to Follow-up Symptom Change and Corresponding SDQ  
                 Impairment Change (Functionally Improved) by Medication Status 
 
 Subthreshold at Baseline (n=46) 
 Medicated year prior to follow-up (n=14) 
 Decrease in sx (non-
ADHD at follow-up) 
No change in sx 
(subthreshold ADHD 
at follow-up) 




 (n=2) (n=6) (n=6) 
Baseline SDQ Impairment % who improved 
functionally (95% CI) 
% who improved 





Distress/intrapersonal 14.2 (1.2, 68.5) 25.2 (6.3, 62.8) 56.5 (23.7, 
84.5) 
Home life 0.0 0.0 18.0 (3.2, 59.3) 
Friendships 14.2 (1.2, 68.5) 0.0 35.0 (10.6, 
70.8) 
Classroom learning 0.0 12.9 (2.1, 51.0) 72.8 (36.4, 
92.6) 
Leisure activities 0.0 0.0 0.0 
Total impairment 0.0 24.0 (6.0, 61.0) 18.0 (3.2, 59.3) 
 Not Medicated year prior to follow-up (n=32) 
 Decrease in sx (non-
ADHD at follow-up) 
No change in sx 
(subthreshold ADHD 
at follow-up) 




 (n=11) (n=9) (n=12) 
Baseline SDQ Impairment % who improved 
functionally (95% CI) 
% who improved 





Distress/intrapersonal 0.0 15.3 (3.8, 45.5) 28.6 (9.8, 59.7) 
Home life 2.2 (0.4, 12.6) 38.6 (9.7, 78.6) 20.3 (6.0, 50.5) 
Friendships 0.0 27.1 (8.1, 60.9) 21.9 (5.8, 56.1) 
Classroom learning** 0.0 18.1 (4.7, 50.0) 54.0 (25.0, 
80.5) 
Leisure activities 0.0 21.5 (6.5, 52.1) 41.3 (14.5, 
74.5) 
Total impairment** 0.0 56.7 (23.6, 84.8) 55.2 (26.1, 
81.1) 
 
** p < .01 for Chi-square analyses 





Table 4.7 Baseline to Follow-up Symptom Change and Corresponding SDQ  
                 Impairment Change (Functionally Improved) by Medication Status 
 
 ADHD at baseline (n=103) 
 Medicated year prior to follow-up (n=58) 
 Decrease in sx 
(non-ADHD at 
follow-up) 
Decrease in sx 
(subthreshold ADHD 
at follow-up) 
No change in sx 
(probable 
ADHD cases at 
follow-up) 
 (n=4) (n=11) (n=43) 
Baseline SDQ 
Impairment 
% who improved 
functionally (95% 
CI) 
% who improved 
functionally (95% CI) 
% who improved 
functionally 
(95% CI) 
Distress/intrapersonal 51.0 (15.5, 85.6) 17.6 (3.3, 57.3) 17.2 (9.1, 30.1) 
Home life 31.1 (5.8, 76.7) 7.3 (1.3, 32.7) 19.5 (10.6, 32.9) 
Friendships 31.1 (5.8, 76.7) 37.3 (14.7, 67.2) 21.9 (12.6, 35.2) 
Classroom learning 0.0 7.0 (1.2, 32.1) 18.7 (8.4, 36.5) 
Leisure activities 55.3 (17.9, 87.5) 32.5 (11.6, 63.7) 19.6, 10.8, 32.8) 
Total impairment 0.0 0.0 18.8 (8.3, 37.0) 
 Not Medicated year prior to follow-up (n=45) 
 Decrease in sx 
(non-ADHD at 
follow-up) 
Decrease in sx 
(subthreshold 
ADHD at follow-up) 
No change in sx 
(probable 
ADHD cases at 
follow-up) 
 (n=9) (n=11) (n=25) 
Baseline SDQ 
Impairment 
% who improved 
functionally (95% 
CI) 
% who improved 
functionally (95% CI) 
% who improved 
functionally 
(95% CI) 
Distress/intrapersonal 14.3 (3.3, 44.8) 35.4 (10.4, 72.0) 8.0 (2.4, 23.0) 
Home life 6.1 (0.9, 31.7) 4.3 (0.7, 22.4) 14.2 (2.6, 51.1) 
Friendships 16.7 (4.3, 47.1) 16.0 (3.3, 51.1) 16.5 (6.9, 34.7) 
Classroom learning 6.1 (0.9, 31.7) 0.0 16.0 (6.8, 33.4) 
Leisure activities 14.3 (3.3, 44.8) 21.1 (5.7, 54.2) 7.7 (2.4, 22.1) 
Total impairment 8.6 (1.8, 32.4) 0.0 11.1 (4.1, 27.0) 
 
** p < .01 for Chi-square analyses 




Table 4.8 Baseline to Follow-up Symptom Change and Corresponding SDQ  
                 Impairment Change (Functionally Declined) by Medication Status 
 
 Subthreshold at Baseline (n=46) 
 Medicated year prior to follow-up (n=14) 
 Decrease in sx (non-
ADHD at follow-up) 
No change in sx 
(subthreshold at 
follow-up) 
Increase in sx 
(probable cases 
at follow-up) 
 (n=2) (n=6) (n=6) 
Baseline SDQ 
Impairment 
% who declined 
functionally (95% CI) 
% who declined 
functionally (95% CI) 
% who declined 
functionally 
(95% CI) 
Distress/intrapersonal 85.8 (31.5, 98.8) 62.5 (25.9, 88.9) 43.5 (15.5, 76.3) 
Home life 85.8 (31.5, 98.8) 11.1 (1.7, 47.0) 25.5 (6.9, 61.2) 
Friendships 85.8 (31.5, 98.8) 74.8 (37.2, 93.7) 21.6 (4.0, 64.7) 
Classroom learning 14.2 (1.2, 68.5) 64.3 (27.5, 89.5) 27.2 (7.4, 63.6) 
Leisure activities 0.0 53.2 (18.2, 85.3) 37.8 (11.8, 73.5) 
Total impairment 14.2 (1.2, 68.5) 49.7 (15.5, 84.2) 27.2 (7.4, 63.6) 
 Not Medicated year prior to follow-up (n=32) 
 Decrease in sx (non-
ADHD at follow-up) 
No change in sx 
(subthreshold 
ADHD at follow-up) 
Increase in sx 
(probable 
ADHD cases at 
follow-up) 
 (n=11) (n=9) (n=12) 
Baseline SDQ 
Impairment 
% who declined 
functionally (95% CI) 
% who declined 
functionally (95% CI) 
% who declined 
functionally 
(95% CI) 
Distress/intrapersonal* 69.5 (30.6, 92.1) 49.3 (17.4, 81.7) 17.8 (4.9, 47.9) 
Home life 47.1 (18.7, 77.5) 16.2 (3.6, 50.0) 33.0 (9.1, 70.9) 
Friendships 23.1 (8.0, 50.7) 49.3 (17.4, 81.7) 14.3 (3.5, 43.4) 
Classroom learning 74.6 (42.3, 92.2) 43.3 (15.3, 76.4) 29.3 (10.2, 
60.0) 
Leisure activities 25.3 (9.3, 53.0) 57.6 (24.6, 85.0) 28.4 (9.9, 58.7) 
Total impairment 33.6 (10.7, 68.0) 9.8 (1.6, 42.0) 18.3 (5.5, 46.2) 
** p < .01 for Chi-square analyses 





Table 4.9 Baseline to Follow-up Symptom Change and Corresponding SDQ  
                 Impairment Change (Functionally Declined) by Medication Status 
 
 ADHD at baseline (n=103) 
 Medicated year prior to follow-up (n=58) 
 Decrease in sx 
(non-ADHD at 
follow-up) 
Decrease in sx 
(subthreshold ADHD 
at follow-up) 
No change in sx 
(probable 
ADHD cases at 
follow-up) 
 (n=4) (n=11) (n=43) 
Baseline SDQ 
Impairment 
% who declined 
functionally (95% 
CI) 
% who declined 
functionally (95% CI) 
% who declined 
functionally 
(95% CI) 
Distress/intrapersonal 49.0 (14.4, 84.5) 36.3 (15.5, 63.8) 38.6 (23.1, 56.7) 
Home life 49.0 (14.4, 84.5) 43.2 (18.9, 71.4) 35.5 (21.0, 53.3) 
Friendships 68.9 (23.3, 94.2) 26.3 (10.3, 52.7) 30.1 (16.5, 48.3) 
Classroom learning 44.8 (12.5, 82.1) 57.9 (29.0, 82.2) 30.9 (17.4, 48.7) 
Leisure activities 24.9 (4.3, 70.8) 24.1 (8.4, 52.5) 32.7 (20.2, 48.4) 
Total impairment 24.9 (4.3, 70.8) 13.9 (3.9, 39.0) 23.4 (11.2, 42.3) 
 Not Medicated year prior to follow-up (n=45) 
 Decrease in sx 
(non-ADHD at 
follow-up) 
Decrease in sx 
(subthreshold ADHD 
at follow-up) 
No change in sx 
(probable 
ADHD cases at 
follow-up) 
 (n=9) (n=11) (n=25) 
Baseline SDQ 
Impairment 
% who declined 
functionally (95% 
CI) 
% who declined 
functionally (95% CI) 
% who declined 
functionally 
(95% CI) 
Distress/intrapersonal* 77.6 (46.2, 93.4) 59.5 (25.1, 86.6) 27.4 (13.2, 48.5) 
Home life 44.2 (11.8, 82.4) 41.0 (12.7, 76.9) 52.8 (27.6, 76.7) 
Friendships* 61.6 (24.1, 89.1) 23.0 (7.0, 54.5) 18.8 (8.4, 36.7) 
Classroom learning 49.4 (14.1, 85.3) 83.4 (59.7, 94.5) 52.6 (27.4, 76.5) 
Leisure activities** 85.7 (55.2, 96.7) 6.2 (1.4, 23.1) 56.7 (31.2, 79.1) 
Total impairment 36.0 (7.9, 78.6) 52.5 (20.4, 82.6) 43.9 (19.6, 71.5) 
** p < .01 for Chi-square analyses 




Table 4.10 Results of Multivariate Logistic Regression for Prediction of ADHD  
                  Medication Use 
 
  OR (95% Confidence Interval) p value 
Independent 
Variables 
  Subthreshold ADHD 
cases 
  Probable ADHD cases 
Overall impairment      
 Abnormal 0.5 (0.1, 2.2) 0.37  1.4 (0.5, 3.4) 0.51 
 Normal/borderline 1.0 -  1.0 - 
Parent perceived burden      
 Medium amount/ 
great deal 
5.5 (1.3, 23.7) 0.02  1.8 (0.7, 4.6) 0.19 
 Not at all, a little 1.0 -  1.0 - 
CD or ODD      
 Yes 2.5 (0.7, 9.9) 0.18  1.2 (0.5, 2.5) 0.72 
 No 1.0 -  1.0 - 
Gender      
 Female 1.4 (0.5, 4.5) 0.54  0.4 (0.2, 0.8) <0.01 
 Male 1.0 -  1.0 - 
 
CD, conduct disorder; ODD, oppositional defiant disorder 
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Chapter 5  
DISCUSSION 
This study considered patterns of symptom and functional impairment change and 
predictors of severe impairment and medication use among children in the community 
with probable ADHD, subthreshold ADHD, and children without ADHD transitioning 
from childhood to adolescence. This chapter revisits the study aims as a framework for 
providing a summary and discussion of the pertinent results and conclusions of this study. 
This chapter also covers a discussion of study implications, an acknowledgement of 
inherent study limitations, strengths, and implications for future research and practice. 
RELATED PREVIOUS RESEARCH FINDINGS, MAIN RESULTS, IMPLICATIONS 
Research Aims I & III:  Aim I: To examine patterns of change between symptoms and 
functional among youth with ADHD, with subthreshold ADHD and without ADHD 
across two time-points; Research Aim III:  To examine patterns of symptom and 
functional impairment change from baseline to follow-up for youth with subthreshold 
ADHD and youth with ADHD based on treatment status [taking ADHD medication 
versus not taking ADHD medication within the last year]. 
Striving to make meaningful sense of patterns of symptom and impairment 
trajectories is an important endeavor for the many  reasons including: (1) ADHD and 
subthreshold ADHD are highly prevalent conditions; (2) The significant long-term 
functionally impairing nature of the disorder; (3) ADHD is under-diagnosed and 
undertreated; (4) Research shows impairment rather than symptoms are the main reason 
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for treatment referrals (Owens, Johannes, & Karpenko, 2009); and, (5) Federal agencies 
have adopted impairment criteria for access to treatment and services and individuals 
with subthreshold ADHD are unlikely to qualify for services (Bussing, Mason, Bell, 
Porter, & Garvan, 2010). 
The analysis portion of the review of the literature revealed two studies which 
investigated whether function could normalize for youth, and found that the 
developmental trajectory of ADHD is often associated with inconsistent function 
(Biederman et al., 1996; Mick et al., 2011). These studies included subclinical groups 
with the ADHD groups and were unable to distinguish functional trajectories of youth 
with subclinical ADHD. Additionally, global assessment of impairment did not allow for 
domain specific assessment of functional impairment. 
Young & Gudjonsson (2008) retrospectively demonstrated individuals continued 
to experience functional impairment even though they no longer meet full diagnostic 
symptom criteria. Using cross-sectional data, Scahill found children with subthreshold 
ADHD were significantly less impaired than children with ADHD, but significantly more 
impaired than children without ADHD and demonstrated the usefulness of treating 
ADHD dimensionally rather than categorically (Scahill et al., 1999). In line with both 
Young & Gudjonsson and Scahill, all three studies that did meet inclusion criteria in the 
analysis review of the literature also demonstrated that youth with subclinical ADHD 
who no longer met symptom count criteria continued to suffer from impairment 
(Biederman, Mick, & Faraone, 2000; Bussing, et al., 2010; Faraone, et al., 2006).  
The studies mentioned above, were constrained methodologically for at least one 
of the following reasons: not including a subclinical group; use of retrospective recall; 
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use of cross-sectional data; or not providing detailed information related to percentages of 
individuals who make reliable improvement in functioning but not symptoms and visa 
versa. Correspondence studies identified in the literature, while they did not meet all of 
the analysis review criteria, made a compelling case for using similar methodology to 
uncover symptom and functioning developmental trajectories (Karpenko, Owens, 
Evangelista, & Dodds, 2009; Owens, et al., 2009; Rosenblatt & Rosenblatt, 2002) among 
youth with subthreshold ADHD to compared to youth with and without ADHD in this 
study. 
The Owens et al. study highlighted a need for research that considers profiles of 
children who show no change in symptoms or a reduction in symptoms (Owens, et al., 
2009). The Karpenko study pinpointed a need to compare nontreated individuals with 
treated individuals when considering corresponding symptom and impairment, as they 
did not consider nontreated individuals (a limitation of using the MTA dataset) 
(Karpenko, et al., 2009). These studies also contributed to an understudied area in ADHD 
research; the relation between patterns of change in symptoms and change in function 
(Owens, et al., 2009). Given the potential importance of subthreshold ADHD and the 
almost complete absence of longitudinal research on this subcategory of ADHD, the 
literature review analysis helped identify gaps in the current literature that this study was 
designed to address. 
Further, it is not clear from the literature if youth with subthreshold ADHD who 
are unmedicated fare particularly worse over time compared to individuals with 
subthreshold ADHD who are taking ADHD medication. To our knowledge, there are no 
published studies that have examined how medication use within the context of ADHD 
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and subthreshold ADHD unfolds with regard to patterns of symptom and impairment 
change. This study sought to discern prospective patterns of symptoms and functional 
impairment change in a community sample for youth with subthreshold ADHD and youth 
with ADHD depending on medication status (taking medication versus not taking 
medication). 
This study is a novel extension to previous RCI studies examining the relationship 
between change in symptoms and reliable change in functioning and considered 
longitudinal data from the South Carolina Project to Learn about ADHD in Youth 
(SCPLAY). Findings from RCI and chi square analyses showed a trend among baseline 
youth with subthreshold ADHD or probable ADHD who were not medicated the year 
prior to follow-up and who were subthreshold ADHD or non-ADHD cases at follow-up; 
that decreasing symptoms are associated with functional decline. This may be explained 
by research suggesting that although symptoms tend to diminish over time, symptom 
declines do not necessarily result in a return to normal function (Willoughby, 2003). 
Further, impairment may increase over time as demands increase and through an additive 
process; with impairment becoming become more noticeable as children age and acquire 
more autonomy (Adler, et al., 2008). 
While most ADHD medication treatment studies only consider symptom change, 
a review of the literature including studies assessing improvements in functioning found 
medication use versus no medication use is associated with greater rates of symptom 
remission and increased social and academic functioning (Steele, et al., 2006). While 
these study findings show evidence of improvements in functioning with medication use, 
findings here show youth with subthreshold ADHD at baseline and medicated the year 
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prior to follow-up tended to decline functionally to a greater degree in four out of five 
domains of functioning and overall functioning compared to youth with subthreshold 
ADHD at follow-up who were not medicated. Individuals presenting with severe 
impairment may be show less overall improvement in functional impairment measures 
over time. Additionally, medication treatment compliance may be as low as 50% in 
children with ADHD (Johnston & Fine, 1993) which may result in poor management of 
symptoms and functioning (Perwien, et al., 2004). 
It should not be assumed that a reduction in symptoms equates with a reduction in 
impairment; nor should it be assumed that if a child continues to meet symptom criteria 
for ADHD that he/she is impaired by the disorder’s symptoms (Owens, et al., 2009). It is 
well documented that symptomatic remission does not equate with recovery of function 
(Biederman, 2011; Gordon et al., 2006; S.P. Hinshaw, Owens, Sami, & Fargeon, 2006; 
Mick, Faraone, & Biederman, 2004). Identifying children who make reliable change in 
both symptom and impairment change, as well as those who make change in one but not 
the other is an important distinction (Owens, et al., 2009). For research, referral, 
treatment, and intervention purposes it is important to identify children and adolescents 
who fail to meet symptom count criteria for ADHD or who fail to achieve full remission 
but continue to struggle with functional burden. Additionally, because subthreshold 
childhood ADHD symptoms predict the presentation of adolescent ADHD (Bussing, et 
al., 2010) a better understanding of the relationship between patterns between symptom 
and impairment change, especially among youth with subthreshold ADHD is warranted 
and is useful in identifying targets for early intervention. 
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Research Aim II:  To examine baseline demographic and psychiatric variables (child 
factors: age, gender, comorbidity, medication; family factors: exposure to parental 
psychopathology, primary parents educational attainment, marital status) 
associated with severe levels of functional impairment at follow-up. 
As discussed in Chapter 2, a review of the literature revealed few studies 
exploring predictors of impaired functioning among youth with ADHD. Though not well 
understood, a number of child and family risk factors have been explored. Child-related 
factors including (Gathje, Lewandowski, & Gordon, 2008), higher levels of comorbidity, 
increased impulsive symptoms (Biederman, Mick, & Faraone, 1998) and treatment use 
(Molina et al., 2009) were found to be associated with impaired functioning. Researchers 
analyzing ADHD symptoms most associated with impairment showed symptom 
prevalence or subtype distinctions are inadequate in predicting impairment (Mota & 
Schachar, 2000). 
Family factors associated with functioning among ADHD youth cited in the 
ADHD literature include: maternal psychopathology (Biederman, et al., 1998), social 
advantage (Molina, et al., 2009), and marital status (Healey, Gopin, Grossman, Campbell, 
& Halperin, 2010). No study was found examining predictors of impairment for youth 
with subthreshold ADHD. Given that subthreshold ADHD may follow a very similar 
impairment trajectory as ADHD that is likely to persist, the current study address this gap 
in the literature and exploring predictors associated with more severe forms of ADHD 
impairment to see if they were similar for youth with ADHD and youth with subthreshold 
ADHD the current study. 
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Findings showed probable ADHD and subthreshold ADHD did not share any 
significant predictors in common. This was an expected finding based on the supposition 
that subthreshold youth would share a similar impairment predictor profile as ADHD 
youth. ADHD medication use and primary parent psychiatric history in the non-ADHD 
model; gender in the subthreshold model, and psychiatric comorbidity in the probable 
ADHD case model were all found to be predictors of severe impairment. These findings 
may be relevant to efforts to intervene earlier in childhood and to help identify high-risk 
individuals who may be good candidates for targeted interventions. 
Research Aim III:  To examine baseline demographic and psychiatric variables (child 
factors: impairment, gender, race, age, comorbidity; family factors: parent reported 
burden, insurance, parent educational level, exposure to parental psychopathology) 
that are associated with ADHD medication use at  follow-up. 
A review of the literature showed several studies that examined predictors of 
treatment utilization for youth with ADHD and only a few studies that examined 
predictors of treatment utilization for youth with subthreshold ADHD. Service contact for 
ADHD is often made because of parent’s perception of problems (perceived burden) or 
parental strain rather than child factors such as comorbidity (Angold et al., 1998; Bussing 
et al., 2003; Sayal, 2006). Additional predictors of treatment seeking and service use for 
children with ADHD include male gender (Beuermeister, 2003; Gau et al., 2010; 
Bussing, 2005), maternal education (college or higher) (Gau et al., 2010), parental mental 
health history, marital status (divorced) (Jensen, Bloedau, and Davis, 1990) and younger 
age (Leslie et al., 2005). 
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Among the few studies considering a subclinical ADHD group, two studies found 
subclinical ADHD predicted stimulant medication use (Bauermeister et al., 2003; Leslie, 
et al., 2005). Reich et al. found that among comparison children, ADHD symptom counts 
and presence of impaired functioning were significant treatment correlates (Reich, 
Huang, & Todd, 2006). Similarly, Angold et al. found among the subclinical group, 
stimulant medication use was significantly related to level of symptoms and was more 
common in individuals with a diagnosis of ODD (Angold, Erkanli, Egger, & Costello, 
2000). No studies were found examining parent perceived burden as a predictor of 
medication use for youth with subthreshold ADHD. 
The longitudinal data used here offered the opportunity to consider predictors of 
ADHD medication use among subthreshold ADHD and probable ADHD symptom 
categories. Most notable among the findings was that parent perceived burden was 
predictive of ADHD medication use for youth with probable ADHD but significantly so 
for youth with subthreshold ADHD. In these data, parent burden more so than youth 
clinical factors (i.e., comorbidity and overall impairment) predicted medication use. This 
finding for subthreshold ADHD is novel and in line with research showing parental strain 
or perceived burden more than symptoms (Angold, et al., 1998) or comorbid conditions 
(including ODD and CD) (Angold, et al., 1998; Bauermeister, et al., 2003) is a major 
reason for service contact for ADHD (Farmer, Stangl, Burns, Costello, & Angold, 1999). 
Similar to other studies, these data show being male significantly predicted 
ADHD medication use for youth with probable ADHD (Bauermeister, 2003; Gau et al., 
2010; Bussing, 2005), however, while not significant, females with subthreshold ADHD 
were more likely to take ADHD medication than males with subthreshold ADHD. This 
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finding was not expected as girls, especially those with inattention problems are more 
likely to be under-referred, and less likely to be treated than boys (Stephen P. Hinshaw & 
Blachman, 2005; Staller & Faraone, 2006). 
Findings underscore the importance of understanding child and family factors 
associated with taking ADHD medication. Identifying parent burden provides an 
opportunity for clinicians to discuss parental perceptions of burden and address parent 
support needs alongside a discussion and consideration of medication therapy. 
Additionally the identified significant predictors of medication use are child and family 
factors that are not difficult for clinicians to ascertain and add to the small existing data 
available in the literature on this subject. 
Possible Areas of Future Research 
This study focused on five important domains of functioning (child distress, home 
life, friendships, classroom learning, and leisure activities) and used the first follow-up 
wave of four waves. Further investigation of these issues is warranted in teens 
transitioning into high school and young adulthood. A consideration of multiple time 
points using this same methodology is also warranted. 
In the present study we calculated a reliable change index (RCI) (Jacobson and 
Truax, 1991) to determine statistically significant impairment change. RCI should not be 
confused with clinical significance which is often defined as a return to normal 
functioning (Jacobson, Roberts, Berns, & McGlinchey, 1999). With the understanding 
that ADHD is a persistent neurobiological disorder, further tests of clinical significance 
were not performed. Future research should consider if the two-method approach put 
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forth by Jacobson & Traux would be too stringent a criterion to use with ADHD and 
subthreshold ADHD populations. 
STUDY STRENGTHS & LIMITATIONS 
This study adds to an absence of population-based longitudinal impairment data 
of children with subthreshold ADHD who are identified in early childhood and followed 
into adolescence. While most ADHD trajectory studies consider only patterns of 
symptom change over time, this study considered patterns of change for both symptoms 
and functioning. It utilized well validated instruments, trained data collectors, and 
extensive data quality control measures. Study sampling design increased case finding 
and analysis accounted for sampling design to give unbiased estimates. It used a 
prospective design with a retention rate of 61% at follow-up. In addition to being cross 
sectional in nature, most studies focus on children, and this study followed youth up to 
age 15. This was a community-based rather than clinic-based study, which is a strength, 
as clinic-based youth are likely to have more severe symptom and functional impairments 
than youth in the community (Gau, et al., 2010) and may result in higher treatment 
seeking rates (Rowland, Lesesne, & Abramowitz, 2002). White boys account for the 
majority of research related to ADHD in youth (Hartung & Widiger, 1998 )and girls and 
African American youth are well represented in this study.  
This study is not without limitations. The SDQ is not a symptom-specific measure 
(assessing impairment in relation to a specific symptom or diagnosis) (Canino, Costello, 
& Angold, 1999) so there is no way to know which symptoms, if any, are directly related 
to the reported impairment. However, using the DISC-IV (a symptom specific measure), 
was not possible because if the symptom criteria, duration criteria, or age of onset criteria 
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for ADHD are not met, the impairment questions are never asked and subthreshold 
impairment and control children’s impairment could not be assessed. Using the 
standardized diagnostic interview (DISC-IV) alone, would not have allowed for a 
consideration of subthreshold youth and youth without ADHD. Symptom specific 
measures are needed that are not constrained by this limitation. 
The use of only parent/caregiver report is another limitation, as the DSM-IV 
recommends the use of multiple informants and the American Academy of Pediatrics 
recommends the need for both parent and teacher report of functional impairment 
(American Psychiatric Association, 2000; Wolraich, Brown, & Brown, 2011). Teacher 
reports of functional impairment were collected, but due to poor response rates, not used. 
Parent subjectivity may also be biased (e.g., underreport due to social desirability, over-
report due to help-seeking, endorse symptoms that affect them the most, and may be 
more reliable reporters for younger children) (Barkley, 2006). While there is often 
disagreement among multiple informants and subjective bias in parent report, parents are 
thought to be crucial for a valid assessment of ADHD (Barkley, Fischer, Smallish, & 
Fletcher, 2002; Cantwell, Lewinsohn, Rohde, & Seeley, 1997). 
Symptom decreases over time might reflect true developmental changes, but also 
may be due to other things such as artifacts of repeated measurement (Hart, et al., 1995) 
and diagnostic inadequacies (e.g., applying symptoms that are not developmentally 
sensitive (Willoughby, 2003). Additionally, the relationship between symptom change 
and impairment in specific domains may be a function of the treatment or care that 
individuals were provided, comorbidity, or other factors. While the impact of those things 
is not known, and the findings are constrained by unadjusted percents and small numbers, 
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this represents some of the only data available describing symptoms and functional 
impairment for youth in a community setting. 
Another limitation of this study is the proportion of baseline participants lost to 
follow-up. If those individuals were less likely to have ADHD symptoms or more likely 
to have ADHD symptoms or to take medication or not take medication, for example, the 
findings are less likely to be representative of the initial sample. Also, due to the low 
prevalence rate of ADHD medication use in this sample the estimates of these predictor 
variables may not be precise. Finally, as the course of ADHD and subthreshold ADHD is 
continually changing, one’s symptom and impairment status at baseline and follow-up 
may not be static and future studies exploring changes in patterns of ADHD symptoms 
and impairment are needed that use repeated observations. 
CONCLUSIONS 
The overall results of this study speak to the importance of identifying individuals 
who may not experience chronically elevated symptom levels over time but who continue 
to experience significant impairments associated with ADHD diminished symptom 
counts. Applying the Jacobson & Traux method to these data demonstrates a useful 
method for identifying individuals who are at risk for poor developmental outcomes. For 
example, despite decreasing symptom counts among youth with ADHD at baseline, 20% 
of those who fell into the subthreshold category at follow-up were significantly impaired 
in at least one functional domain. This study also identified a minority of children with 
ADHD and subthreshold ADHD who despite elevated or increasing symptoms over time 
were not reported to have troublesome functional impairment. This investigation supports 
the argument for using an alternative to narrowly dichotomizing ADHD. It is hoped that 
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through a more careful consideration of symptom and impairment profiles resources can 
be targeted to help children and adolescents with ADHD and subthreshold ADHD lead 
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APPENDIX B – STUDY CONCEPTUAL MODEL 
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APPENDIX C – DIAGNOSTIC CRITERIA FOR ADHD 
Diagnostic Criteria for ADHD (taken from the Diagnostic and Statistical Manual of 
Mental Disorders, 4th Ed. (DSM-IV). American Psychiatric Association, 1994) 
 
A.  Either 1 or 2 
    1)  Six (or more) of the following symptoms of inattention have persisted for at least 6 months 
to a degree that is maladaptive and inconsistent with developmental level: 
Inattention 
        a) Often fails to give close attention to details or makes careless mistakes in schoolwork, 
work, or other activities 
        b) Often has difficulty sustaining attention in tasks or play activities 
        c) Often does not seem to listen when spoken to directly 
        d)  Often does not follow through on instructions and fails to finish schoolwork, chores, or 
duties in the workplace (not due to oppositional behavior or failure to understand instructions) 
        e) Often has difficulty organizing tasks and activities 
        f) Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort 
(such as schoolwork or homework) 
        g) Often loses things necessary for tasks or activities (eg, toys, school assignments, pencils, 
books, or tools) 
        h) Is often easily distracted by extraneous stimuli 
        i) Is often forgetful in daily activities 
    2)  Six (or more) of the following symptoms of hyperactivity-impulsivity have persisted for at 
least 6 months to a degree that is maladaptive and inconsistent with developmental level: 
Hyperactivity 
        a) Often fidgets with hands or feet or squirms in seat 
        b) Often leaves seat in classroom or in other situations in which remaining seated is expected 
        c) Often runs about or climbs excessively in situations in which it is inappropriate (in 
adolescents or adults, may be limited to subjective feelings of restlessness) 
        d)  Often has difficulty playing or engaging in leisure activities quietly 
        e) Is often "on the go" or often acts as if "driven by a motor" 
        f) Often talks excessively 
Impulsivity 
        g) Often blurts out answers before questions have been completed 
        h) Often has difficulty awaiting turn 
        i) Often interrupts or intrudes on others (eg, butts into conversations or games) 
B.  Some hyperactive-impulsive or inattentive symptoms that caused impairment were present 
before 7 years of age. 
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C.  Some impairment from the symptoms is present in 2 or more settings (eg, at school [or work] 
or at home). 
D.  There must be clear evidence of clinically significant impairment in social, academic, or 
occupational functioning. 
E.  The symptoms do not occur exclusively during the course of a pervasive developmental 
disorder, schizophrenia, or other psychotic disorder and are not better accounted for by another 
mental disorder (eg, mood disorder, anxiety disorder, dissociative disorder, or personality 
disorder). 
Code based on type: 
314.01  Attention-Deficit/Hyperactivity Disorder, Combined Type: if both criteria A1 and A2 
are met for the past 6 months 
314.00  Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type: if 
criterion A1 is met but criterion A2 is not met for the past 6 months 
314.01  Attention-Deficit/Hyperactivity Disorder, Predominantly Hyperactive, Impulsive 
Type: if criterion A2 is met but criterion A1 is not met for the past 6 months 
314.9    Attention-Deficit/Hyperactivity Disorder Not Otherwise Specified 
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(Modified from: Figure 1: Project to Learn about Attention-Deficit/Hyperactivity Disorder in Youth Screening and Case Ascertainment Flowchart )
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